Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
104 "Stomach"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Article image
Association study of TYMS gene expression with TYMS and ENOSF1 genetic variants in neoadjuvant chemotherapy response of gastric cancer
Khadijeh Arjmandi, Iman Salahshourifar, Shiva Irani, Fereshteh Ameli, Mohsen Esfandbod
J Pathol Transl Med. 2025;59(2):105-114.   Published online February 25, 2025
DOI: https://doi.org/10.4132/jptm.2024.11.05
  • 3,175 View
  • 141 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDF
Background
The present research was designed to study the associations between genetic variants of TYMS and ENOSF1 genes with TYMS and ENOSF1 gene expression in neoadjuvant chemotherapy response among patients with gastric cancer. Methods: Formalin-embedded and paraffin-fixed matched tumor and normal gastric cancer tissue samples from patients who received neoadjuvant 5-fluorouracil (5-FU) treatment were obtained. DNA and RNA were extracted for all samples. A 28-bp variable number tandem repeat (VNTR) at the 5' untranslated region of TYMS gene and rs2612091 and rs2741171 variants in the ENOSF1 gene were genotyped for normal tissue samples. The real-time polymerase chain reaction method was used to study the expression of ENOSF1 and TYMS genes in both normal and tumor tissues. Data were analyzed using REST 2000 and SPSS ver. 26.0 software programs. Results: A significant association between TYMS 2R3R VNTR genotypes and 5-FU therapy was found (p = .032). The 3R3R and 2R2R genotypes were significantly associated with increased and decreased survival time, respectively (p = .003). The 3R3R genotype was significantly associated with TYMS overexpression (p < .001). Moreover, a significant association was found between the rs2612091 genotype and treatment outcome (p = .017). Conclusions: This study highlights the impact of TYMS and ENOSF1 genes as predictive indicators for survival and response to 5-FU–based neoadjuvant chemotherapy in gastric cancer patients.

Citations

Citations to this article as recorded by  
  • Innovative biomaterial strategies for mitigating radiotherapy toxicity: multidimensional mechanistic interventions of nano-microscale materials and hydrogels
    Yifan Liu, Fengdi Jiang, Jie Song, Huaijin Qiao, Junlong Dai, Hao Bai, Shuyu Zhang
    Coordination Chemistry Reviews.2026; 549: 217313.     CrossRef
Review
Article image
A standardized pathology report for gastric cancer: 2nd edition
Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi, Hee Kyung Chang, Soomin Ahn, Mee Soo Chang, Song-Hee Han, Yoonjin Kwak, An Na Seo, Sung Hak Lee, Mee-Yon Cho
J Pathol Transl Med. 2023;57(1):1-27.   Published online January 15, 2023
DOI: https://doi.org/10.4132/jptm.2022.12.23
  • 34,210 View
  • 1,526 Download
  • 22 Web of Science
  • 19 Crossref
AbstractAbstract PDFSupplementary Material
The first edition of ‘A Standardized Pathology Report for Gastric Cancer’ was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago. Since then, significant advances have been made in the pathologic diagnosis, molecular genetics, and management of gastric cancer (GC). To reflect those changes, a committee for publishing a second edition of the report was formed within the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. This second edition consists of two parts: standard data elements and conditional data elements. The standard data elements contain the basic pathologic findings and items necessary to predict the prognosis of GC patients, and they are adequate for routine surgical pathology service. Other diagnostic and prognostic factors relevant to adjuvant therapy, including molecular biomarkers, are classified as conditional data elements to allow each pathologist to selectively choose items appropriate to the environment in their institution. We trust that the standardized pathology report will be helpful for GC diagnosis and facilitate large-scale multidisciplinary collaborative studies.

Citations

Citations to this article as recorded by  
  • Spatial and Temporal Tumor Heterogeneity in Gastric Cancer: Discordance of Predictive Biomarkers
    Hye Seung Lee
    Journal of Gastric Cancer.2025; 25(1): 192.     CrossRef
  • PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
    Yunjoo Cho, Soomin Ahn, Kyoung-Mee Kim
    Journal of Gastric Cancer.2025; 25(1): 177.     CrossRef
  • Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2023
    Dong Jin Kim, Jeong Ho Song, Ji-Hyeon Park, Sojung Kim, Sin Hye Park, Cheol Min Shin, Yoonjin Kwak, Kyunghye Bang, Chung-sik Gong, Sung Eun Oh, Yoo Min Kim, Young Suk Park, Jeesun Kim, Ji Eun Jung, Mi Ran Jung, Bang Wool Eom, Ki Bum Park, Jae Hun Chung, S
    Journal of Gastric Cancer.2025; 25(1): 115.     CrossRef
  • A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines: 2024 Update
    Sang Soo Eom, Keun Won Ryu, Hye Sook Han, Seong-Ho Kong
    Journal of Gastric Cancer.2025; 25(1): 153.     CrossRef
  • Korea, Japan, Europe, and the United States: Why are guidelines for gastric cancer different?
    Emily E. Stroobant, Seong-Ho Kong, Maria Bencivenga, Takahiro Kinoshita, Tae-Han Kim, Takeshi Sano, Giovanni de Manzoni, Han-Kwang Yang, Yuko Kitagawa, Vivian E. Strong
    Gastric Cancer.2025; 28(4): 559.     CrossRef
  • Can the Japanese guidelines for endoscopic submucosal dissection be safely applied to Korean gastric cancer patients? A multicenter retrospective study based on the Korean Gastric Cancer Association nationwide survey
    Hayemin Lee, Mi Ryeong Park, Junhyun Lee
    Annals of Surgical Treatment and Research.2025; 109(2): 81.     CrossRef
  • Double optimal transport for differential gene regulatory network inference with unpaired samples
    Mengyu Li, Bencong Zhu, Cheng Meng, Xiaodan Fan, Laura Cantini
    Bioinformatics.2025;[Epub]     CrossRef
  • A Randomized Controlled Trial to Evaluate the Effect of Fibrin Glue on Bleeding after Gastric Endoscopic Submucosal Dissection
    Tae-Se Kim, Tae-Jun Kim, Yang Won Min, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jae J. Kim
    Gut and Liver.2025; 19(5): 677.     CrossRef
  • Diagnostic accuracy of stereomicroscopy assessment of invasion depth in ex vivo specimens of early gastric cancer
    Jing Wang, Lin Chang, Dong-Feng Niu, Yan Yan, Chang-Qi Cao, Shi-Jie Li, Qi Wu
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • SMMILe enables accurate spatial quantification in digital pathology using multiple-instance learning
    Zeyu Gao, Anyu Mao, Yuxing Dong, Hannah Clayton, Jialun Wu, Jiashuai Liu, ChunBao Wang, Kai He, Tieliang Gong, Chen Li, Mireia Crispin-Ortuzar
    Nature Cancer.2025; 6(12): 2025.     CrossRef
  • Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis
    Sujin Oh, Soo Kyung Nam, Keun-Wook Lee, Hye Seung Lee, Yujun Park, Yoonjin Kwak, Kyu Sang Lee, Ji-Won Kim, Jin Won Kim, Minsu Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim
    Cancer Research and Treatment.2024; 56(1): 219.     CrossRef
  • Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study
    Yeshong Park, Yeon Bi Han, Jinju Kim, MeeYoung Kang, Boram Lee, Eun Sung Ahn, Saemi Han, Haeryoung Kim, Hee-Young Na, Ho-Seong Han, Yoo-Seok Yoon
    Pancreatology.2024; 24(4): 562.     CrossRef
  • Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center
    Elliott J. Yee, Danielle Gilbert, Jeffrey Kaplan, Sachin Wani, Sunnie S. Kim, Martin D. McCarter, Camille L. Stewart
    Cancers.2024; 16(7): 1428.     CrossRef
  • Interpretation of PD-L1 expression in gastric cancer: summary of a consensus meeting of Korean gastrointestinal pathologists
    Soomin Ahn, Yoonjin Kwak, Gui Young Kwon, Kyoung-Mee Kim, Moonsik Kim, Hyunki Kim, Young Soo Park, Hyeon Jeong Oh, Kyoungyul Lee, Sung Hak Lee, Hye Seung Lee
    Journal of Pathology and Translational Medicine.2024; 58(3): 103.     CrossRef
  • Expression of claudin 18.2 in poorly cohesive carcinoma and its association with clinicopathologic parameters in East Asian patients
    Moonsik Kim, Byung Woog Kang, Jihyun Park, Jin Ho Baek, Jong Gwang Kim
    Pathology - Research and Practice.2024; 263: 155628.     CrossRef
  • Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer
    T.-Y. Kim, Y. Kwak, S.K. Nam, D. Han, D.-Y. Oh, S.-A. Im, H.S. Lee
    ESMO Open.2024; 9(12): 104000.     CrossRef
  • Pathological Interpretation of Gastric Tumors in Endoscopic Submucosal Dissection
    Jung Yeon Kim
    Journal of Digestive Cancer Research.2023; 11(1): 15.     CrossRef
  • Histopathology of Gastric Cancer
    Baek-hui Kim, Sung Hak Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(2): 143.     CrossRef
  • Endoscopic submucosal dissection hands-on training with artificial mucosal layer EndoGEL
    Tae-Se Kim, Jun Haeng Lee
    Journal of Innovative Medical Technology.2023; 1(1): 5.     CrossRef
Case Study
Article image
Heterotopic mesenteric ossification: a report of two cases
Hisham F. Bahmad, Olga Lopez, Tyson Sutherland, Marisa Vinas, Kfir Ben-David, Lydia Howard, Robert Poppiti, Sarah Alghamdi
J Pathol Transl Med. 2022;56(5):294-300.   Published online September 13, 2022
DOI: https://doi.org/10.4132/jptm.2022.07.23
  • 5,343 View
  • 105 Download
  • 2 Crossref
AbstractAbstract PDF
Heterotopic mesenteric ossification (HMO) is abnormal bone formation in tissues which usually do not undergo ossification. There are approximately 75 cases reported worldwide. We present two cases of HMO. The first case is that of a 39-year-old man who presented with abdominal pain and a computerized tomography scan of the abdomen and pelvis revealed an apple core lesion resulting in small bowel obstruction. The second case is that of a 36-year-old woman who presented 2 months after undergoing robotic gastric sleeve resection complaining of weakness and emesis. An esophagogram revealed kinking at the distal esophagus. Surgical resection was performed in both, yielding the diagnosis of HMO. There are various theories as to the pathophysiology of HMO, but no clearly defined mechanism has been established. Management should be conservative whenever possible to prevent further ossification with subsequent surgical intervention.

Citations

Citations to this article as recorded by  
  • Fatal Moans and Bones in Crohn's
    Joyce Opara, Heather Jarrell, Nicole R. Jackson
    American Journal of Forensic Medicine & Pathology.2025; 46(2): 151.     CrossRef
  • Heterotopic mesenteric ossification caused by trauma: A case report
    Bi-Fang Zhang, Jiang Liu, Shuai Zhang, Ling Chen, Jia-Zheng Lu, Ming-Qing Zhang
    World Journal of Gastrointestinal Endoscopy.2024; 16(8): 494.     CrossRef
Original Articles
Article image
Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy
Jongwon Lee, In-Seob Lee, Ji Yong Ahn, Young Soo Park, Jihun Kim
J Pathol Transl Med. 2022;56(2):63-72.   Published online November 16, 2021
DOI: https://doi.org/10.4132/jptm.2021.10.12
  • 8,450 View
  • 469 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary Material
Background
Extremely well-differentiated adenocarcinoma (EWDA) is a deceptively bland-looking adenocarcinoma of the stomach. It often causes diagnostic problems, especially in endoscopic biopsy samples. To better recognize this deceptively bland lesion, we carefully reviewed a series of EWDAs treated at our institution.
Methods
A total of 55 specimens from 19 patients were obtained. Endoscopic, gross and microscopic features defining EWDA were described and documented. For comparison, hyperplastic polyp specimens were randomly selected and analyzed.
Results
Most cases (18 of 19, 94.7%) were advanced gastric cancer (AGC) and primarily located in the body of the stomach (15 of 19, 79.0%). The majority of AGCs were non-ulcerated (11 of 18, 61.1%) with an undermining growth pattern and a relatively small mucosal involvement. Specific histologic features included an irregular glandular shape, an undulating apical cytoplasmic border, disproportionately large glands, a variably distended mucinous cytoplasm. Classical features, such as small infiltrating glands or desmoplastic reactions, were barely observed. Identification of irregularly spaced nuclei and disruption of the foveolar epithelial structure, along with atypical features described above were helpful in making a diagnosis especially in gastric forceps biopsies.
Conclusions
Awareness of the histomorphologic characteristics described in this report would lead to timely diagnosis and prevent repeated endoscopic procedures.

Citations

Citations to this article as recorded by  
  • Artificial intelligence-assisted diagnosis of early gastric cancer: present practice and future prospects
    Changda Lei, Wenqiang Sun, Kun Wang, Ruixia Weng, Xiuji Kan, Rui Li
    Annals of Medicine.2025;[Epub]     CrossRef
  • Unusual or Uncommon Histology of Gastric Cancer
    Jinho Shin, Young Soo Park
    Journal of Gastric Cancer.2024; 24(1): 69.     CrossRef
  • A case of gastric adenocarcinoma with pyloric gland-type infiltrating submucosa
    Kaiho Hirata, Shusuke Yagi, Hideki Miyazaki, Kazuhiko Yamada, Naoki Akazawa, Naoki Enomoto, Kyoko Nohara, Chizu Yokoi, Toru Igari, Norihiro Kokudo
    Surgical Case Reports.2024;[Epub]     CrossRef
  • Gastric-type extremely well-differentiated adenocarcinoma of the stomach: A rare tumor with diagnostic difficulties and high inter-observer variation in endoscopic pinch biopsies
    Soomin Ahn, Sujin Park, Hyun Hee Koh, Han Gyeol Kim, Hyunjin Kim, Jae Yeong Son, Boram Lee, Hyunwoo Lee, Soohyun Hwang, Junhun Cho, Yun Kyung Lee, Ryoji Kushima, Amitabh Srivastava, Kyoung-Mee Kim
    Pathology - Research and Practice.2024; 263: 155599.     CrossRef
Article image
Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer
Sean A. Rasmussen, Thomas Arnason, Weei-Yuarn Huang
J Pathol Transl Med. 2021;55(2):118-124.   Published online January 22, 2021
DOI: https://doi.org/10.4132/jptm.2020.12.22
  • 5,229 View
  • 134 Download
  • 9 Web of Science
  • 9 Crossref
AbstractAbstract PDF
Background
Patients with hereditary diffuse gastric cancer often undergo prophylactic gastrectomy to minimize cancer risk. Because intramucosal poorly cohesive carcinomas in this setting are typically not grossly visible, many pathologists assess the entire gastrectomy specimen microscopically. With 150 or more slides per case, this is a major time burden for pathologists. This study utilizes deep learning methods to analyze digitized slides and detect regions of carcinoma.
Methods
Prophylactic gastrectomy specimens from seven patients with germline CDH1 mutations were analyzed (five for training/validation and two for testing, with a total of 133 tumor foci). All hematoxylin and eosin slides containing cancer foci were digitally scanned, and patches of size 256×256 pixels were randomly extracted from regions of cancer as well as from regions of normal background tissue, resulting in 15,851 images for training/validation and 970 images for testing. A model with DenseNet-169 architecture was trained for 150 epochs, then evaluated on images from the test set. External validation was conducted on 814 images scanned at an outside institution.
Results
On individual patches, the trained model achieved a receiver operating characteristic (ROC) area under the curve (AUC) of 0.9986. This enabled it to maintain a sensitivity of 90% with a false-positive rate of less than 0.1%. On the external validation dataset, the model achieved a similar ROC AUC of 0.9984. On whole slide images, the network detected 100% of tumor foci and correctly eliminated an average of 99.9% of the non-cancer slide area from consideration.
Conclusions
Overall, our model shows encouraging progress towards computer-assisted diagnosis of hereditary diffuse gastric cancer.

Citations

Citations to this article as recorded by  
  • Now and future of artificial intelligence-based signet ring cell diagnosis: A survey
    Zhu Meng, Junhao Dong, Limei Guo, Fei Su, Jiaxuan Liu, Guangxi Wang, Zhicheng Zhao
    Expert Systems with Applications.2026; 296: 129188.     CrossRef
  • Development and application of deep learning-based diagnostics for pathologic diagnosis of gastric endoscopic submucosal dissection specimens
    Soomin Ahn, Yiyu Hong, Sujin Park, Yunjoo Cho, Inwoo Hwang, Ji Min Na, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Jae J. Kim, Kyoung-Mee Kim
    Gastric Cancer.2025; 28(4): 609.     CrossRef
  • A Comprehensive Literature Review of the CDH1 Mutation and Its Role in Gastric Cancer
    Malik Samardali, Jehad Samardaly, Ibrahim Shanti
    Cureus.2025;[Epub]     CrossRef
  • Deep learning for multiclass tumor cell detection in histopathology slides of hereditary diffuse gastric cancer
    Robin Lomans, Valentina Angerilli, Joey Spronck, Liudmila L. Kodach, Irene Gullo, Fátima Carneiro, Rachel S. van der Post, Francesco Ciompi
    iScience.2025; 28(8): 113064.     CrossRef
  • Non-endoscopic Applications of Machine Learning in Gastric Cancer: A Systematic Review
    Marianne Linley L. Sy-Janairo, Jose Isagani B. Janairo
    Journal of Gastrointestinal Cancer.2024; 55(1): 47.     CrossRef
  • Artificial intelligence applicated in gastric cancer: A bibliometric and visual analysis via CiteSpace
    Guoyang Zhang, Jingjing Song, Zongfeng Feng, Wentao Zhao, Pan Huang, Li Liu, Yang Zhang, Xufeng Su, Yukang Wu, Yi Cao, Zhengrong Li, Zhigang Jie
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Deep learning of endoscopic features for the assessment of neoadjuvant therapy response in locally advanced rectal cancer
    Anqi Wang, Jieli Zhou, Gang Wang, Beibei Zhang, Hongyi Xin, Haiyang Zhou
    Asian Journal of Surgery.2023; 46(9): 3568.     CrossRef
  • Preparing Data for Artificial Intelligence in Pathology with Clinical-Grade Performance
    Yuanqing Yang, Kai Sun, Yanhua Gao, Kuansong Wang, Gang Yu
    Diagnostics.2023; 13(19): 3115.     CrossRef
  • Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by Immunohistochemistry
    Sean A. Rasmussen, Valerie J. Taylor, Alexi P. Surette, Penny J. Barnes, Gillian C. Bethune
    Applied Immunohistochemistry & Molecular Morphology.2022; 30(10): 668.     CrossRef
Case Studies
Article image
Gastric crystal-storing histiocytosis with concomitant mucosa-associated lymphoid tissue lymphoma
Mee Joo, Nam-Hoon Kim
J Pathol Transl Med. 2020;54(4):332-335.   Published online May 22, 2020
DOI: https://doi.org/10.4132/jptm.2020.04.20
  • 6,120 View
  • 114 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Crystal-storing histiocytosis (CSH) is a rare entity that is characterized by intrahistiocytic accumulation of crystallized immunoglobulins. CSH is not a malignant process per se, but the majority of CSH cases are associated with underlying lymphoproliferative disorder. Although CSH can occur in a variety of organs, gastric CSH is very rare. We present a localized gastric CSH with concomitant mucosaassociated lymphoid tissue (MALT) lymphoma, manifesting as an ulcer bleeding in a 56-year-old man. Histologically, the biopsied gastric mucosa demonstrated expansion of the lamina propria by prominent collections of large eosinophilic mononuclear cells containing fibrillary crystalloid inclusions. Immunohistochemical studies revealed that the crystal-storing cells were histiocytes harboring kappa light chain-restricted immunoglobulin crystals. Within the lesion, atypical centrocyte-like cells forming lymphoepithelial lesions were seen, consistent with MALT lymphoma. Since this entity is rare and unfamiliar, difficulties in diagnosis may arise. Particularly, in this case, the lymphomatous area was obscured by florid CSH, making the diagnosis more challenging.

Citations

Citations to this article as recorded by  
  • Sunny side up
    João Pedro Pereira, Joanne Lopes, Fatima Carneiro, Francisco Baldaque-Silva
    Frontline Gastroenterology.2025; 16(4): 344.     CrossRef
  • Crystal-Storing Histiocytosis of the Stomach: An Unusual Clinical Context of a Rare Entity
    Jenna Magri, Katsiaryna Khatskevich, Lauren Shealy, David Lewin, Chadi Hajar
    International Journal of Surgical Pathology.2025;[Epub]     CrossRef
  • Crystal-storing histiocytosis in the stomach: A case report and review of the literature
    Linghong Kong, Liyan Xue, Yanfeng Zhong, Shenglan Wang, Danfeng Zheng, Lining Wang, Yang Jiao, Xinpeng Zhang, Huizhong Xue, Xiaogang Liu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Lambda-Restricted Crystal-Storing Histiocytosis of Stomach: A Case Report and Review of Literature
    Nalini Bansal, Pankaj Puri, Nishant Nagpal, Rahul Naithani, Rahul Gupta
    Cureus.2021;[Epub]     CrossRef
  • Immunoglobulin-Storing Histiocytosis: A Case Based Systemic Review
    Hanne Wiese-Hansen, Friedemann Leh, Anette Lodvir Hemsing, Håkon Reikvam
    Journal of Clinical Medicine.2021; 10(9): 1834.     CrossRef
Article image
Gastric IgG4-related disease presenting as a mass lesion and masquerading as a gastrointestinal stromal tumor
Banumathi Ramakrishna, Rohan Yewale, Kavita Vijayakumar, Patta Radhakrishna, Balakrishnan Siddartha Ramakrishna
J Pathol Transl Med. 2020;54(3):258-262.   Published online March 4, 2020
DOI: https://doi.org/10.4132/jptm.2020.02.10
  • 7,369 View
  • 159 Download
  • 8 Web of Science
  • 9 Crossref
AbstractAbstract PDF
IgG4-related disease of the stomach is a rare disorder, and only a few cases have been reported. We present two cases that were identified over a 2-month period in our center. Two male patients aged 52 and 48 years presented with mass lesion in the stomach, which were clinically thought to be gastrointestinal stromal tumor, and they underwent excision of the lesion. Microscopic examination revealed marked fibrosis, which was storiform in one case, associated with diffuse lymphoplasmacytic infiltration and an increase in IgG4-positive plasma cells on immunohistochemistry. Serum IgG4 level was markedly elevated. Although rare, IgG4-related disease should be considered in the differential diagnosis of gastric submucosal mass lesions.

Citations

Citations to this article as recorded by  
  • Isolated IgG4-related disease of terminal ileum: Report of a rare case and review of literature
    Subham Bhowmik, Hemanga K. Bhattacharjee, Joyner Abraham, Raju Sharma, Prasenjit Das
    Journal of Cancer Research and Therapeutics.2025; 21(1): 200.     CrossRef
  • Great Mimics in Oncology: A Retrospective Study from a Tertiary Care Centre of Eastern India
    Suvendu Maji, Jayesh kumar Jha, Vikram Chaturvedi
    Indian Journal of Surgical Oncology.2025; 16(1): 64.     CrossRef
  • Systemic diseases affecting the GI tract: A review of clinical and histopathologic manifestations
    Maryam K. Pezhouh, Dora Lam-Himlin, Atif Zaheer, Lysandra Voltaggio
    Annals of Diagnostic Pathology.2024; 73: 152351.     CrossRef
  • Utilizing Immunoglobulin G4 Immunohistochemistry for Risk Stratification in Patients with Papillary Thyroid Carcinoma Associated with Hashimoto Thyroiditis
    Faridul Haq, Gyeongsin Park, Sora Jeon, Mitsuyoshi Hirokawa, Chan Kwon Jung
    Endocrinology and Metabolism.2024; 39(3): 468.     CrossRef
  • Compromiso gástrico por enfermedad relacionada con IgG4
    Gilberto Jaramillo Trujillo, Oscar Fernando Ruiz, Melissa González Pabón, Maria Andrea Jaramillo Trujillo
    Revista Repertorio de Medicina y Cirugía.2024; 33(3): 319.     CrossRef
  • CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer
    Bei Ji, Lili Qiao, Wei Zhai
    Digestive Diseases and Sciences.2023; 68(3): 791.     CrossRef
  • IgG4-related diseases of the digestive tract
    J.-Matthias Löhr, Miroslav Vujasinovic, Jonas Rosendahl, John H. Stone, Ulrich Beuers
    Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 185.     CrossRef
  • Clinicopathological characteristics of gastric IgG4‐related disease: Systematic scoping review
    Haruki Sawada, Torrey Czech, Krixie Silangcruz, Landon Kozai, Adham Obeidat, Eric Andrew Wien, Midori Filiz Nishimura, Asami Nishikori, Yasuharu Sato, Yoshito Nishimura
    Journal of Gastroenterology and Hepatology.2022; 37(10): 1865.     CrossRef
  • Utility of gastric biopsy in diagnosing IgG4‐related gastrointestinal disease
    Kaori Uchino, Kenji Notohara, Takeshi Uehara, Yasuhiro Kuraishi, Junya Itakura, Akihiro Matsukawa
    Pathology International.2021; 71(2): 124.     CrossRef
Review
Article image
Tumor immune response and immunotherapy in gastric cancer
Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee
J Pathol Transl Med. 2020;54(1):20-33.   Published online November 1, 2019
DOI: https://doi.org/10.4132/jptm.2019.10.08
  • 17,976 View
  • 748 Download
  • 72 Web of Science
  • 67 Crossref
AbstractAbstract PDF
Remarkable developments in immuno-oncology have changed the landscape of gastric cancer (GC) treatment. Because immunotherapy intervenes with tumor immune response rather than directly targeting tumor cells, it is important to develop a greater understanding of tumor immunity. This review paper summarizes the tumor immune reaction and immune escape mechanisms while focusing on the role of T cells and their co-inhibitory signals, such as the immune checkpoint molecules programmed death-1 and programmed deathligand 1 (PD-L1). This paper also describes past clinical trials of immunotherapy for patients with GC and details their clinical implications. Strong predictive markers are essential to improve response to immunotherapy. Microsatellite instability, Epstein-Barr virus, PD-L1 expression, and tumor mutational burden are now regarded as potent predictive markers for immunotherapy in patients with GC. Novel immunotherapy and combination therapy targeting new immune checkpoint molecules such as lymphocyte-activation gene 3, T cell immunoglobulin, and mucin domain containing-3, and indoleamine 2,3-dioxygenase have been suggested, and trials are ongoing to evaluate their safety and efficacy. Immunotherapy is an important treatment option for patients with GC and has great potential for improving patient outcome, and further research in immuno-oncology should be carried out.

Citations

Citations to this article as recorded by  
  • Using glucocorticoid receptor-related genes to create and validate a survival model predicting gastric cancer
    Ke Guo, Ping Huang, Jiasheng Zhang, Bo Zhang, Linyang Li, Jiaxin Li
    Computational Biology and Chemistry.2026; 120: 108726.     CrossRef
  • Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment
    Wenting Dong, Xuepeng Qian, Honglin Liu, Jinhai Huo, Weiming Wang
    Biomolecules.2026; 16(1): 160.     CrossRef
  • FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3‐methylated diffuse esophagogastric junction tumor
    Suguru Maruyama, Yu Imamura, Tasuku Toihata, Ikumi Haraguchi, Manabu Takamatsu, Makiko Yamashita, Yuichiro Nakashima, Eiji Oki, Kenichi Taguchi, Manabu Yamamoto, Shinji Mine, Akihiko Okamura, Jun Kanamori, Souya Nunobe, Takeshi Sano, Shigehisa Kitano, Tet
    Cancer Science.2025; 116(1): 178.     CrossRef
  • Immune biomarkers and predictive signatures in gastric cancer: Optimizing immunotherapy responses
    Sundaram Vickram, Shofia Saghya Infant, S. Manikandan, D. Jenila Rani, C.M. Mathan Muthu, Hitesh Chopra
    Pathology - Research and Practice.2025; 265: 155743.     CrossRef
  • Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)
    In-Ho Kim, Seung Joo Kang, Wonyoung Choi, An Na Seo, Bang Wool Eom, Beodeul Kang, Bum Jun Kim, Byung-Hoon Min, Chung Hyun Tae, Chang In Choi, Choong-kun Lee, Ho Jung An, Hwa Kyung Byun, Hyeon-Su Im, Hyung-Don Kim, Jang Ho Cho, Kyoungjune Pak, Jae-Joon Kim
    Journal of Gastric Cancer.2025; 25(1): 5.     CrossRef
  • Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
    Dong Luo, Yunmei Liu, Zhengmao Lu, Lei Huang
    Molecular Medicine.2025;[Epub]     CrossRef
  • Prognostic value of the triglyceride-glucose index in gastric cancer
    Tugce Eskazan, Suat Saribas, Bekir Kocazeybek
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Deciphering the dual role of autophagy in gastric cancer and gastroesophageal junction cancer: from tumor suppression to cancer progression
    Lili Lei, Junling Zhang, Ran Wei, Bingqi Dong, Xin Wang, Ying Zhou
    Discover Oncology.2025;[Epub]     CrossRef
  • Comparison of clinicopathological parameters with the presence of Epstein–Barr virus and the absence of DNA mismatch repair proteins in gastric adenocarcinomas
    Özge Eyeoğlu, Serra Kayaçetin
    Asian Biomedicine.2025; 19(2): 86.     CrossRef
  • The impact of combined immunotherapy on the cellular composition of the tumor microenvironment in patients with gastric carcinoma
    L.A. Tashireva, A.Yu. Kalinchuk, D.M. Loos, E.A. Tsarenkova, A.V. Avgustinovich, S.G. Afanas’ev, S.V. Vtorushin
    Russian Journal of Archive of Pathology.2025; 87(4): 24.     CrossRef
  • Immunotherapy in gastric adenocarcinoma – a rapidly evolving treatment landscape
    Yang Wang, Geoffrey Chong
    Critical Reviews in Oncology/Hematology.2025; 216: 104941.     CrossRef
  • Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway
    Quan Jiang, Hao Chen, Shixin Zhou, Tao Zhu, Wenshuai Liu, Hao Wu, Yong Zhang, Fenglin Liu, Yihong Sun
    Cellular Oncology.2024; 47(1): 303.     CrossRef
  • Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells
    Lipan Wei, Xiuqian Wu, Lan Wang, Ling Chen, Xuejun Wu, Tiantian Song, Yuanyuan Wang, Wenjun Chang, Aizhen Guo, Yongdong Niu, Haihua Huang
    BMC Cancer.2024;[Epub]     CrossRef
  • Identification and characterization of CLEC11A and its derived immune signature in gastric cancer
    Qing Zheng, Zhenqi Gong, Baizhi Li, Runzi Cheng, Weican Luo, Cong Huang, Huaiming Wang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Cervical cancer subtype identification and model building based on lipid metabolism and post-infection microenvironment immune landscape
    Yongzhi Chen, Rongjie Cui, Dun Xiong, Yuan Zhao, Jianyu Pang, Samina Gul, Qi Qi, Yuheng Tang, Xuhong Zhou, Wenru Tang
    Heliyon.2024; 10(9): e30746.     CrossRef
  • Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer
    Chenchen Wang, Ying Chen, Ru Zhou, Ya’nan Yang, Yantian Fang
    Current Medicinal Chemistry.2024; 31(17): 2467.     CrossRef
  • Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
    Bin Peng, Yinglin Lin, Gao Yi, Mingzhen Lin, Yao Xiao, Yezhenghong Qiu, Wenxia Yao, Xinke Zhou, Zhaoyu Liu
    Scientific Reports.2024;[Epub]     CrossRef
  • Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma
    Yoonjin Kwak, Soo Kyung Nam, Yujun Park, Yun-Suhk Suh, Sang-Hoon Ahn, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Hyung-Ho Kim, Han-Kwang Yang, Hye Seung Lee
    Modern Pathology.2024; 37(10): 100568.     CrossRef
  • Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer
    Hao Yang, Xinyi Gou, Caizhen Feng, Yinli Zhang, Fan Chai, Nan Hong, Yingjiang Ye, Yi Wang, Bo Gao, Jin Cheng
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • A standardized pathology report for gastric cancer: 2nd edition
    Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
    Journal of Pathology and Translational Medicine.2023; 57(1): 1.     CrossRef
  • A Standardized Pathology Report for Gastric Cancer: 2nd Edition
    Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
    Journal of Gastric Cancer.2023; 23(1): 107.     CrossRef
  • Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
    Tae-Han Kim, In-Ho Kim, Seung Joo Kang, Miyoung Choi, Baek-Hui Kim, Bang Wool Eom, Bum Jun Kim, Byung-Hoon Min, Chang In Choi, Cheol Min Shin, Chung Hyun Tae, Chung sik Gong, Dong Jin Kim, Arthur Eung-Hyuck Cho, Eun Jeong Gong, Geum Jong Song, Hyeon-Su Im
    Journal of Gastric Cancer.2023; 23(1): 3.     CrossRef
  • Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
    Marek Majewski, Kamil Torres, Paulina Mertowska, Sebastian Mertowski, Izabela Korona-Głowniak, Jan Korulczyk, Witold Zgodziński, Ewelina Grywalska
    International Journal of Molecular Sciences.2023; 24(6): 5824.     CrossRef
  • Research Progress of Immunotherapy for Gastric Cancer
    Zhipeng Zhang, Ningning Liu, Mingyu Sun
    Technology in Cancer Research & Treatment.2023;[Epub]     CrossRef
  • Case Report: A rare synchronous multiple gastric carcinoma achieved progression-free disease through NGS-guided serial treatment
    Xinyi Shao, Jin Yin, Di Wang, Erjiong Huang, Yini Zhang, Jiani C. Yin, Chen Huang, Hao Wu, Xiaoli Wu
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Artificial Intelligence-Enabled Gastric Cancer Interpretations
    Mustafa Yousif, Liron Pantanowitz
    Surgical Pathology Clinics.2023; 16(4): 673.     CrossRef
  • The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric Cancer
    Jae Yeon Jang, Youngkyung Jeon, Sun Young Jeong, Sung Hee Lim, Won Ki Kang, Jeeyun Lee, Seung Tae Kim
    Journal of Gastric Cancer.2023; 23(3): 476.     CrossRef
  • Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
    Moonsik Kim, Ji Yun Jeong, An Na Seo
    Diagnostics.2023; 13(17): 2782.     CrossRef
  • The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
    Yuting Pan, Yue Ma, Guanghai Dai
    Nutrients.2023; 15(19): 4290.     CrossRef
  • Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE
    Kenichiro Furukawa, Keiichi Hatakeyama, Masanori Terashima, Takeshi Nagashima, Kenichi Urakami, Keiichi Ohshima, Akifumi Notsu, Takashi Sugino, Taisuke Yagi, Keiichi Fujiya, Satoshi Kamiya, Makoto Hikage, Yutaka Tanizawa, Etsuro Bando, Yae Kanai, Yasuto A
    Gastric Cancer.2022; 25(1): 138.     CrossRef
  • Immunotherapy for Gastric Cancer: A 2021 Update
    Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Nikolaos-Iasonas Kouris, George Papaxoinis, Michalis V Karamouzis, Anna Koumarianou, Dimitrios Schizas
    Immunotherapy.2022; 14(1): 41.     CrossRef
  • The immune microenvironment in gastric adenocarcinoma
    Yana Zavros, Juanita L. Merchant
    Nature Reviews Gastroenterology & Hepatology.2022; 19(7): 451.     CrossRef
  • Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
    Raghad Khalid AL-Ishaq, Lenka Koklesova, Peter Kubatka, Dietrich Büsselberg
    Cancers.2022; 14(9): 2140.     CrossRef
  • An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
    Xiaowen Zhao, Pingfan Wu, Dongling Liu, Changtian Li, Ling Xue, Zhe Liu, Meng Zhu, Jie Yang, Ziyi Chen, Yaling Li, Yali She, Kathiravan Srinivasan
    Journal of Healthcare Engineering.2022; 2022: 1.     CrossRef
  • RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy
    Peng Song, Sheng Zhou, Xiaoyang Qi, Yuwen Jiao, Yu Gong, Jie Zhao, Haojun Yang, Zhifen Qian, Jun Qian, Liming Tang
    Journal of Bioinformatics and Computational Biology.2022;[Epub]     CrossRef
  • Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs
    Zehua Fan, Yanqun Wang, Rong Niu
    Functional & Integrative Genomics.2022; 22(5): 919.     CrossRef
  • Complete Response of High Microsatellite Instability Gastric Cancer and Synchronous Microsatellite Stability Rectal Cancer
    Zachary E Hunzeker, Pooja Bhakta, Sindusha R Gudipally, Sri Bharathi Kavuri, Rohit Venkatesan, Chukwuyejulumafor Nwanze
    Cureus.2022;[Epub]     CrossRef
  • Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor Progression
    Yuhan Wei, Jianwei Zhang, Xueke Fan, Zhi Zheng, Xiaoyue Jiang, Dexi Chen, Yuting Lu, Yingrui Li, Miao Wang, Min Hu, Qi Du, Liuting Yang, Hongzhong Li, Yi Xiao, Yongfu Li, Jiangtao Jin, Deying Wang, Xiangliang Yuan, Qin Li
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Tumor vessel normalization and immunotherapy in gastric cancer
    Xianzhe Yu, Shan He, Jian Shen, Qiushi Huang, Peng Yang, Lin Huang, Dan Pu, Li Wang, Lu Li, Jinghua Liu, Zelong Liu, Lingling Zhu
    Therapeutic Advances in Medical Oncology.2022;[Epub]     CrossRef
  • FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
    Han Wang, Junchang Zhang, Huan Li, Hong Yu, Songyao Chen, Shuhao Liu, Changhua Zhang, Yulong He
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Molecular Pathology of Gastric Cancer
    Moonsik Kim, An Na Seo
    Journal of Gastric Cancer.2022; 22(4): 264.     CrossRef
  • Bioinformatics Analysis and Structure of Gastric Cancer Prognosis Model Based on Lipid Metabolism and Immune Microenvironment
    Yongzhi Chen, Hongjun Yuan, Qian Yu, Jianyu Pang, Miaomiao Sheng, Wenru Tang
    Genes.2022; 13(9): 1581.     CrossRef
  • Clinical implications of interleukins-31, 32, and 33 in gastric cancer
    Qing-Hua Liu, Ji-Wei Zhang, Lei Xia, Steven G Wise, Brett David Hambly, Kun Tao, Shi-San Bao
    World Journal of Gastrointestinal Oncology.2022; 14(9): 1808.     CrossRef
  • Microbiota and the Immune System—Actors in the Gastric Cancer Story
    Marek Majewski, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Ewelina Grywalska, Kamil Torres
    Cancers.2022; 14(15): 3832.     CrossRef
  • Bioinformatics and Experimental Analyses Reveal MAP4K4 as a Potential Marker for Gastric Cancer
    Junping Zhang, Xiaoping Cai, Weifeng Cui, Zheng Wei
    Genes.2022; 13(10): 1786.     CrossRef
  • Common strategies for effective immunotherapy of gastroesophageal cancers using immune checkpoint inhibitors
    Shuang Ma, Fei Chen
    Pathology - Research and Practice.2022; 238: 154110.     CrossRef
  • High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer
    Shouyu Ke, Feng Xie, Yixian Guo, Jieqiong Chen, Zeyu Wang, Yimeng Yu, Haigang Geng, Danhua Xu, Xu Liu, Xiang Xia, Fengrong Yu, Chunchao Zhu, Zizhen Zhang, Gang Zhao, Bin Li, Wenyi Zhao
    iScience.2022; 25(12): 105529.     CrossRef
  • Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma
    Jingjing Pan, Xinyuan Gu, Jing Luo, Xinye Qian, Qiang Gao, Tianjie Li, Longying Ye, Chenlu Li
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Inhibition of NF‐κB is required for oleanolic acid to downregulate PD‐L1 by promoting DNA demethylation in gastric cancer cells
    Xirong Lu, Yuyi Li, Wei Yang, Minghao Tao, Yanmiao Dai, Jinkang Xu, Qianfei Xu
    Journal of Biochemical and Molecular Toxicology.2021;[Epub]     CrossRef
  • Prognostic Value of C-Reactive Protein to Albumin Ratio in Gastric Cancer: A Meta-Analysis
    Liang Yue, Yi Lu, Yulin Li, Yilin Wang
    Nutrition and Cancer.2021; 73(10): 1864.     CrossRef
  • Immunogenic characteristics of microsatellite instability‐low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses
    Yu Imamura, Tasuku Toihata, Ikumi Haraguchi, Yoko Ogata, Manabu Takamatsu, Aya Kuchiba, Norio Tanaka, Osamu Gotoh, Seiichi Mori, Yuichiro Nakashima, Eiji Oki, Masaki Mori, Yoshinao Oda, Kenichi Taguchi, Manabu Yamamoto, Masaru Morita, Naoya Yoshida, Hideo
    International Journal of Cancer.2021; 148(5): 1260.     CrossRef
  • Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
    Taohua Yue, Shuai Zuo, Jing Zhu, Shihao Guo, Zhihao Huang, Jichang Li, Xin Wang, Yucun Liu, Shanwen Chen, Pengyuan Wang
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Tumor microenvironment characterization in stage IV gastric cancer
    Feng Yang, Zhenbao Wang, Xianxue Zhang
    Bioscience Reports.2021;[Epub]     CrossRef
  • E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer
    Hui Li, Shufen Zhao, Liwei Shen, Peige Wang, Shihai Liu, Yingji Ma, Zhiwei Liang, Gongjun Wang, Jing Lv, Wensheng Qiu
    Aging.2021; 13(10): 13626.     CrossRef
  • Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer
    S. H. Petersen, L. F. Kua, S. Nakajima, W. P. Yong, K. Kono
    Scientific Reports.2021;[Epub]     CrossRef
  • Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients
    Quan Jiang, Jie Sun, Hao Chen, Chen Ding, Zhaoqing Tang, Yuanyuan Ruan, Fenglin Liu, Yihong Sun
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Microsatellite instability in Gastric Cancer: Between lights and shadows
    Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, Silvia Giordano
    Cancer Treatment Reviews.2021; 95: 102175.     CrossRef
  • Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma
    Zai-Sheng Ye, Miao Zheng, Qin-Ying Liu, Yi Zeng, Sheng-Hong Wei, Yi Wang, Zhi-Tao Lin, Chen Shu, Qiu-Hong Zheng, Lu-Chuan Chen
    World Journal of Gastroenterology.2021; 27(21): 2871.     CrossRef
  • Immunotherapy of gastric cancer: Past, future perspective and challenges
    Jun Xie, Liping Fu, Li Jin
    Pathology - Research and Practice.2021; 218: 153322.     CrossRef
  • Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
    Sumi Yun, Sukmook Lee, Ho-Young Lee, Hyeon Jeong Oh, Yoonjin Kwak, Hye Seung Lee
    International Journal of Molecular Sciences.2021; 22(13): 7042.     CrossRef
  • Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages
    Yan Yang, Yang Yang, Meili Chen, Jianquan Chen, Jinyan Wang, Yajun Ma, Hanqing Qian
    Biomaterials Science.2021; 9(19): 6597.     CrossRef
  • Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
    Sizhe Hu, Xiaokang Zhao, Feng Qian, Cancan Jin, Kaishun Hou, Tao Huang
    Computational and Mathematical Methods in Medicine.2021; 2021: 1.     CrossRef
  • Comprehensive Analysis to Identify MAGEA3 Expression Correlated With Immune Infiltrates and Lymph Node Metastasis in Gastric Cancer
    Jinji Jin, Jianxin Tu, Jiahuan Ren, Yiqi Cai, Wenjing Chen, Lifang Zhang, Qiyu Zhang, Guanbao Zhu
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Effect of P2X7 receptor on tumorigenesis and its pharmacological properties
    Wen-jun Zhang, Ce-gui Hu, Zheng-ming Zhu, Hong-liang Luo
    Biomedicine & Pharmacotherapy.2020; 125: 109844.     CrossRef
  • Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
    Byung Woog Kang, Ian Chau
    ESMO Open.2020; 5(4): e000791.     CrossRef
  • Is Ramucirumab Still the Only Second-Line Treatment in Metastatic Gastric Cancer?
    Khalil El Gharib, Hampig Raphael Kourie
    Pharmacogenomics.2020; 21(17): 1203.     CrossRef
  • Deep Learning Predicts Underlying Features on Pathology Images with Therapeutic Relevance for Breast and Gastric Cancer
    Renan Valieris, Lucas Amaro, Cynthia Aparecida Bueno de Toledo Osório, Adriana Passos Bueno, Rafael Andres Rosales Mitrowsky, Dirce Maria Carraro, Diana Noronha Nunes, Emmanuel Dias-Neto, Israel Tojal da Silva
    Cancers.2020; 12(12): 3687.     CrossRef
Case Study
Multiple Neuroendocrine Tumors in Stomach and Duodenum in a Multiple Endocrine Neoplasia Type 1 Patient
Bohyun Kim, Han-Kwang Yang, Woo Ho Kim
J Pathol Transl Med. 2018;52(2):126-129.   Published online December 21, 2017
DOI: https://doi.org/10.4132/jptm.2017.09.16
  • 8,775 View
  • 145 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDF
A 67-year-old woman with a history of subtotal parathyroidectomy, distal pancreatectomy, and total splenectomy 23 years prior underwent surgical gastric resection for neuroendocrine tumors of the stomach and duodenum. Meticulous examination of the entire stomach and duodenum revealed multiple scattered, minute neuroendocrine tumors. To the best of our knowledge, this is the first case report of a patient diagnosed with gastroduodenal neuroendocrine tumors associated with multiple endocrine neoplasia type 1 (MEN 1) in whom complete histologic mapping of the whole gastrectomy specimen was performed. The presence of MEN 1–associated neuroendocrine tumors in the stomach is very rare, but should be considered in patients diagnosed with MEN 1 who present with a new tumor in the stomach.

Citations

Citations to this article as recorded by  
  • A Case of Asymptomatic Multiple Endocrine Neoplasia Type I with Thymic Carcinoid
    Suk Ki Park, Moon Won Lee, In Sub Han, Young Joo Park, Sung Yong Han, Joon Woo Park, Bong Eun Lee, Gwang Ha Kim, Sang Soo Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2019; 19(1): 65.     CrossRef
Original Articles
Extramural Perineural Invasion in pT3 and pT4 Gastric Carcinomas
Alejandro España-Ferrufino, Leonardo S. Lino-Silva, Rosa A. Salcedo-Hernández
J Pathol Transl Med. 2018;52(2):79-84.   Published online November 9, 2017
DOI: https://doi.org/10.4132/jptm.2017.11.01
  • 10,165 View
  • 143 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDF
Background
Perineural invasion (PNI) is widely studied in malignant tumors, and its prognostic significance is well demonstrated. Most studies have focused on evaluating the mural PNI (mPNI); however, extramural PNI (ePNI) may influence the prognosis in gastric cancer. We evaluated the prognostic value of ePNI compared with mPNI in gastric cancer in this observational comparative cross-sectional study.
Methods
Seventy-three pT3 and pT4 gastric carcinomas with PNI were evaluated. Forty-eight (65.7%) were in the mPNI group and the remaining in the ePNI group.
Results
Clinicopathologic characteristics between the two groups were similar, except for the outcomes. The 5-year disease-specific survival (DSS) rate was 64% for the mPNI group and 50% for the ePNI group (p=.039), a difference that did not remain significant in multivariate analysis. The only independent adverse prognostic factor in multivariate analysis was the presence of lymph node metastasis (hazard ratio, 1.757; 95% confidence interval, 1.082 to 2.854; p=.023).
Conclusions
We demonstrated the prognostic effect of ePNI for DSS in surgically resected pT3–pT4 gastric cancer patients. ePNI could be considered in the staging and prognostic systems of gastric cancer to stratify patients with a high risk of recurrence.

Citations

Citations to this article as recorded by  
  • Investigation of Conditioned Media-Mediated Communication between Pancreatic Cancer Cells and Neurons
    Didem Karakaş
    Acta Medica Nicomedia.2025; 8(1): 15.     CrossRef
  • Innervating 3D in vitro models: bioengineering and design blueprints
    Mariana-Tomás de Carvalho, Margarida Henriques-Pereira, Maria V. Monteiro, Meriem Lamghari, João F. Mano, Vítor M. Gaspar
    Trends in Biotechnology.2025; 43(11): 2743.     CrossRef
  • Development and validation of a preoperative CT-based risk score integrating morphological and body composition parameters to predict recurrence-free survival in gastric cancer patients following curative surgery
    Ruochen Cong, Jialei Ming, Ruonan Xu, Liyu Zhu, Xinyue Wang, Zhengqi Zhu
    European Journal of Radiology.2025; 191: 112318.     CrossRef
  • Comparison of 2D and 3D measured iodine concentration of gastric adenocarcinoma on spectral-CT and their relationship with perineural invasion
    Tianxia Bei, Xiaoqiang Yao, Xuejun Chen, Yue Wu, Jing Li, Jinrong Qu
    BMC Medical Imaging.2025;[Epub]     CrossRef
  • Neural control of tumor immunity
    Burak Kizil, Francesco De Virgiliis, Christoph Scheiermann
    The FEBS Journal.2024; 291(21): 4670.     CrossRef
  • Spectral CT-based nomogram for preoperative prediction of perineural invasion in locally advanced gastric cancer: a prospective study
    Jing Li, Shuning Xu, Yi Wang, Mengjie Fang, Fei Ma, Chunmiao Xu, Hailiang Li
    European Radiology.2023; 33(7): 5172.     CrossRef
  • Crosstalk between cancer cells and the nervous system
    Meng Huang, Gu Gong, Yicheng Deng, Xinmiao Long, Wenyong Long, Qing Liu, Wei Zhao, Rufu Chen
    Medicine Advances.2023; 1(3): 173.     CrossRef
  • Targeting tumor innervation: premises, promises, and challenges
    Xinyu Li, Xueqiang Peng, Shuo Yang, Shibo Wei, Qing Fan, Jingang Liu, Liang Yang, Hangyu Li
    Cell Death Discovery.2022;[Epub]     CrossRef
  • Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk
    Deborah A. Silverman, Vena K. Martinez, Patrick M. Dougherty, Jeffrey N. Myers, George A. Calin, Moran Amit
    Cancer Research.2021; 81(6): 1431.     CrossRef
  • Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
    Qing Tao, Wen Zhu, Xiaohui Zhao, Mei Li, Yongqian Shu, Deqiang Wang, Xiaoqin Li
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Perineural invasion as a predictive factor for survival outcome in gastric cancer patients: a systematic review and meta-analysis
    Bochao Zhao, Wu Lv, Di Mei, Rui Luo, Shiyang Bao, Baojun Huang, Jie Lin
    Journal of Clinical Pathology.2020; 73(9): 544.     CrossRef
  • Consensus-Expressed CXCL8 and MMP9 Identified by Meta-Analyzed Perineural Invasion Gene Signature in Gastric Cancer Microarray Data
    Xiuzhi Jia, Minjia Lu, Chen Rui, Ying Xiao
    Frontiers in Genetics.2019;[Epub]     CrossRef
HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient
Dang Anh Thu Phan, Vu Thien Nguyen, Thi Ngoc Ha Hua, Quoc Dat Ngo, Thi Phuong Thao Doan, Sao Trung Nguyen, Anh Tu Thai, Van Thanh Nguyen
J Pathol Transl Med. 2017;51(4):396-402.   Published online June 19, 2017
DOI: https://doi.org/10.4132/jptm.2017.04.24
  • 11,412 View
  • 163 Download
  • 10 Web of Science
  • 9 Crossref
AbstractAbstract PDF
Background
Human epidermal growth factor receptor 2 (HER2) is related to the pathogenesis and poor outcome of numerous types of carcinomas, including gastric carcinoma. Gastric cancer patients with HER2 positivity have become potential candidates for targeted therapy with trastuzumab.
Methods
We investigated 208 gastric cancer specimens using immunohistochemistry (IHC), fluorescence in situ hybridization and dual in situ hybridization (ISH). We also investigated the concordance between IHC and ISH. The correlation between HER2 status and various clinicopathological findings was also investigated.
Results
In total, 15.9% (33/208) and 24.5% (51/208) of gastric cancers showed HER2 gene amplification and protein overexpression, respectively. A high level of concordance between ISH and IHC analyses (91.3%, κ = 0.76) was found. A significant correlation between HER2 status and intestinal-type (p < .05) and differentiated carcinomas (p < .05) was also noted. The HER2 heterogeneity was high in gastric cancers; we found 68.8% phenotypic heterogeneity and 57.6% genotypic heterogeneity. Heterogeneity in HER2 protein expression and gene amplification showed a close association with diffuse histologic type and IHC 2+.
Conclusions
HER2 protein overexpression and gene amplification were detected in 24.5% and 15.9% of gastric cancer specimens, respectively. Intestinal-type showed a higher level of HER2 protein overexpression and gene amplification than diffuse type. HER2 status also showed a significant relationship with well- and moderately-differentiated carcinomas. The ratio of phenotypic and genotypic heterogeneity of HER2 was high in gastric carcinomas and was associated with HER2 IHC 2+ and diffuse histologic type.

Citations

Citations to this article as recorded by  
  • Human epidermal growth factor receptor 2 expression and socio-demographic, clinical, and histopathological characteristics in gastric carcinoma at St Francis Hospital Nsambya, Uganda
    Steven Wanda, Gorretti Nassali, Brian Bbosa, Francis Basimbe, Joviah Akulu, Davis Nsamba, Praise Nimusiima, Joshua Muhumuza, Emmanuel Othieno, Maxwel Dancan Okuku
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Expression of Her-2 and Ki-67 in Gastric Cancer Formalin Fixed Paraffin Embedded Tissue Blocks and Their Correlation with Histological Grades at the Uganda Cancer Institute Pathology Laboratory
    Hassan Wasswa, Abraham Birungi, Lawrence Amadile, Richard Kasadha, Saphurah Nabaasa, Jolly Ninsiima, Tonny Okecha, Frank Ssedyabane, Raymond Atwine, Lauben Tibenderana
    Pathology and Laboratory Medicine International.2024; Volume 16: 23.     CrossRef
  • Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy
    Qian Li, Minzhi Lv, Lihua Lv, Nida Cao, Aiguang Zhao, Jiayan Chen, Xi Tang, Rongkui Luo, Shan Yu, Yan Zhou, Yuehong Cui, Wei Guo, Tianshu Liu
    Cancer Medicine.2023; 12(4): 4110.     CrossRef
  • A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma
    Rafid A. Abood, Saad Alomar, Sawsan S. Alharoon
    Journal of Public Health in Africa.2023; 14(9): 4.     CrossRef
  • Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors
    Hideki Yamaguchi, Yuko Nagamura, Makoto Miyazaki
    Cancers.2022; 14(15): 3750.     CrossRef
  • Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer
    Renshen Xiang, Yuping Rong, Yuhang Ge, Wei Song, Jun Ren, Tao Fu
    Aging.2021; 13(4): 5928.     CrossRef
  • Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling
    Renshen Xiang, Wei Song, Jun Ren, Jing Wu, Jincheng Fu, Tao Fu
    Stem Cell Research & Therapy.2021;[Epub]     CrossRef
  • Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer
    Yoshie Kobayashi, Seung-Oe Lim, Hirohito Yamaguchi
    Seminars in Cancer Biology.2020; 65: 51.     CrossRef
  • Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer
    Yu-Chang Chuang, Hsin-Yi Wu, Yu-Ling Lin, Shey-Cherng Tzou, Cheng-Hsun Chuang, Ting-Yan Jian, Pin-Rong Chen, Yuan-Ching Chang, Chi-Hsin Lin, Tse-Hung Huang, Chao-Ching Wang, Yi-Lin Chan, Kuang-Wen Liao
    Biological Procedures Online.2018;[Epub]     CrossRef
Review
Rare Gastric Lesions Associated with Helicobacter pylori Infection: A Histopathological Review
Mee Joo
J Pathol Transl Med. 2017;51(4):341-351.   Published online June 5, 2017
DOI: https://doi.org/10.4132/jptm.2017.04.03
  • 14,820 View
  • 350 Download
  • 17 Web of Science
  • 15 Crossref
AbstractAbstract PDF
Helicobacter pylori infection is associated with chronic gastritis, peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. However, some rare gastric lesions exhibiting distinctive histological features may also be associated with H. pylori infection, including lymphocytic gastritis, granulomatous gastritis, Russell body gastritis, or crystal-storing histiocytosis. Although diverse factors can contribute to their development, there is convincing evidence that H. pylori infection may play a pathogenic role. These findings are mainly based on studies in patients with these lesions who exhibited clinical and histological improvements after H. pylori eradication therapy. Thus, H. pylori eradication therapy might be indicated in patients with no other underlying disease, particularly in countries with a high prevalence of H. pylori infection. This review describes the characteristic histological features of these rare lesions and evaluates the evidence regarding a causative role for H. pylori infection in their pathogenesis.

Citations

Citations to this article as recorded by  
  • Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings
    Zeeshan Umar, Jia-Wei Tang, Barry J. Marshall, Alfred Chin Yen Tay, Liang Wang
    Critical Reviews in Microbiology.2025; 51(2): 369.     CrossRef
  • Granulomatous gastritis due to gastric sarcoidosis presenting as gastric outlet obstruction: Case report of a rare entity
    Arkadeep Dhali, Rick Maity, Prajes Kumar Chattopadhyay, Jyotirmoy Biswas, Anjali Garg, Gopal Krishna Dhali
    International Journal of Surgery Case Reports.2025; 127: 110987.     CrossRef
  • Crystal-Storing Histiocytosis of the Stomach: An Unusual Clinical Context of a Rare Entity
    Jenna Magri, Katsiaryna Khatskevich, Lauren Shealy, David Lewin, Chadi Hajar
    International Journal of Surgical Pathology.2025;[Epub]     CrossRef
  • Crystal-Storing Histiocytosis: The Iceberg of More Serious Conditions
    Mousa Mobarki, Alexandra Papoudou-Bai, Jean Marc Dumollard, Abdulaziz H. Alhazmi, Shaqraa Musawi, Mohammed Ali Madkhali, Khalid Y. Muqri, Michel Péoc’h, Georgia Karpathiou
    Diagnostics.2023; 13(2): 271.     CrossRef
  • Acute systemic infection-associated Russell body gastroesophagitis: A case report and literature review
    Elizaveta Flerova, Susan Inniss, Nneamaka Nwaoduah, Richard P. Denicola, Jialing Huang
    Human Pathology Reports.2023; 31: 300696.     CrossRef
  • Infectious Gastric Diseases Other than Helicobacter
    Hyemin Jo, Cheol Min Shin
    The Korean Journal of Gastroenterology.2023; 82(6): 269.     CrossRef
  • H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil
    Igor Brasil-Costa, Cintya de Oliveira Souza, Leni Célia Reis Monteiro, Maria Elisabete Silva Santos, Edivaldo Herculano Correa De Oliveira, Rommel Mario Rodriguez Burbano
    Pathogens.2022; 11(4): 414.     CrossRef
  • Crystal-storing histiocytosis in the stomach: A case report and review of the literature
    Linghong Kong, Liyan Xue, Yanfeng Zhong, Shenglan Wang, Danfeng Zheng, Lining Wang, Yang Jiao, Xinpeng Zhang, Huizhong Xue, Xiaogang Liu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Dynamics of inflammatory changes of the gastric mucosa in children with duodenal ulcer
    T.V. Sorokman, P.M. Moldovan, L.Yu. Khlunovska, I.Ya. Lozyuk
    CHILD`S HEALTH.2022; 16(4): 285.     CrossRef
  • Clinicopathological characteristics and aetiological factors of granulomatous gastritis
    Yuanxin Liang, Shengjie Cui, Alexandros D Polydorides
    Histopathology.2021; 79(6): 1040.     CrossRef
  • A case of Russell body gastritis with multifocal lesions
    Michinobu Umakoshi, Ken Miyabe, Hajime Ishii, Yukitsugu Kudo-Asabe, Yukinobu Ito, Makoto Yoshida, Daichi Maeda, Masato Sageshima, Akiteru Goto
    SAGE Open Medical Case Reports.2020;[Epub]     CrossRef
  • Gastric crystal-storing histiocytosis with concomitant mucosa-associated lymphoid tissue lymphoma
    Mee Joo, Nam-Hoon Kim
    Journal of Pathology and Translational Medicine.2020; 54(4): 332.     CrossRef
  • Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review
    Manuel Beltran, Sharad Khurana, Yennifer Gil, Jason T. Lewis, Rohit Kumar, James M. Foran, Masayuki Nagasawa
    Case Reports in Hematology.2020; 2020: 1.     CrossRef
  • Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018
    György M. Buzás
    Minerva Gastroenterologica e Dietologica.2018;[Epub]     CrossRef
  • Crystal-storing Histiocytosis in the Stomach
    Christina A. Arnold, Wendy L. Frankel, Ling Guo, Chandra Krishnan, Sheryl Pfeil, Melinda Schumacher, Lysandra Voltaggio, Martha M. Yearsley, Wei Chen
    American Journal of Surgical Pathology.2018; 42(10): 1317.     CrossRef
Case Study
Perivascular Epithelioid Cell Tumor in the Stomach
Sun Ah Shin, Jiwoon Choi, Kyung Chul Moon, Woo Ho Kim
J Pathol Transl Med. 2017;51(4):428-432.   Published online April 4, 2017
DOI: https://doi.org/10.4132/jptm.2016.09.16
  • 9,772 View
  • 141 Download
  • 6 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Perivascular epithelioid cell tumors or PEComas can arise in any location in the body. However, a limited number of cases of gastric PEComa have been reported. We present two cases of gastric PEComas. The first case involved a 62-year-old woman who presented with a 4.2 cm gastric subepithelial mass in the prepyloric antrum, and the second case involved a 67-year-old man with a 5.0 cm mass slightly below the gastroesophageal junction. Microscopic examination revealed that both tumors were composed of perivascular epithelioid cells that were immunoreactive for melanocytic and smooth muscle markers. Prior to surgery, the clinical impression of both tumors was gastrointestinal stromal tumor (GIST), and the second case was erroneously diagnosed as GIST even after microscopic examination. Although gastric PEComa is a very rare neoplasm, it should be considered in the differential diagnosis of gastric submucosal lesions.

Citations

Citations to this article as recorded by  
  • A Perivascular Epithelioid Cell Tumor in the Ascending Colon: A Rare Case Involving a Patient With Tuberous Sclerosis
    Kai Seharada, Masato Kitazawa, Satoshi Nakamura, Yuta Yamamoto, Yuji Soejima
    Cureus.2025;[Epub]     CrossRef
  • Malignant Perivascular Epithelioid Cell Tumor of Ovary: A Rare Case Report
    Anuradha Sharma, Reetika Sharma, Jyoti Bala, Monika Sharma
    Journal of Mid-life Health.2025; 16(1): 107.     CrossRef
  • Unusual paediatric sigmoid perivascular epithelioid cell tumour with regional lymph node metastasis treated using gemcitabine and docetaxel: a case report and literature review
    Hsiu-Chung Cheng, Chia-Yu Kuo, Ching-Wen Huang, Hsiang-Hung Shih, Chih-Hung Lin, Jaw-Yuan Wang
    Journal of International Medical Research.2021;[Epub]     CrossRef
  • Gastric Perivascular Epithelioid Cell Tumor (PEComa)
    Jinghong Xu, Yu Yan, Xueping Xiang, Peter Jiang, Xiangrong Hu, Wenjun Yang
    American Journal of Clinical Pathology.2019; 152(2): 221.     CrossRef
  • Robotic wedge resection of a rare gastric perivascular epithelioid cell tumor: A case report
    Alessandra Marano, Francesca Maione, Yanghee Woo, Luca Pellegrino, Paolo Geretto, Diego Sasia, Mirella Fortunato, Giulio Fraternali Orcioni, Roberto Priotto, Renato Fasoli, Felice Borghi
    World Journal of Clinical Cases.2019; 7(23): 4011.     CrossRef
Review
Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives
Yoon Young Choi, Sung Hoon Noh, Jae-Ho Cheong
J Pathol Transl Med. 2016;50(1):1-9.   Published online October 26, 2015
DOI: https://doi.org/10.4132/jptm.2015.09.10
  • 15,165 View
  • 157 Download
  • 21 Web of Science
  • 22 Crossref
AbstractAbstract PDF
Gastric cancer is a global health burden and has the highest incidence in East Asia. This disease is complex in nature because it arises from multiple interactions of genetic, local environmental, and host factors, resulting in biological heterogeneity. This genetic intricacy converges on molecular characteristics reflecting the pathophysiology, tumor biology, and clinical outcome. Therefore, understanding the molecular characteristics at a genomic level is pivotal to improving the clinical care of patients with gastric cancer. A recent landmark study, The Cancer Genome Atlas (TCGA) project, showed the molecular landscape of gastric cancer through a comprehensive molecular evaluation of 295 primary gastric cancers. The proposed molecular classification divided gastric cancer into four subtypes: Epstein-Barr virus–positive, microsatellite unstable, genomic stable, and chromosomal instability. This information will be taken into account in future clinical trials and will be translated into clinical therapeutic decisions. To fully realize the clinical benefit, many challenges must be overcome. Rapid growth of high-throughput biology and functional validation of molecular targets will further deepen our knowledge of molecular dimensions of this cancer, allowing for personalized precision medicine.

Citations

Citations to this article as recorded by  
  • Establishment and characterization of a new mouse gastric carcinoma cell line, MCC
    Yushen Wang, Xianju Li, Yi Wang, Jun Qin
    Cancer Cell International.2025;[Epub]     CrossRef
  • Advancements and challenges in gastric cancer: epidemiology, biomarkers, and therapeutic strategies
    Marina Nishimuni, Laura Carolina Lopez Claro, Maria Ignez Freitas Melro Braghiroli
    Surgical and Experimental Pathology.2024;[Epub]     CrossRef
  • Tissue Biomarkers in Gastric Cancer Treatment: Present and Future
    Giulia Airò, Virginia Agnetti, Fabiana Pratticò, Marianna Peroni, Simona Bui, Giovanni Mura, Maria Urbanowicz-Nijaki, Eleonora Lai, Marco Puzzoni, Fabiana Contu, Nerina Denaro, Mario Scartozzi, Cinzia Solinas, Chiara Tommasi
    International Journal of Translational Medicine.2024; 4(4): 640.     CrossRef
  • Research Progress of MSI Gastric Cancer Subtypes
    成菊 马
    Advances in Clinical Medicine.2022; 12(07): 6719.     CrossRef
  • OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome
    Jaishree Pandian, Ponmathi Panneerpandian, Balaji T. Sekar, Karthikeyan Selvarasu, Kumaresan Ganesan
    Functional & Integrative Genomics.2022; 22(6): 1345.     CrossRef
  • Secondary Primary Cancer after Primary Gastric Cancer: Literature Review and Big Data Analysis Using the Health Insurance Review and Assessment Service (HIRA) Database of Republic of Korea
    Jeong Ho Song, Yeonkyoung Lee, Jaesung Heo, Sang-Yong Son, Hoon Hur, Sang-Uk Han
    Cancers.2022; 14(24): 6165.     CrossRef
  • Microsatellite instability: a review of what the oncologist should know
    Kai Li, Haiqing Luo, Lianfang Huang, Hui Luo, Xiao Zhu
    Cancer Cell International.2020;[Epub]     CrossRef
  • Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
    Chul Kyu Roh, Yoon Young Choi, Seohee Choi, Won Jun Seo, Minah Cho, Eunji Jang, Taeil Son, Hyoung-Il Kim, Hyeseon Kim, Woo Jin Hyung, Yong-Min Huh, Sung Hoon Noh, Jae-Ho Cheong
    Yonsei Medical Journal.2019; 60(2): 132.     CrossRef
  • Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon
    Yoon Young Choi, Minah Cho, In Gyu Kwon, Taeil Son, Hyoung-Il Kim, Seung Ho Choi, Jae-Ho Cheong, Woo Jin Hyung
    Yonsei Medical Journal.2019; 60(3): 235.     CrossRef
  • Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
    Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    Cancer Immunology, Immunotherapy.2019; 68(11): 1779.     CrossRef
  • Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer
    Mengsha Tong, Chunyu Yu, Jinwen Shi, Wenwen Huang, Sai Ge, Mingwei Liu, Lei Song, Dongdong Zhan, Xia Xia, Wanlin Liu, Jinwen Feng, Wenhao Shi, Jiafu Ji, Jing Gao, Tieliu Shi, Weimin Zhu, Chen Ding, Yi Wang, Fuchu He, Lin Shen, Tingting Li, Jun Qin
    iScience.2019; 22: 44.     CrossRef
  • Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
    Jiwon Koh, Soo Kyung Nam, Youn Woo Lee, Jin Won Kim, Keun-Wook Lee, Chan-Young Ock, Do-Youn Oh, Sang-Hoon Ahn, Hyung-Ho Kim, Keon-Wook Kang, Woo Ho Kim, Ho-Young Lee, Hye Seung Lee
    Biomolecules.2019; 9(12): 782.     CrossRef
  • Targeted drug delivery of capecitabine to mice xenograft gastric cancer by PAMAM dendrimer nanocarrier
    Sharareh Jafari, Fatemeh Nabavizadeh, Jalal Vahedian, Mehdi Shafie Ardestani, Hedayat Samandari, Ali Zare Mehrjerdi
    african journal of gastroenterology and hepatology.2019; 2(1): 28.     CrossRef
  • New therapeutic options opened by the molecular classification of gastric cancer
    Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu
    World Journal of Gastroenterology.2018; 24(18): 1942.     CrossRef
  • Proposed Molecular and miRNA Classification of Gastric Cancer
    Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri
    International Journal of Molecular Sciences.2018; 19(6): 1683.     CrossRef
  • High serum MMP-14 predicts worse survival in gastric cancer
    Aaro Kasurinen, Taina Tervahartiala, Alli Laitinen, Arto Kokkola, Timo Sorsa, Camilla Böckelman, Caj Haglund, Dajun Deng
    PLOS ONE.2018; 13(12): e0208800.     CrossRef
  • miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway
    Jianjun Wang, Yang Jiao, Lunmeng Cui, Lili Jiang
    Bioscience, Biotechnology, and Biochemistry.2017; 81(1): 119.     CrossRef
  • Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients
    Jiwon Koh, Hee Eun Lee, Woo Ho Kim, Hye Seung Lee, Ju-Seog Lee
    PLOS ONE.2017; 12(3): e0174814.     CrossRef
  • Perioperative chemotherapy for resectable gastric cancer – what is the evidence?
    Erling A Bringeland, Hans H Wasmuth, Jon E Grønbech
    Scandinavian Journal of Gastroenterology.2017; 52(6-7): 647.     CrossRef
  • Molecular classifications of gastric cancers: Novel insights and possible future applications
    Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino, Mariella Giovannoni, Nicoletta Pella, Mario Scartozzi, Lorenzo Antonuzzo,
    World Journal of Gastrointestinal Oncology.2017; 9(5): 194.     CrossRef
  • GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
    Puja Khanna, Pei Jou Chua, Belinda Shu Ee Wong, Changhong Yin, Aye Aye Thike, Wei Keat Wan, Puay Hoon Tan, Gyeong Hun Baeg
    Oncotarget.2017; 8(70): 115370.     CrossRef
  • Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
    Jiwon Koh, Chan-Young Ock, Jin Won Kim, Soo Kyung Nam, Yoonjin Kwak, Sumi Yun, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    Oncotarget.2017; 8(16): 26356.     CrossRef
Case Studies
IgG4-Related Disease Presented as a Mural Mass in the Stomach
Chang Gok Woo, Jeong Hwan Yook, Ah Young Kim, Jihun Kim
J Pathol Transl Med. 2016;50(1):67-70.   Published online September 30, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.28
  • 10,574 View
  • 92 Download
  • 21 Web of Science
  • 22 Crossref
AbstractAbstract PDF
Isolated gastric IgG4-related disease (IgG4-RD) is a very rare tumefactive inflammatory condition, with only a few cases reported to date. A 48-year-old woman was incidentally found to have a subepithelial tumor in the stomach. Given a presumptive diagnosis of gastrointestinal stromal tumor or neuroendocrine tumor, she underwent wedge resection. The lesion was vaguely nodular and mainly involved the submucosa and proper muscle layer. Microscopically, all classical features of type I autoimmune pancreatitis including lymphoplasmacytic infiltration, storiform fibrosis, obliterative phlebitis, and numerous IgG4-positive plasma cells were seen. She had no evidence of IgG4-RD in other organs. Although very rare, IgG4-RD should be considered one of the differential diagnoses in the setting of gastric wall thickening or subepithelial mass-like lesion. Deep biopsy with awareness of this entity might avoid unnecessary surgical intervention.

Citations

Citations to this article as recorded by  
  • Compromiso gástrico por enfermedad relacionada con IgG4
    Gilberto Jaramillo Trujillo, Oscar Fernando Ruiz, Melissa González Pabón, Maria Andrea Jaramillo Trujillo
    Revista Repertorio de Medicina y Cirugía.2024; 33(3): 319.     CrossRef
  • Value of High‐Frequency Ultrasonography in the Qualitative and Semi‐Quantitative Assessment of Immunoglobulin G4‐Related Submandibular Sialadenitis
    Lei Chen, Lin Nong, Jumei Liu, Luzeng Chen, Yuhong Shao, Xiuming Sun
    Journal of Ultrasound in Medicine.2023; 42(10): 2235.     CrossRef
  • IgG4-related pseudotumours: a series of 12 cases and a review of the literature
    Andrea Maccagno, Bianca Grosser, László Füzesi, Björn Konukiewitz, Dmytro Vlasenko, Dorothea Weckermann, Stephan Raab, Johannes Zenk, Abbas Agaimy, Bruno Märkl
    Pathology.2022; 54(5): 563.     CrossRef
  • IgG4-Related Disease With Gastrointestinal Involvement: Case Reports and Literature Review
    Xinhe Zhang, Xing Jin, Lin Guan, Xuyong Lin, Xuedan Li, Yiling Li
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Clinicopathological characteristics of gastric IgG4‐related disease: Systematic scoping review
    Haruki Sawada, Torrey Czech, Krixie Silangcruz, Landon Kozai, Adham Obeidat, Eric Andrew Wien, Midori Filiz Nishimura, Asami Nishikori, Yasuharu Sato, Yoshito Nishimura
    Journal of Gastroenterology and Hepatology.2022; 37(10): 1865.     CrossRef
  • Utility of gastric biopsy in diagnosing IgG4‐related gastrointestinal disease
    Kaori Uchino, Kenji Notohara, Takeshi Uehara, Yasuhiro Kuraishi, Junya Itakura, Akihiro Matsukawa
    Pathology International.2021; 71(2): 124.     CrossRef
  • A reappraisal of sclerosing nodular and/or polypoid lesions of the gastrointestinal tract rich in IgG4‐positive plasma cells
    Runjan Chetty
    Histopathology.2020; 76(6): 832.     CrossRef
  • Gastric IgG4-related disease presenting as a mass lesion and masquerading as a gastrointestinal stromal tumor
    Banumathi Ramakrishna, Rohan Yewale, Kavita Vijayakumar, Patta Radhakrishna, Balakrishnan Siddartha Ramakrishna
    Journal of Pathology and Translational Medicine.2020; 54(3): 258.     CrossRef
  • IgG4-related Sclerosing Disease Forming a Gastric Submucosal Tumor Diagnosed after Laparoscopic Endoscopic Cooperative Surgery—Report of a Case—
    Tatsuki ISHIKAWA, Katsunori NAKANO, Masafumi OSAKA, Yayoi KADOTANI, Kaori OKUGAWA, Kiyokazu AKIOKA, Kenta SHIGEMORI, Yohei HOSOKAWA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2020; 81(2): 254.     CrossRef
  • Calcifying fibrous tumor of the gastrointestinal tract: A clinicopathologic review and update
    Donald Turbiville, Xu-Chen Zhang
    World Journal of Gastroenterology.2020; 26(37): 5597.     CrossRef
  • A Suspected Case of IgG4-Related Appendiceal Pseudotumor
    Yudai Hojo, Yoshiharu Shirakata, Ai Izumi, Jun Matsui, Tokuyuki Yamashita, Hikaru Aoki, Makoto Kurimoto, Masaaki Hirata, Naoki Goda, Hiroaki Ito, Jun Tamura
    The Japanese Journal of Gastroenterological Surgery.2020; 53(12): 976.     CrossRef
  • Immunoglobulin G4-related gastric pseudotumor – An impostor: Case report
    Manuel Santiago Mosquera, Andrea Suarez Gómez, Hugo Herrera, Karen Moreno-Medina, Alejandro González-Orozco, Carlos J-Perez Rivera
    International Journal of Surgery Case Reports.2020; 75: 333.     CrossRef
  • Imaging and pathological features of gastric lesion of immunoglobulin G4-related disease: A case report and review of the recent literature
    Dai Inoue, Norihide Yoneda, Kotaro Yoshida, Hiromi Nuka, Jun Kinoshita, Sachio Fushida, Fumihito Toshima, Tetsuya Minami, Masayuki Takahira, Shoko Hamaoka, Hiroko Ikeda, Toshifumi Gabata, Mitsuhiro Kawano
    Modern Rheumatology.2019; 29(2): 377.     CrossRef
  • Immunoglobulin G4-Related Gastric Ulcer Mimicking Advanced Stomach Cancer in a Patient with Type I Autoimmune Pancreatitis
    Joung Ha Park, Jin Hee Noh, Jang ho Lee, Goeun Lee, Seung-Mo Hong, Kwang Bum Cho, Myung-Hwan Kim
    The Korean Journal of Medicine.2019; 94(3): 287.     CrossRef
  • Review of IgG4-related disease
    Raquel Sánchez-Oro, Elsa María Alonso-Muñoz, Lidia Martí Romero
    Gastroenterología y Hepatología (English Edition).2019; 42(10): 638.     CrossRef
  • Revisión de la enfermedad relacionada con la IgG4
    Raquel Sánchez-Oro, Elsa María Alonso-Muñoz, Lidia Martí Romero
    Gastroenterología y Hepatología.2019; 42(10): 638.     CrossRef
  • Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey
    Kenji Notohara, Terumi Kamisawa, Kazushige Uchida, Yoh Zen, Mitsuhiro Kawano, Satomi Kasashima, Yasuharu Sato, Masahiro Shiokawa, Takeshi Uehara, Hajime Yoshifuji, Hiroko Hayashi, Koichi Inoue, Keisuke Iwasaki, Hiroo Kawano, Hiroyuki Matsubayashi, Yukitos
    Journal of Gastroenterology.2018; 53(7): 845.     CrossRef
  • IgG4-Related Disease Mimicking Crohn’s Disease: A Case Report and Review of Literature
    Fabiana Ciccone, Antonio Ciccone, Mirko Di Ruscio, Filippo Vernia, Gianluca Cipolloni, Gino Coletti, Giuseppe Calvisi, Giuseppe Frieri, Giovanni Latella
    Digestive Diseases and Sciences.2018; 63(4): 1072.     CrossRef
  • IgG4-related Disease in the Stomach which Was Confused with Gastrointestinal Stromal Tumor (GIST): Two Case Reports and Review of the Literature
    Ho Seok Seo, Yoon Ju Jung, Cho Hyun Park, Kyo Young Song, Eun Sun Jung
    Journal of Gastric Cancer.2018; 18(1): 99.     CrossRef
  • Multivisceral IgG4-related disease presenting as recurrent massive gastrointestinal bleeding: a case report and literature review
    Xuexue Deng, Ronghua Fang, Jianshu Zhang, Rongqiong Li
    BMC Gastroenterology.2018;[Epub]     CrossRef
  • IgG4-Related Sclerosing Disease Presenting as a Gastric Submucosal Tumor
    Takashi Masuda, Toshifumi Matsumoto, Yushi Kaishakuji, Hirotada Tajiri, Akinori Egashira, Hirofumi Kawanaka
    The Japanese Journal of Gastroenterological Surgery.2018; 51(10): 599.     CrossRef
  • A rare case of IgG4-related disease: a gastric mass, associated with regional lymphadenopathy
    Dimitar Bulanov, Elena Arabadzhieva, Sasho Bonev, Atanas Yonkov, Diana Kyoseva, Tihomir Dikov, Violeta Dimitrova
    BMC Surgery.2016;[Epub]     CrossRef
Gastric-Type Extremely Well-Differentiated Adenocarcinoma of the Stomach: A Challenge for Preoperative Diagnosis
Mee Joo, Song Hee Han
J Pathol Transl Med. 2016;50(1):71-74.   Published online September 30, 2015
DOI: https://doi.org/10.4132/jptm.2015.07.14
  • 13,497 View
  • 179 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Gastric-type extremely well-differentiated adenocarcinoma (EWDA) is a rare type of gastric adenocarcinoma characterized by infiltration of well-formed mucinous glands with little or no nuclear atypia, which resemble foveolar epithelium or pyloric glands. Because of its high degree of differentiation, preoperative biopsy diagnosis of gastric-type EWDA is very difficult. We encountered a case of gastric-type EWDA, manifesting as a Borrmann type 4 lesion, in a 47-year-old man. Despite four repeated biopsies, the preoperative biopsy diagnosis was not conclusive due to the scarcity of diagnostic tumor cells and lack of knowledge regarding the unusual histologic findings of gastric-type EWDA. We herein describe the histologic findings of gastric-type EWDA in detail, with the aim of facilitating a preoperative biopsy diagnosis and understanding of this rare type of gastric adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Unusual or Uncommon Histology of Gastric Cancer
    Jinho Shin, Young Soo Park
    Journal of Gastric Cancer.2024; 24(1): 69.     CrossRef
  • Clinical pathological characteristics of “crawling-type” gastric adenocarcinoma cancer: A case report
    Yong-Wei Xu, Yan Song, Jun Tian, Ba-Cui Zhang, Yu-Sheng Yang, Jing Wang
    World Journal of Gastrointestinal Oncology.2024; 16(4): 1660.     CrossRef
  • Gastric-type extremely well-differentiated adenocarcinoma of the stomach: A rare tumor with diagnostic difficulties and high inter-observer variation in endoscopic pinch biopsies
    Soomin Ahn, Sujin Park, Hyun Hee Koh, Han Gyeol Kim, Hyunjin Kim, Jae Yeong Son, Boram Lee, Hyunwoo Lee, Soohyun Hwang, Junhun Cho, Yun Kyung Lee, Ryoji Kushima, Amitabh Srivastava, Kyoung-Mee Kim
    Pathology - Research and Practice.2024; 263: 155599.     CrossRef
  • Clinicopathological features of gastric adenocarcinoma of fundic gland type
    Bao-Zhen Guo, Zhen-Zhen Liu, Gao-Fei Shen, Fei Zhu, Hui-Fen Lian, Xin Li, Jun-Yi Zheng, Jin-Peng Li, Shui-Miao Deng, Rui Huang
    World Chinese Journal of Digestology.2023; 31(6): 244.     CrossRef
  • Characterization of pathological stomach tissue using polarization-sensitive second harmonic generation microscopy
    Hwanhee Jeon, MacAulay Harvey, Richard Cisek, Elisha Bennett, Danielle Tokarz
    Biomedical Optics Express.2023; 14(10): 5376.     CrossRef
  • Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy
    Jongwon Lee, In-Seob Lee, Ji Yong Ahn, Young Soo Park, Jihun Kim
    Journal of Pathology and Translational Medicine.2022; 56(2): 63.     CrossRef
  • Helicobacter pylori-negative Gastric Cancer
    Sun-Young Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 10.     CrossRef
  • Preoperative diagnosis of a gastric extremely well-differentiated adenocarcinoma
    Katsushi Suenaga, Shiro Matsumoto, Alan Kawarai Lefor, Yoshimasa Miura, Yoshinori Hosoya, Daigo Kuboki, Hidenori Haruta, Kentaro Kurashina, Atsushi Kihara, Daisuke Matsubara, Yasunari Sakuma, Joji Kitayama, Naohiro Sata
    International Journal of Surgery Case Reports.2020; 73(C): 319.     CrossRef
  • Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection
    Chengfang Li, Xinglong Wu, Shuang Yang, Xiaorong Yang, Jin Yao, Hong Zheng
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Gastric Adenocarcinoma of the Fundic Gland Type
    Mark A Benedict, Gregory Y Lauwers, Dhanpat Jain
    American Journal of Clinical Pathology.2018; 149(6): 461.     CrossRef
Original Articles
Endogenous Gastric-Resident Mesenchymal Stem Cells Contribute to Formation of Cancer Stroma and Progression of Gastric Cancer
Eun-Kyung Kim, Hye-Jung Kim, Young-Il Yang, Jong Tae Kim, Min-Young Choi, Chang Soo Choi, Kwang-Hee Kim, Jeong-Han Lee, Won-Hee Jang, Soon-Ho Cheong
Korean J Pathol. 2013;47(6):507-518.   Published online December 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.6.507
  • 10,217 View
  • 53 Download
  • 17 Crossref
AbstractAbstract PDF
Background

Carcinoma-associated fibroblasts (CAFs) contribute to carcinogenesis and cancer progression, although their origin and role remain unclear. We recently identified and investigated the in situ identity and implications of gastric submucosa-resident mesenchymal stem cells (GS-MSCs) in the progression of gastric carcinogenesis.

Methods

We isolated GS-MSCs from gastric submucosa using hydrogel-supported organ culture and defined their identity. Isolated cells were assessed in vitro by immunophenotype and mesengenic multipotency. Reciprocal interactions between GS-MSCs and gastric cancer cells were evaluated. To determine the role of GS-MSCs, xenografts were constructed of gastric cancer cells admixed with or without GS-MSCs.

Results

Isolated cells fulfilled MSCs requirements in regard to plastic adherence, stromal cell immunophenotype, and multipotency. We demonstrated a paracrine loop that gastric cancer cells enhanced the migration, proliferation, and differentiation of GS-MSCs; additionally, GS-MSCs promoted the proliferation of gastric cancer cell in vitro. Xenograft experiments showed that GS-MSCs significantly promoted cancer growth and angiogenesis. GS-MSCs that integrated into gastric cancer became not only CAFs but also rarely endothelial cells which contributed to the formation of cellular and vascular cancer stroma.

Conclusions

Endogenous GS-MSCs play an important role in gastric cancer progression.

Citations

Citations to this article as recorded by  
  • The therapeutic potential of mesenchymal stem cells in intestinal diseases: from mechanisms to clinical translation
    Jia-Zhi Yang, Li-Yan He, Xian-Zhou Lu
    Stem Cell Research & Therapy.2025;[Epub]     CrossRef
  • Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles
    Maryam Dolatshahi, Ahmad Reza Bahrami, Qaiser Iftikhar Sheikh, Mohsen Ghanbari, Maryam M. Matin
    Archives of Pharmacal Research.2024; 47(1): 1.     CrossRef
  • Extracellular vesicles derived from SARS-CoV-2 M-protein-induced triple negative breast cancer cells promoted the ability of tissue stem cells supporting cancer progression
    Hoai-Nga Thi Nguyen, Cat-Khanh Vuong, Mizuho Fukushige, Momoko Usuda, Liora Kaho Takagi, Toshiharu Yamashita, Mana Obata-Yasuoka, Hiromi Hamada, Motoo Osaka, Toru Tsukada, Yuji Hiramatsu, Osamu Ohneda
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression
    Yanyan Zhang, Charles Wang, Jian Jian Li
    Experimental Hematology & Oncology.2024;[Epub]     CrossRef
  • Mesenchymal stem cells and their potential therapeutic benefits and challenges in the treatment and pathogenesis of gastric cancer
    Asma'a H. Mohamed, Alaa Shafie, Waleed Al Abdulmonem, Hassan Swed Alzahrani, Amal Adnan Ashour, Ahmed Hjazi, Azfar Jamal, Allolo D. Aldreiwish, Mohammad Azhar Kamal, Fuzail Ahmad, Nazia Khan
    Pathology - Research and Practice.2024; 260: 155422.     CrossRef
  • Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer
    Peiyuan Li, Huan Zhang, Tao Chen, Yajing Zhou, Jiaoyang Yang, Jin Zhou
    Matrix Biology.2024; 132: 59.     CrossRef
  • Mesenchymal Stem Cell-Derived Exosomes Modulate Angiogenesis in Gastric Cancer
    Fawzy Akad, Veronica Mocanu, Sorin Nicolae Peiu, Viorel Scripcariu, Bogdan Filip, Daniel Timofte, Florin Zugun-Eloae, Magdalena Cuciureanu, Monica Hancianu, Teodor Oboroceanu, Laura Condur, Radu Florin Popa
    Biomedicines.2023; 11(4): 1031.     CrossRef
  • LRRC15 expression indicates high level of stemness regulated by TWIST1 in mesenchymal stem cells
    Kensuke Toriumi, Yuta Onodera, Toshiyuki Takehara, Tatsufumi Mori, Joe Hasei, Kanae Shigi, Natsumi Iwawaki, Toshifumi Ozaki, Masao Akagi, Mahito Nakanishi, Takeshi Teramura
    iScience.2023; 26(7): 106946.     CrossRef
  • Rat Adipose-Derived Stromal Cells (ADSCs) Increases the Glioblastoma Growth and Decreases the Animal Survival
    Isabele Cristiana Iser, Liziane Raquel Beckenkamp, Juliana Hofstatter Azambuja, Francine Luciano Rahmeier, Paula Andreghetto Bracco, Ana Paula Santin Bertoni, Rita de Cássia Sant’Anna Alves, Elizandra Braganhol, Léder Leal Xavier, Marilda da Cruz Fernande
    Stem Cell Reviews and Reports.2022; 18(4): 1495.     CrossRef
  • Mesenchymal/stromal stem cells: necessary factors in tumour progression
    Xinyu Li, Qing Fan, Xueqiang Peng, Shuo Yang, Shibo Wei, Jingang Liu, Liang Yang, Hangyu Li
    Cell Death Discovery.2022;[Epub]     CrossRef
  • Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression
    Sabine Galland, Ivan Stamenkovic
    The Journal of Pathology.2020; 250(5): 555.     CrossRef
  • A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy
    Yoon Khei Ho, Jun Yung Woo, Geraldine Xue En Tu, Lih-Wen Deng, Heng-Phon Too
    Scientific Reports.2020;[Epub]     CrossRef
  • Fruit-Derived Polysaccharides and Terpenoids: Recent Update on the Gastroprotective Effects and Mechanisms
    Mohammed Safwan Ali Khan, Syeda Umme Kulsoom Khundmiri, Syeda Rukhaiya Khundmiri, Mohammad M. Al-Sanea, Pooi Ling Mok
    Frontiers in Pharmacology.2018;[Epub]     CrossRef
  • Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
    Li Sun, Qianqian Wang, Bin Chen, Yuanyuan Zhao, Bo Shen, Hua Wang, Jing Xu, Miaolin Zhu, Xiangdong Zhao, Changgen Xu, Zhihong Chen, Mei Wang, Wenrong Xu, Wei Zhu
    Cell Death & Disease.2018;[Epub]     CrossRef
  • Mesenchymal stem cells: key players in cancer progression
    Sarah M. Ridge, Francis J. Sullivan, Sharon A. Glynn
    Molecular Cancer.2017;[Epub]     CrossRef
  • Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8
    Wei Li, Ying Zhou, Jin Yang, Xu Zhang, Huanhuan Zhang, Ting Zhang, Shaolin Zhao, Ping Zheng, Juan Huo, Huiyi Wu
    Journal of Experimental & Clinical Cancer Research.2015;[Epub]     CrossRef
  • Mesenchymal stem cells – A new hope for radiotherapy-induced tissue damage?
    Nils H. Nicolay, Ramon Lopez Perez, Juergen Debus, Peter E. Huber
    Cancer Letters.2015; 366(2): 133.     CrossRef
Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes
Joo-Yeun Kim, Na Ri Shin, Ahrong Kim, Hyun-Jeong Lee, Won-young Park, Jee-Yeon Kim, Chang-Hun Lee, Gi-Young Huh, Do Youn Park
Korean J Pathol. 2013;47(1):28-35.   Published online February 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.1.28
  • 12,539 View
  • 126 Download
  • 76 Crossref
AbstractAbstract PDF
Background

Gastric cancers with microsatellite instabilities (MSI) have been reported to be associated with favorable prognosis. However, the significance of the effect of MSI on the clinicopathological features, as well as its association with mucin phenotype, remains unclear.

Methods

MSI status was assessed in 414 cases of gastric cancer using polymerase chain reaction analysis of five microsatellite loci, as recommended by National Cancer Institution criteria. The expression of mucins (MUC5AC, MUC6, MUC2, and CD10) was assessed.

Results

Out of 414 total cases of gastric cancer, 380 (91.7%), 11 (2.7%), and 23 (5.6%) were microsatellite stable (MSS), low-level MSI (MSI-L), and high-level MSI (MSI-H), respectively. Compared to MSS/MSI-L, MSI-H gastric cancers were associated with older age (p=0.010), tumor size (p=0.014), excavated gross (p=0.042), intestinal type (p=0.028), aggressive behaviors (increase of T stage [p=0.009]), perineural invasion [p=0.022], and lymphovascular emboli [p=0.027]). MSI-H gastric cancers were associated with tumor necrosis (p=0.041), tumor-infiltrating lymphocytes (≥2/high power field, p<0.001), expanding growth patterns (p=0.038), gastric predominant mucin phenotypes (p=0.028), and MUC6 expression (p=0.016). Tumor necrosis (≥10% of mass, p=0.031), tumor-infiltrating lymphocytes (p<0.001), intestinal type (p=0.014), and gastric mucin phenotypes (p=0.020) could represent independent features associated with MSI-H gastric cancers. MSI-H intestinal type gastric cancers had a tendency for poor prognosis in univariate analysis (p=0.054) but no association in Cox multivariate analysis (p=0.197).

Conclusions

Our data suggest that MSI-H gastric cancers exhibit distinct aggressive biologic behaviors and a gastric mucin phenotype. This contradicts previous reports that describe MSI-H gastric cancer as being associated with favorable prognosis.

Citations

Citations to this article as recorded by  
  • Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
    Lei Wang, Mengting Sun, Jinyang Li, Linghong Wan, Yuting Tan, Shuoran Tian, Yongying Hou, Linyu Wu, Ziyi Peng, Xiao Hu, Qihua Zhang, Zening Huang, Mengyi Han, Shiyin Peng, Yuwei Pan, Yuanfeng Ren, Mengsi Zhang, Dongfeng Chen, Qin Liu, Xianfeng Li, Zhong-y
    Clinical Cancer Research.2025; 31(1): 74.     CrossRef
  • How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
    Christelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, Maria Alsina, Tania Fleitas-Kanonnikoff, Radka Lordick Obermannová, Anna Dorothea Wagner, Dominic Yap Wei Ting, Diana Enea, Angelica Petrillo, Elizabeth C. Smyth
    Cancer Treatment Reviews.2025; 134: 102890.     CrossRef
  • T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers
    Shiying Tang, Xiaofang Che, Jinyan Wang, Ce Li, Xin He, Kezuo Hou, Xiaojie Zhang, Jia Guo, Bowen Yang, Danni Li, Lili Cao, Xiujuan Qu, Zhenning Wang, Yunpeng Liu
    Nature Communications.2025;[Epub]     CrossRef
  • Prediction of a Panel of Programmed Cell Death Protein-1 (PD-1) Inhibitor–Sensitive Biomarkers Using Multiphase Computed Tomography Imaging Textural Features: Retrospective Cohort Analysis
    Shiqi Wang, Na Chai, Jingji Xu, Pengfei Yu, Luguang Huang, Quan Wang, Zhifeng Zhao, Bin Yang, Jiangpeng Wei, Xiangjie Wang, Gang Ji, Minwen Zheng
    JMIR Cancer.2025; 11: e67379.     CrossRef
  • Isolated tumor cell clusters (ITC) in lymph nodes and PD-L1 expression on tumor-associated immune cells are prognostic factors for microsatellite instable-high gastric cancers
    Menghan Cui, Yangli Zhou, Yin Han, Nannan Chen, Min Zhao, Yan Wang, Fengxia He
    Translational Oncology.2025; 59: 102465.     CrossRef
  • Microsatellite Instability and BAT-26 Marker Expression in a Mexican Prostate Cancer Population with Different Gleason Scores
    Ana K. Flores-Islas, Manuel A. Rico-Méndez, Marisol Godínez-Rubí, Martha Arisbeth Villanueva-Pérez, Erick Sierra-Díaz, Ana Laura Pereira-Suárez, Saul A. Beltrán-Ontiveros, Perla Y. Gutiérrez-Arzapalo, José M. Moreno-Ortiz, Adrián Ramírez-de-Arellano
    Diseases.2025; 13(7): 202.     CrossRef
  • Prognostic implications of ERBB2 amplification and mismatch repair in gastric adenocarcinoma: a single-center study
    Han Xia, Zekang Li, Minyi Wang, Dachuan Zhang, Xiao Zheng, Jun Wu, Chen Wu
    Gastrointestinal Tumors.2025;[Epub]     CrossRef
  • Microsatellite Instability in Chronic Gastritis Associated with Gastric Cancer
    A. V. Kononov, V. A. Rubtsov, E. V. Demidova, M. N. Parygina, A. G. Shimanskaya, S. I. Mozgovoi, E. G. Pomorgailo, М. V. Markelova
    Russian Journal of Gastroenterology, Hepatology, Coloproctology.2025; 35(4): 48.     CrossRef
  • Non–Pure Intestinal Phenotype as an Indicator of Progression in Sporadic Nonampullary Duodenal Adenomas: A Multicenter Retrospective Cohort Study
    Ryotaro Uema, Yoshito Hayashi, Masato Komori, Narihiro Shibukawa, Noriko Hayashi, Masayoshi Horimoto, Takuya Yamada, Masashi Yamamoto, Satoshi Hiyama, Kazuo Kinoshita, Hideharu Ogiyama, Shinjiro Yamaguchi, Satoshi Egawa, Takashi Kanesaka, Minoru Kato, Shu
    Clinical and Translational Gastroenterology.2024; 15(1): e00649.     CrossRef
  • Intratumoral and peritumoral CT-based radiomics for predicting the microsatellite instability in gastric cancer
    Xingchi Chen, Zijian Zhuang, Lin Pen, Jing Xue, Haitao Zhu, Lirong Zhang, Dongqing Wang
    Abdominal Radiology.2024; 49(5): 1363.     CrossRef
  • The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review
    J. Bos, T.S. Groen-van Schooten, C.P. Brugman, F.S. Jamaludin, H.W.M. van Laarhoven, S. Derks
    Cancer Treatment Reviews.2024; 127: 102737.     CrossRef
  • Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair
    Akira Ooki, Hiroki Osumi, Koichiro Yoshino, Kensei Yamaguchi
    Gastric Cancer.2024; 27(5): 907.     CrossRef
  • The mechanism of RGS5 regulating gastric cancer mismatch repair protein
    Zhenwei Yang, Ranran Zhang, Jialong Liu, Sufang Tian, Hailin Zhang, Lingxiu Zeng, Yangyang Zhang, Liping Gao, Meng Wang, Wenqing Shan, Jing Liu
    Molecular Carcinogenesis.2024; 63(9): 1750.     CrossRef
  • Prognostic significance of microsatellite instability in patients with resectable gastric cancer
    Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Leonardo Cardili, André Roncon Dias, Venancio Avancini Ferreira Alves, Evandro Sobroza de Mello, Ulysses Ribeiro
    Journal of Gastrointestinal Surgery.2024; 28(10): 1687.     CrossRef
  • Access to radiotherapy in improving gastric cancer care quality and equality
    Minmin Wang, Kepei Huang, Xiaohan Fan, Jia Wang, Yinzi Jin, Zhi-Jie Zheng
    Communications Medicine.2024;[Epub]     CrossRef
  • Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer
    Sung Hak Lee, Yujin Lee, Hyun‐Jong Jang
    International Journal of Cancer.2023; 152(2): 298.     CrossRef
  • Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
    Yasushi Sato, Koichi Okamoto, Yutaka Kawano, Akinari Kasai, Tomoyuki Kawaguchi, Tamotsu Sagawa, Masahiro Sogabe, Hiroshi Miyamoto, Tetsuji Takayama
    Journal of Clinical Medicine.2023; 12(14): 4646.     CrossRef
  • The results of treatment for resectable gastric cancer with microsatellite instability
    H. Sun, S. N. Nered, A. A. Tryakin, E. V. Artamonova, A. E. Kalinin, V. E. Bugaev, A. M. Stroganova, N. S. Besova, P. P. Arkhiri, V. I. Marshall, R. Sh. Abdulaeva, I. S. Stilidi
    Pelvic Surgery and Oncology.2023; 13(2): 17.     CrossRef
  • Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy
    Hui Wu, Wenyuan Ma, Congfa Jiang, Ning Li, Xin Xu, Yongfeng Ding, Haiping Jiang
    Annals of Surgical Oncology.2023; 30(13): 8572.     CrossRef
  • Dual-layer spectral-detector CT for predicting microsatellite instability status and prognosis in locally advanced gastric cancer
    Yongjian Zhu, Peng Wang, Bingzhi Wang, Zhichao Jiang, Ying Li, Jun Jiang, Yuxin Zhong, Liyan Xue, Liming Jiang
    Insights into Imaging.2023;[Epub]     CrossRef
  • Concordance between microsatellite instability testing and immunohistochemistry for mismatch repair proteins and efficient screening of mismatch repair deficient gastric cancer
    Gou Yamamoto, Tetsuya Ito, Okihide Suzuki, Nao Kamae, Miho Kakuta, Akemi Takahashi, Katsuya Iuchi, Tomio Arai, Hideyuki Ishida, Kiwamu Akagi
    Oncology Letters.2023;[Epub]     CrossRef
  • Low incidence of microsatellite instability in gastric cancers and its association with the clinicopathological characteristics: a comparative study
    Fateme Fooladi Talari, Ali Bozorg, Sirous Zeinali, Mohammadreza Zali, Zhale Mohsenifar, Hamid Asadzadeh Aghdaei, Kaveh Baghaei
    Scientific Reports.2023;[Epub]     CrossRef
  • Mutational separation and clinical outcomes of TP53 and CDH1 in gastric cancer
    He-Li Liu, Huan Peng, Chang-Hao Huang, Hai-Yan Zhou, Jie Ge
    World Journal of Gastrointestinal Surgery.2023; 15(12): 2855.     CrossRef
  • Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
    Haibo Qiu
    Global Medical Genetics.2022; 09(02): 060.     CrossRef
  • Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan
    Tsutomu Yoshida, Go Ogura, Mikiko Tanabe, Takuo Hayashi, Chiho Ohbayashi, Mizutomo Azuma, Chikara Kunisaki, Yoichi Akazawa, Soji Ozawa, Sohei Matsumoto, Takayoshi Suzuki, Akira Mitoro, Tetsu Fukunaga, Akiko Shimizu, Go Fujimoto, Takashi Yao
    Cancer Biology & Therapy.2022; 23(1): 191.     CrossRef
  • Development of Tissue-Agnostic Treatments for Patients with Cancer
    Steven Lemery, Lola Fashoyin-Aje, Leigh Marcus, Sandra Casak, Julie Schneider, Marc Theoret, Paul Kluetz, Richard Pazdur, Julia A. Beaver
    Annual Review of Cancer Biology.2022; 6(1): 147.     CrossRef
  • A multicenter study on the preoperative prediction of gastric cancer microsatellite instability status based on computed tomography radiomics
    Xiuqun Liang, Yinbo Wu, Ying Liu, Danping Yu, Chencui Huang, Zhi Li
    Abdominal Radiology.2022; 47(6): 2036.     CrossRef
  • Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer
    Zhenghang Wang, Qi Zhang, Changsong Qi, Yuezong Bai, Feilong Zhao, Hui Chen, Zhongwu Li, Xicheng Wang, Mifen Chen, Jifang Gong, Zhi Peng, Xiaotian Zhang, Jinping Cai, Shiqing Chen, Xiaochen Zhao, Lin Shen, Jian Li
    Journal for ImmunoTherapy of Cancer.2022; 10(6): e004703.     CrossRef
  • Eldest gastric cancer patient with high microsatellite instability responding to pembrolizumab
    Akinobu Wakasugi, Akinori Sasaki, Risa Okamoto, Yasuaki Motomura
    International Cancer Conference Journal.2022; 12(1): 59.     CrossRef
  • Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer
    Xiao-Li Wei, Jian-Ying Xu, De-Shen Wang, Dong-Liang Chen, Chao Ren, Jia-Ning Li, Feng Wang, Feng-Hua Wang, Rui-Hua Xu
    Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
  • Clinical and morphological portrait of tumors with microsatellite instability
    A. A. Musaelyan, V. D. Nazarov, A. S. Budnikova, S. V. Lapin, S. L. Vorobyev, V. L. Emanuel, A. A. Zakharenko, S. V. Orlov
    Advances in Molecular Oncology.2021; 8(2): 52.     CrossRef
  • How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches
    Michele Ghidini, Angelica Petrillo, Andrea Botticelli, Dario Trapani, Alessandro Parisi, Anna La Salvia, Elham Sajjadi, Roberto Piciotti, Nicola Fusco, Shelize Khakoo
    Journal of Clinical Medicine.2021; 10(7): 1412.     CrossRef
  • Microsatellite instability in Gastric Cancer: Between lights and shadows
    Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, Silvia Giordano
    Cancer Treatment Reviews.2021; 95: 102175.     CrossRef
  • Impact of microsatellite status on negative lymph node count and prognostic relevance after curative gastrectomy
    Zhenghao Cai, Junjun Ma, Shuchun Li, Abe Fingerhut, Jing Sun, Lu Zang, Chao Yan, Wentao Liu, Zhenggang Zhu, Minhua Zheng
    Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer
    Zhenghao Cai, Haiqin Song, Abe Fingerhut, Jing Sun, Junjun Ma, Luyang Zhang, Shuchun Li, Chaoran Yu, Minhua Zheng, Lu Zang
    BMC Cancer.2021;[Epub]     CrossRef
  • Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability–High Gastric Cancer
    Minsuk Kwon, Minae An, Samuel J. Klempner, Hyuk Lee, Kyoung-Mee Kim, Jason K. Sa, Hee Jin Cho, Jung Yong Hong, Taehyang Lee, Yang Won Min, Tae Jun Kim, Byung-Hoon Min, Woong-Yang Park, Won Ki Kang, Kyu-Tae Kim, Seung Tae Kim, Jeeyun Lee
    Cancer Discovery.2021; 11(9): 2168.     CrossRef
  • Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article
    Alexander R. Siebenhüner, Sara De Dosso, Daniel Helbling, Christoforos Astaras, Petr Szturz, Peter Moosmann, Stefanie Pederiva, Thomas Winder, Philippe Von Burg, Markus Borner
    Oncology Research and Treatment.2021; 44(9): 485.     CrossRef
  • High homogeneity of mismatch repair deficiency in advanced prostate cancer
    Christoph Fraune, Ronald Simon, Doris Höflmayer, Katharina Möller, David Dum, Franziska Büscheck, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Martina Kluth, Andrea Hinsch, Eike Burandt, Till Sebastian Clauditz, Waldemar Wilczak, Guido Sauter, Stefan Steu
    Virchows Archiv.2020; 476(5): 745.     CrossRef
  • High homogeneity of MMR deficiency in ovarian cancer
    Christoph Fraune, Janina Rosebrock, Ronald Simon, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Martina Kluth, Franziska Büscheck, Doris Höflmayer, Barbara Schmalfeldt, Volkmar Müller, Linn Wölber, Isabell Witzel, Peter Paluchowski, Christian Wilke, Uwe He
    Gynecologic Oncology.2020; 156(3): 669.     CrossRef
  • Molecular Classification of Gastric Cancer among Alaska Native People
    Holly Martinson, Dominic Mallari, Christine Richter, Tsung-Teh Wu, James Tiesinga, Steven Alberts, Matthew Olnes
    Cancers.2020; 12(1): 198.     CrossRef
  • Tumor immune response and immunotherapy in gastric cancer
    Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee
    Journal of Pathology and Translational Medicine.2020; 54(1): 20.     CrossRef
  • MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass
    Christoph Fraune, Ronald Simon, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Christian Kähler, Martina Kluth, Doris Höflmayer, Franziska Büscheck, David Dum, Andreas M. Luebke, Eike Burandt, Till Sebastian Clauditz, Waldemar Wilczak, Guido Sauter, Stefan
    Urologic Oncology: Seminars and Original Investigations.2020; 38(5): 488.     CrossRef
  • MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
    Christoph Fraune, Eike Burandt, Ronald Simon, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Martina Kluth, Franziska Büscheck, Doris Höflmayer, Niclas Ch. Blessin, Tim Mandelkow, Wenchao Li, Daniel Perez, Jakob R. Izbicki, Waldemar Wilczak, Guido Sauter, J
    Annals of Surgical Oncology.2020; 27(10): 3997.     CrossRef
  • CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
    Jerry B. Harvey, Luan H. Phan, Oscar E. Villarreal, Jessica L. Bowser
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer
    Zhihao Lu, Huan Chen, Shuang Li, Jifang Gong, Jian Li, Jianling Zou, Lihong Wu, Jianing Yu, Wenbo Han, Huaibo Sun, Xi Jiao, Xiaotian Zhang, Zhi Peng, Ming Lu, Zhenghang Wang, Henghui Zhang, Lin Shen
    Journal for ImmunoTherapy of Cancer.2020; 8(2): e000374.     CrossRef
  • Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray
    Chong Zhao, Zhiqiang Feng, Hongzhen He, Dan Zang, Hong Du, Hongli Huang, Yanlei Du, Jie He, Yongjian Zhou, Yuqiang Nie, Girijesh Kumar Patel
    PLOS ONE.2020; 15(10): e0238836.     CrossRef
  • Clinicopathologic Characteristics and Long-Term Outcome of Gastric Cancer Patients with Family History: Seven-Year Follow-Up Study for Korean Health Check-Up Subjects
    Jooyoung Lee, Su Jin Chung, Ji Min Choi, Yoo Min Han, Joo Sung Kim, Greger Lindberg
    Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
  • Implication of expression of MMR proteins and clinicopathological characteristics in gastric cancer
    Renu Verma, Puja Sakhuja, Ritu Srivastava, Prakash Chand Sharma
    Asia-Pacific Journal of Oncology.2020; : 1.     CrossRef
  • Prognostic significance of microsatellite‐instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy
    Georg Martin Haag, Elena Czink, Aysel Ahadova, Thomas Schmidt, Leila Sisic, Susanne Blank, Ulrike Heger, Leonidas Apostolidis, Anne Katrin Berger, Christoph Springfeld, Felix Lasitschka, Dirk Jäger, Magnus von Knebel Doeberitz, Matthias Kloor
    International Journal of Cancer.2019; 144(7): 1697.     CrossRef
  • Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer
    Zhihao Lu, Jianling Zou, Ying Hu, Shuang Li, Tao Zhou, Jifang Gong, Jian Li, Xiaotian Zhang, Jun Zhou, Ming Lu, Xicheng Wang, Zhi Peng, Changsong Qi, Yanyan Li, Jie Li, Yan Li, Jianyin Zou, Xiao Du, Henghui Zhang, Lin Shen
    JAMA Network Open.2019; 2(7): e197621.     CrossRef
  • Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications
    Carolina Martinez-Ciarpaglini, Tania Fleitas-Kanonnikoff, Valentina Gambardella, Marta Llorca, Cristina Mongort, Regina Mengual, Gema Nieto, Lara Navarro, Marisol Huerta, Susana Rosello, Desamparados Roda, Noelia Tarazona, Samuel Navarro, Gloria Ribas, An
    ESMO Open.2019; 4(3): e000470.     CrossRef
  • The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma
    Gagandeep Brar, Manish A. Shah
    Therapeutic Advances in Gastroenterology.2019;[Epub]     CrossRef
  • Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
    Alessandro Cavaliere, Valeria Merz, Simona Casalino, Camilla Zecchetto, Francesca Simionato, Hayley Louise Salt, Serena Contarelli, Raffaela Santoro, Davide Melisi
    Journal of Gastric Cancer.2019; 19(4): 375.     CrossRef
  • MICROSATELLITE INSTABILITY AND GASTRIC CARCINOMA. REVIEW OF THELITERATURE
    D. L. Rotin, O. V. Paklina, I. O. Tin’kova, D. N. Grekov
    Russian Journal of Biotherapy.2019; 18(4): 17.     CrossRef
  • Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer
    K Polom, L Marano, D Marrelli, R De Luca, G Roviello, V Savelli, P Tan, F Roviello
    Journal of British Surgery.2018; 105(3): 159.     CrossRef
  • Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes
    Chae H Kwon, Young K Kim, Sojeong Lee, Ahrong Kim, Hye J Park, Yuri Choi, Yeo J Won, Do Y Park, Gregory Y Lauwers
    Histopathology.2018; 72(4): 556.     CrossRef
  • Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches
    Margherita Ratti, Andrea Lampis, Jens C. Hahne, Rodolfo Passalacqua, Nicola Valeri
    Cellular and Molecular Life Sciences.2018; 75(22): 4151.     CrossRef
  • High-throughput Protein and mRNA Expression–based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications
    Sangjeong Ahn, So-Jeong Lee, Yonugkeum Kim, Ahrong Kim, Nari Shin, Kyung Un Choi, Chang-Hun Lee, Gi Yeong Huh, Kyong-Mee Kim, Namrata Setia, Gregory Y. Lauwers, Do Youn Park
    American Journal of Surgical Pathology.2017; 41(1): 106.     CrossRef
  • Molecular Testing for Gastrointestinal Cancer
    Hye Seung Lee, Woo Ho Kim, Yoonjin Kwak, Jiwon Koh, Jeong Mo Bae, Kyoung-Mee Kim, Mee Soo Chang, Hye Seung Han, Joon Mee Kim, Hwal Woong Kim, Hee Kyung Chang, Young Hee Choi, Ji Y. Park, Mi Jin Gu, Min Jin Lhee, Jung Yeon Kim, Hee Sung Kim, Mee-Yon Cho
    Journal of Pathology and Translational Medicine.2017; 51(2): 103.     CrossRef
  • Molecular testing of gastrointestinal tumours
    Matthew Evans, Matthew Smith, Brendan O'Sullivan, Philippe Taniere
    Diagnostic Histopathology.2017; 23(10): 442.     CrossRef
  • Gastric Carcinomas With Lymphoid Stroma
    Raul S Gonzalez, Justin M M Cates, Frank Revetta, Loralee A McMahon, Kay Washington
    American Journal of Clinical Pathology.2017; 148(6): 477.     CrossRef
  • Meta-Analysis of Prognostic Role of Ki-67 Labeling Index in Gastric Carcinoma
    Jung-Soo Pyo, Nae Yu Kim
    The International Journal of Biological Markers.2017; 32(4): 447.     CrossRef
  • Tissue-Agnostic Drug Development
    Keith T. Flaherty, Dung T. Le, Steven Lemery
    American Society of Clinical Oncology Educational Book.2017; (37): 222.     CrossRef
  • Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection
    Mi Jung Kwon, Kab-Choong Kim, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Hye Kyung Lee, Ho Suk Kang, Kyueng-Whan Min
    Oncotarget.2017; 8(47): 82399.     CrossRef
  • Hypermutation and microsatellite instability in gastrointestinal cancers
    Kizuki Yuza, Masayuki Nagahashi, Satoshi Watanabe, Kazuaki Takabe, Toshifumi Wakai
    Oncotarget.2017; 8(67): 112103.     CrossRef
  • The Emerging Role of Immunotherapy in Gastric and Esophageal Adenocarcinoma
    Bruno Bockorny, Eirini Pectasides
    Future Oncology.2016; 12(15): 1833.     CrossRef
  • Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland
    Katarzyna Karpińska-Kaczmarczyk, Magdalena Lewandowska, Małgorzata Ławniczak, Andrzej Białek, Elżbieta Urasińska
    Medical Science Monitor.2016; 22: 2886.     CrossRef
  • Immunotherapy for Gastroesophageal Cancer
    Emily Goode, Elizabeth Smyth
    Journal of Clinical Medicine.2016; 5(10): 84.     CrossRef
  • Lauren classification and individualized chemotherapy in gastric cancer
    JUNLI MA, HONG SHEN, LINDA KAPESA, SHAN ZENG
    Oncology Letters.2016; 11(5): 2959.     CrossRef
  • High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability
    Karol Polom, Daniele Marrelli, Valeria Pascale, Giandomenico Roviello, Costantino Voglino, Henry Rho, Carla Vindigni, Mario Marini, Raffaele Macchiarelli, Franco Roviello
    Journal of Cancer Research and Clinical Oncology.2016; 142(8): 1817.     CrossRef
  • MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis
    Jung-Soo Pyo, Jin Hee Sohn, Guhyun Kang, Dong-Hoon Kim, Kyungeun Kim, In-Gu Do, Dong Hyun Kim
    Journal of Pathology and Translational Medicine.2015; 49(3): 249.     CrossRef
  • Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma
    Jiwoon Choi, Soo Kyung Nam, Do Joong Park, Hwal Woong Kim, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    APMIS.2015; 123(3): 215.     CrossRef
  • Clinicopathologic and molecular features associated with patient age in gastric cancer
    Ji Yeon Seo, Eun Hyo Jin, Hyun Jin Jo, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Hyun Chae Jung, Dong Ho Lee
    World Journal of Gastroenterology.2015; 21(22): 6905.     CrossRef
  • Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
    Ismael Riquelme, Kathleen Saavedra, Jaime A. Espinoza, Helga Weber, Patricia García, Bruno Nervi, Marcelo Garrido, Alejandro H. Corvalán, Juan Carlos Roa, Carolina Bizama
    Oncotarget.2015; 6(28): 24750.     CrossRef
  • A phylogenetic model for understanding the effect of gene duplication on cancer progression
    Qin Ma, Jaxk H. Reeves, David A. Liberles, Lili Yu, Zheng Chang, Jing Zhao, Juan Cui, Ying Xu, Liang Liu
    Nucleic Acids Research.2014; 42(5): 2870.     CrossRef
  • The analysis of microsatellite instability in extracolonic gastrointestinal malignancy
    Andrew S. Williams, Weei-Yuarn Huang
    Pathology.2013; 45(6): 540.     CrossRef
Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma
Youngran Kang, Woon Yong Jung, Hyunjoo Lee, Eunjung Lee, Aeree Kim, Baek-hui Kim
Korean J Pathol. 2012;46(6):523-531.   Published online December 26, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.6.523
  • 10,300 View
  • 50 Download
  • 31 Crossref
AbstractAbstract PDF
Background

Sirtuin 1 (SIRT1) and deleted in breast cancer 1 (DBC1) are known as tumor suppressor or promoter genes. This may be due to their diverse functions and interaction with other proteins. Gastric adenocarcinoma is one of the most common malignancies, but little is known about its carcinogenesis. Therefore, we investigated the association of immunohistochemical expression of SIRT1, DBC1, p53, and β-catenin and their variable clinicopathological characteristics.

Methods

We obtained samples from 452 patients who underwent gastrectomy. Tissue microarray blocks were constructed and immonohistochemical staining was performed.

Results

Expression of DBC1 and SIRT1 was associated with lower histologic grade, intestinal type of Lauren classification, and lower pT (p<0.001) and pN stage (DBC1, p=0.002; SIRT1, p<0.001). Association between absence of lymphatic invasion, and SIRT1 (p=0.001) and DBC1 (p=0.004) was observed. Cytoplasmic β-catenin expression was associated with lower histologic grade, pT, pN, tumor-node-metastasis (TNM) stage, DBC1 (p<0.001), and SIRT1 (p=0.001). Expression of SIRT1 and DBC1 was not associated with p53 (p=0.063 and p=0.060). DBC1 was an independent good prognostic factor in multivariate analysis (p=0.012).

Conclusions

SIRC1 and DBC1 can be considered to be good prognostic factors in gastric adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Regulatory role of DBC1 in inflammation and autoimmune diseases
    Jinzhi Wu, Fan Yang, Guanhua Xu, Xinlei Ma, Jin Lin, Weiqian Chen
    Rheumatology & Autoimmunity.2025; 5(1): 15.     CrossRef
  • Prognostic and clinicopathological value of dbc1 expression in human cancers: a systematic review and meta-analysis
    Haojia Wang, Xinhong Cheng, Bruce Xianzhuo Zhang, Yong Wang, Shuo Gao, Fanghui Ding, Xiaojing Song, Dandan Li, Haixu Ni, Yang Luo, Xun Li
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Mechanistic insights into the dual role of CCAR2/DBC1 in cancer
    Hwa Jin Kim, Sue Jin Moon, Jeong Hoon Kim
    Experimental & Molecular Medicine.2023; 55(8): 1691.     CrossRef
  • Sirtuins (SIRTs) As a Novel Target in Gastric Cancer
    Agata Poniewierska-Baran, Paulina Warias, Katarzyna Zgutka
    International Journal of Molecular Sciences.2022; 23(23): 15119.     CrossRef
  • Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
    Amandine Badie, Christian Gaiddon, Georg Mellitzer
    Cancers.2022; 14(21): 5472.     CrossRef
  • Advances on the role of the deleted in breast cancer (DBC1) in cancer and autoimmune diseases
    Qiannan Fang, Joseph A Bellanti, Song Guo Zheng
    Journal of Leukocyte Biology.2021; 109(2): 449.     CrossRef
  • miR-1301-3p Promotes Cell Proliferation and Facilitates Cell Cycle Progression via Targeting SIRT1 in Gastric Cancer
    Dakui Luo, Hao Fan, Xiang Ma, Chao Yang, Yu He, Yugang Ge, Mingkun Jiang, Zekuan Xu, Li Yang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis
    Gavin S. Johnson, Praveen Rajendran, Roderick H. Dashwood
    Cancer Science.2020; 111(10): 3416.     CrossRef
  • Role of Histone Acetylation in Gastric Cancer: Implications of Dietetic Compounds and Clinical Perspectives
    Danielle Q Calcagno, Fernanda Wisnieski, Elizangela R da Silva Mota, Stefanie B Maia de Sousa, Jéssica M Costa da Silva, Mariana F Leal, Carolina O Gigek, Leonardo C Santos, Lucas T Rasmussen, Paulo P Assumpção, Rommel R Burbano, Marília AC Smith
    Epigenomics.2019; 11(3): 349.     CrossRef
  • Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis
    Min Sun, Mengyu Du, Wenhua Zhang, Sisi Xiong, Xingrui Gong, Peijie Lei, Jin Zha, Hongrui Zhu, Heng Li, Dong Huang, Xinsheng Gu
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology
    Martina Magni, Giacomo Buscemi, Laura Zannini
    Mutation Research/Reviews in Mutation Research.2018; 776: 1.     CrossRef
  • NANOGP8 expression regulates gastric cancer cell progression by transactivating DBC1 in gastric cancer MKN‑45 cells
    Li Li, Ru Feng, Sujuan Fei, Jiang Cao, Qinqin Zhu, Guozhong Ji, Jianwei Zhou
    Oncology Letters.2018;[Epub]     CrossRef
  • Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma
    Changcan Li, Jianhua Liao, Shaohan Wu, Junwei Fan, Zhihai Peng, Zhaowen Wang
    Biochemical and Biophysical Research Communications.2017; 494(3-4): 511.     CrossRef
  • Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer
    Xiaobing Shen, Pengfei Li, Yuchao Xu, Xiaowei Chen, Haixiang Sun, Ying Zhao, Mengqi Liu, Wenwen Zhang
    Oncotarget.2017; 8(43): 74359.     CrossRef
  • Co-ordinated overexpression of SIRT1 and STAT3 is associated with poor survival outcome in gastric cancer patients
    Shu Zhang, Shuling Huang, Chao Deng, Yu Cao, Jun Yang, Guangxia Chen, Bin Zhang, Chaoqin Duan, Jiong Shi, Bo Kong, Helmut Friess, Nanyi Zhao, Chen Huang, Xiaoli Huang, Lei Wang, Xiaoping Zou
    Oncotarget.2017; 8(12): 18848.     CrossRef
  • The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
    Changwen Wang, Wen Yang, Fang Dong, Yawen Guo, Jie Tan, Shengnan Ruan, Tao Huang
    Oncotarget.2017; 8(39): 66343.     CrossRef
  • SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer
    Min-Sun Jin, Chang Lim Hyun, In Ae Park, Ji Young Kim, Yul Ri Chung, Seock-Ah Im, Kyung-Hun Lee, Hyeong-Gon Moon, Han Suk Ryu
    Tumor Biology.2016; 37(4): 4743.     CrossRef
  • Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis
    Bin Jiang, Jin-huang Chen, Wen-zheng Yuan, Jin-tong Ji, Zheng-yi Liu, Liang Wu, Qiang Tang, Xiao-gang Shu
    Journal of Huazhong University of Science and Technology [Medical Sciences].2016; 36(2): 278.     CrossRef
  • Significance of silent mating type information regulation 2 homolog 1 and claudin 4 expression in gastric carcinoma and precursor lesions
    Nashwa M. Emara, Ranih Z. Amer, Khaled M. Elsadek Attia, Heba M. Rashad, Adel Z. Elseady, Abd El-Latif M. Elbalshy
    Egyptian Journal of Pathology.2016; 36(2): 158.     CrossRef
  • Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype
    Yul Ri Chung, Hyojin Kim, Soo Young Park, In Ae Park, Ja June Jang, Ji-Young Choe, Yoon Yang Jung, Seock-Ah Im, Hyeong-Gon Moon, Kyung-Hun Lee, Koung Jin Suh, Tae-Yong Kim, Dong-Young Noh, Wonshik Han, Han Suk Ryu
    Human Pathology.2015; 46(7): 1027.     CrossRef
  • SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment
    Guanglin Qiu, Xuqi Li, Xiangming Che, Chao Wei, Shicai He, Jing Lu, Zongliang Jia, Ke Pang, Lin Fan
    FEBS Letters.2015; 589(16): 2034.     CrossRef
  • DBC1 Functions as a Tumor Suppressor by Regulating p53 Stability
    Bo Qin, Katherine Minter-Dykhouse, Jia Yu, Jun Zhang, Tongzheng Liu, Haoxing Zhang, SeungBaek Lee, JungJin Kim, Liewei Wang, Zhenkun Lou
    Cell Reports.2015; 10(8): 1324.     CrossRef
  • DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-κB activity
    YONGWEI HUAN, DEPING WU, DAYONG ZHOU, BO SUN, GUOXIN LI
    Oncology Reports.2015; 34(2): 843.     CrossRef
  • Resveratrol relieves ischemia‑induced oxidative stress in the hippocampus by activating SIRT1
    Zhuangzhi Meng, Jianguo Li, Honglin Zhao, Haiying Liu, Guowei Zhang, Lingzhan Wang, He Hu, Di Li, Mingjing Liu, Fulong Bi, Xiaoping Wang, Geng Tian, Qiang Liu, Batu Buren
    Experimental and Therapeutic Medicine.2015;[Epub]     CrossRef
  • CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells
    Wootae Kim, Joo-Won Jeong, Ja-Eun Kim
    Tumor Biology.2014; 35(11): 10919.     CrossRef
  • Radioprotective and Antioxidant Effect of Resveratrol in Hippocampus by Activating Sirt1
    Jianguo Li, Li Feng, Yonghua Xing, Yan Wang, Liqing Du, Chang Xu, Jia Cao, Qin Wang, Saijun Fan, Qiang Liu, Feiyue Fan
    International Journal of Molecular Sciences.2014; 15(4): 5928.     CrossRef
  • SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer
    Akira Noguchi, Keiji Kikuchi, Huachuan Zheng, Hiroyuki Takahashi, Yohei Miyagi, Ichiro Aoki, Yasuo Takano
    Cancer Medicine.2014; 3(6): 1553.     CrossRef
  • Sirtuins and Cancer: New Insights and Cell Signaling
    Marcos Vinícius Macedo de Oliveira, João Marcus Oliveira Andrade, Alanna Fernandes Paraíso, Sérgio Henrique Sousa Santos
    Cancer Investigation.2013; 31(10): 645.     CrossRef
  • Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer
    Eduardo Nunes Chini, Claudia C. S. Chini, Veronica Nin, Carlos Escande
    Bioscience Reports.2013;[Epub]     CrossRef
  • SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer
    Wonkyung Jung, Kwang Dae Hong, Woon Yong Jung, Eunjung Lee, Bong Kyung Shin, Han Kyeom Kim, Aeree Kim, Baek-hui Kim
    Korean Journal of Pathology.2013; 47(4): 332.     CrossRef
  • Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1
    Li-Hua Zhang, Qin Huang, Xiang-Shan Fan, Hong-Yan Wu, Jun Yang, An-Ning Feng
    Pathology - Research and Practice.2013; 209(10): 611.     CrossRef
Case Reports
Multifocal Adenocarcinomas Arising within a Gastric Inverted Hyperplastic Polyp
Hyun-Soo Kim, Eun-Jung Hwang, Jae-Young Jang, Juhie Lee, Youn Wha Kim
Korean J Pathol. 2012;46(4):387-391.   Published online August 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.4.387
  • 9,226 View
  • 65 Download
  • 14 Crossref
AbstractAbstract PDF

We present herein the occurrence of multifocal adenocarcinomas with a minute signet ring cell carcinoma that arose within a gastric inverted hyperplastic polyp (IHP) in a 40-year-old woman. Endoscopic ultrasonography demonstrated a heterogeneous hypoechoic mass in the third layer of the gastric wall. The endoscopic submucosal dissection specimen measuring 3.5×3.2×1.8 cm was a well-circumscribed protruding lesion that had a slit-shaped cavity. Histologically, the lesion consisted mainly of endophytic proliferation of hyperplastic columnar cells resembling normal foveolar epithelium. In addition, six foci of adenocarcinomas and a minute focus of signet ring cell carcinoma were randomly distributed in the superficial and deep regions. The adenocarcinoma was gradually transitioning from dysplasia, while the signet ring cell carcinoma was surrounded by hyperplastic foveolar epithelium. This is the first report of a gastric IHP with multifocal intramucosal adenocarcinomas and a signet ring cell carcinoma, and endoscopic submucosal dissection is used to completely resect it.

Citations

Citations to this article as recorded by  
  • Case report and literature analysis of ectopic gastric glands combined with intestinal-type gastric cancer in an HP-negative background
    Shiyu Peng, Shuxin Tian
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Clinicopathologic and endoscopic characteristics of ten patients with gastric hamartomatous inverted polyp: a single center case series
    Ningning Dong, Fandong Meng, Bing Yue, Junzhen Hou
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Gastric hamartomatous inverted polyp: Report of three cases with a review of the endoscopic and clinicopathological features
    Takuya Ohtsu, Yu Takahashi, Mitsuo Tokuhara, Tomomitsu Tahara, Mitsuaki Ishida, Chika Miyasaka, Koji Tsuta, Makoto Naganuma
    DEN Open.2023;[Epub]     CrossRef
  • Gastric Inverted Hyperplastic Polyp Removed Using Endoscopic Submucosal Dissection
    Jee Won Boo, Joon Sung Kim, Byung-Wook Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(1): 63.     CrossRef
  • The Many Faces of Gastric Inverted Polyps: a case report
    S.I. Kim, M.Y. Agapov, T.F. Savostyanov, A.A. Paratovskaya, I.A. Sokolova
    Russian Journal of Evidence-Based Gastroenterology.2023; 12(2): 88.     CrossRef
  • Large gastric hamartomatous inverted polyp accompanied by advanced gastric cancer: A case report
    Gyerim Park, Jihye Kim, Sung Hak Lee, Younghoon Kim
    World Journal of Clinical Cases.2023; 11(28): 6967.     CrossRef
  • Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach
    Hourin Cho, Taiki Hashimoto, Tomoaki Naka, Yasushi Yatabe, Ichiro Oda, Yutaka Saito, Takaki Yoshikawa, Shigeki Sekine
    Journal of Gastroenterology.2022; 57(5): 333.     CrossRef
  • Gastric Inverted Polyps—Distinctive Subepithelial Lesions of the Stomach
    Ji-Ye Kim, Soomin Ahn, Kyoung-Mee Kim, Sun Hee Chang, Han Seong Kim, Jun Haeng Lee, Jae J. Kim, Tae Sung Sohn, Hye Ju Kang, Mee Joo
    American Journal of Surgical Pathology.2021; 45(5): 680.     CrossRef
  • Signet-ring Cell Carcinoma in Hyperplastic Polyp of the Stomach
    Kenta Yoshida, Tatsuya Mikami, Takao Oyama, Yuki Sato, Taro Saito, Takafumi Mikami, Chieko Itabashi, Yasushi Soma, Shinsaku Fukuda
    Internal Medicine.2019; 58(24): 3531.     CrossRef
  • Inverted Hyperplastic Polyp in Stomach: A Case Report and Literature Review
    Yeon Ho Lee, Moon Kyung Joo, Beom Jae Lee, Ji-Ae Lee, Taehyun Kim, Jin Gu Yoon, Jung Min Lee, Jong-Jae Park
    The Korean Journal of Gastroenterology.2016; 67(2): 98.     CrossRef
  • Inflammatory myofibroblastic tumor‐like stromal proliferation within gastric inverted hyperplastic polyp
    Byeong‐Joo Noh, Ji Won Min, Ji‐Youn Sung, Yong‐Koo Park, Juhie Lee, Youn Wha Kim
    Pathology International.2016; 66(3): 180.     CrossRef
  • Gastric inverted hyperplastic polyp: A rare cause of iron deficiency anemia
    Jin Tak Yun, Seung Woo Lee, Dong Pil Kim, Seung Hwa Choi, Seok-Hwan Kim, Jun Kyu Park, Sun Hee Jang, Yun Jung Park, Ye Gyu Sung, Hae Jung Sul
    World Journal of Gastroenterology.2016; 22(15): 4066.     CrossRef
  • Gastric Inverted Hyperplasic Polyp Composed Only of Pyloric Glands
    Minsun Jung, Kyueng-Whan Min, Young-Joon Ryu
    International Journal of Surgical Pathology.2015; 23(4): 313.     CrossRef
  • A Pedunculated Submucosal Lesion in the Stomach with Inverted Downgrowth
    Yoshihiko Miyamoto, Naoki Muguruma, Seisuke Okamura, Yasuyuki Okada, Shinji Kitamura, Koichi Okamoto, Akiko Yoneda, Noriko Kagawa, Tetsuji Takayama
    Internal Medicine.2014; 53(15): 1625.     CrossRef
Collision of Adenocarcinoma and Schwannoma of the Stomach: A Case Report
Jai Hyang Go
Korean J Pathol. 2012;46(4):373-376.   Published online August 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.4.373
  • 8,422 View
  • 36 Download
  • 4 Crossref
AbstractAbstract PDF

The simultaneous occurrence of an adenocarcinoma and schwannoma is extremely rare in the stomach, and only one such case has been previously reported, which presented as two separate masses. Indeed, the collision of these tumors has never been reported. We report the case of a 61-year-old male patient who was diagnosed with the synchronous development of a schwannoma and advanced mucinous adenocarcinoma of the stomach, in which the carcinoma cells focally invaded the schwannoma.

Citations

Citations to this article as recorded by  
  • What About Gastric Schwannoma? A Review Article
    Sara Lauricella, Sergio Valeri, Gianluca Mascianà, Ida Francesca Gallo, Erica Mazzotta, Chiara Pagnoni, Saponaro Costanza, Lorenza Falcone, Domenico Benvenuto, Marco Caricato, Gabriella Teresa Capolupo
    Journal of Gastrointestinal Cancer.2021; 52(1): 57.     CrossRef
  • SYNCHRONOUS DEVELOPMENT OF SCHWANNOMA AND PRIMARY ADENOCARCINOMA IN THE STOMACH: A CASE REPORT
    Algirdas Šlepavičius, Valdas Gasilionis, Alvydas Česas
    Visuomenės sveikata.2019; 28(7): 75.     CrossRef
  • Gastric Collision Tumors: An Insight into Their Origin and Clinical Significance
    Adamantios Michalinos, Anastasia Constantinidou, Michael Kontos
    Gastroenterology Research and Practice.2015; 2015: 1.     CrossRef
  • Coexistence of gastrointestinal stromal tumor and inflammatory myofibroblastic tumor of the stomach presenting as a collision tumor: first case report and literature review
    Hyeong Chan Shin, Mi Jin Gu, Se Won Kim, Jae Woon Kim, Joon Hyuk Choi
    Diagnostic Pathology.2015;[Epub]     CrossRef
Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: Report of Two Cases and Review of the Literature
Youngran Kang, Wonkyung Jung, In-Gu Do, Eui Jin Lee, Min Hyeong Lee, Kyoung-Mee Kim, Jongsang Choi
Korean J Pathol. 2012;46(3):292-296.   Published online June 22, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.3.292
  • 10,357 View
  • 75 Download
  • 30 Crossref
AbstractAbstract PDF

Plexiform angiomyxoid myofibroblastic tumor (PAMT) of the stomach is a recently recognized entity. Because of its rarity, only 22 cases have been reported in the English-language literature and most of these are single case reports. We report two cases of gastric PAMT. The tumor cells were bland and plexiform arranged in a myxoid stroma, which was positive for alcian blue. Immunohistochemically, the tumor cells were positive for smooth muscle actin, but negative for c-kit, CD34, desmin, S-100 protein, epithelial membrane antigen, neurofilament, and protein kinase C-theta. Mutation analyses for exon 9, 11, 13, and 17 of KIT genes and 12, 14, and 18 of the platelet-derived growth factor receptor alpha (PDGFRA) genes were performed and the tumors were wild-type for mutation.

Citations

Citations to this article as recorded by  
  • Plexiform Fibromyxoma in the Stomach: Immunohistochemical Profile and Comprehensive Genetic Characterization
    Annabella Di Mauro, Rosalia Anna Rega, Maddalena Leongito, Vittorio Albino, Raffaele Palaia, Alberto Gualandi, Andrea Belli, Imma D’Arbitrio, Pasquale Moccia, Salvatore Tafuto, Annarosaria De Chiara, Alessandro Ottaiano, Gerardo Ferrara
    International Journal of Molecular Sciences.2024; 25(9): 4847.     CrossRef
  • Endoscopic submucosal excavation for gastric plexiform fibromyxoma: A case report and systematic review of literature
    Ziqin Xia, Zhidai Zhou, Wei Guo, Hongling Wang, Fan Wang, Feng Zhou
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Recurrent plexiform angiomyxoid myofibroblastic tumour (PAMT) of the stomach with aggressive behaviour
    Pavithra Ayyanar, Hemanta Kumar Nayak, Subash Chandra Samal, Madhabananda Kar, Pritinanda Mishra, Susama Patra
    Pathology.2022; 54(5): 650.     CrossRef
  • An Unusual Stomach Tumour: Plexiform Angiomyxoid Fibroma Stomach—A Case Report
    Sharath K. Krishnan, Ravindran Chirukandath, Togy Zachariah, Rajiv Sajan Thomas
    Indian Journal of Surgical Oncology.2022; 13(4): 691.     CrossRef
  • Gastric Plexiform Fibromyxoma: A Case Report and Literature Review
    路 张
    Advances in Clinical Medicine.2022; 12(12): 12033.     CrossRef
  • Plexiform angiomyxoid myofibroblastic tumor treated by endoscopic submucosal dissection: A case report and review of the literature
    Jian-Di Wu, Yi-Xiong Chen, Chang Luo, Feng-Hua Xu, Lei Zhang, Xiao-Hua Hou, Jun Song
    World Journal of Gastroenterology.2021; 27(31): 5288.     CrossRef
  • Gastric Plexiform Fibromyxoma with Two Different Growth Patterns on Histological Images: a Case Report
    Zhenyu Li, Qingming Jiang, Dongfang Guo, Yangling Peng, Jing Zhang, Xinyu Chen
    Journal of Gastric Cancer.2021; 21(2): 213.     CrossRef
  • Gastric plexiform fibromyxoma resected by endoscopic submucosal dissection: A case report and review of literature
    XiaoBo Zhao, XinLou Li, Xin Huang, Le Shang, JianZhong Zhang, JiHua Wu
    Human Pathology: Case Reports.2021; 23: 200468.     CrossRef
  • Plexiform fibromyxoma: a clinicopathological and immunohistochemical analysis of two cases with a literature review
    Shaofei Ma, Jing Wang, Zhanjun Lu, Chaoying Shi, Daohua Yang, Jun Lin
    Journal of International Medical Research.2021;[Epub]     CrossRef
  • A rare case of plexiform fibromyxoma in stomach: FNA diagnosis with histological correlation and differential diagnoses
    Yujun Gan, Ghassan Hammoud, Magda Esebua
    Annals of Diagnostic Pathology.2020; 44: 151453.     CrossRef
  • Gastric plexiform fibromyxoma: A case report
    Jin-Yu Pei, Bin Tan, Peng Liu, Guang-Hua Cao, Zu-Sen Wang, Lin-Lin Qu
    World Journal of Clinical Cases.2020; 8(22): 5639.     CrossRef
  • GASTRIC PLEXIFORM FIBROMYXOMA, AN UNCOMMON MESENCHYMAL TUMOR
    Cristina Magadán Álvarez, Jose M. Olmos-Martínez, M Soledad Trugeda Carrera, María José Fernandez Diaz, Enrique Toledo Martínez, Remigio Mazorra Horts, Marta M Mayorga Fernández, Ruben Darío Arias Pacheco, Berta Martín Rivas
    Revista Española de Enfermedades Digestivas.2020;[Epub]     CrossRef
  • Pediatric plexiform fibromyxoma
    Mitsuharu Fukazawa, Hiroshi Koga, Shoji Hiroshige, Toshifumi Matsumoto, Yuichi Nakazono, Yasuji Yoshikawa
    Medicine.2019; 98(3): e14186.     CrossRef
  • An Update on Clinicopathological and Molecular Features of Plexiform Fibromyxoma
    Hsuan-An Su, Hsu-Heng Yen, Chih-Jung Chen
    Canadian Journal of Gastroenterology and Hepatology.2019; 2019: 1.     CrossRef
  • A rare case of plexiform angiomyxoid myofibroblastic tumor in the stomach which was diagnosed at the earliest stage in the literature
    Xi Li, Shuangqing Li, Shenghua Xiong, Zhujun Wang, Hu Zhang
    Gastroenterology Report.2018; 6(4): 313.     CrossRef
  • Plexiform fibromyxoma of the small bowel: A case report
    Wei-Guang Zhang, Liang-Bi Xu, Yi-Ning Xiang, Chen-Hong Duan
    World Journal of Clinical Cases.2018; 6(15): 1067.     CrossRef
  • Plexiform angiomyxoid myofibroblastic tumor of the stomach: A case report
    Li Liang, Lin Fanzong, Zhang Peixi, Han Cuihong
    Diagnostic Cytopathology.2017; 45(1): 55.     CrossRef
  • Duodenal plexiform fibromyxoma as a cause of obscure upper gastrointestinal bleeding
    Demetrios Moris, Evangelia Spanou, Stavros Sougioultzis, Nikolaos Dimitrokallis, Polyxeni Kalisperati, Ioanna Delladetsima, Evangelos Felekouras
    Medicine.2017; 96(1): e5883.     CrossRef
  • Computed tomography and magnetic resonance imaging of a plexiform angiomyxoid myofibroblastic tumor: a case report
    Hiroyuki Akai, Shigeru Kiryu, Masaru Shinozaki, Yasunori Ohta, Yoshiyasu Nakano, Koichiro Yasaka, Kuni Ohtomo
    BMC Medical Imaging.2017;[Epub]     CrossRef
  • Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: a Rare Case
    Su Mi Kim, Ji Yeong An, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Kyung-Mee Kim, Sung Kim, Jae Moon Bae
    Journal of Gastric Cancer.2017; 17(3): 277.     CrossRef
  • Imaging findings of gastric plexiform fibromyxoma with a cystic change
    Min-Xia Yang, Zhen-Hua Zhao, Jian-Feng Yang, Bing Chen, Xun-Ze Shen, Jian-Guo Wei, Bo-Yin Wang
    Medicine.2017; 96(52): e8967.     CrossRef
  • Gastrointestinal stromal tumor with a PDGFRA mutation masquerading as gastric plexiform fibromyxoma: A comparative clinicopathological study of two cases
    Jun Zhou, Jingjing Xu, Guozhong Jiang, Yihui Ma, Jingwen Qi, Wencai Li, Dandan Zhang
    Oncology Letters.2017; 13(2): 887.     CrossRef
  • Gastric plexiform fibromyxoma tumor in a child – Case report and review of the literature
    Michael W. Morris, Lisa Sullivan, David E. Sawaya, Michael A. Steiner, Michael J. Nowicki
    Journal of Pediatric Surgery Case Reports.2016; 4: 38.     CrossRef
  • Unusual focal keratin expression in plexiform angiomyxoid myofibroblastic tumor
    Giuseppe Quero, Teresa Musarra, Alfredo Carrato, Michelangelo Fici, Maurizio Martini, Angelo Paolo Dei Tos, Sergio Alfieri, Riccardo Ricci
    Medicine.2016; 95(28): e4207.     CrossRef
  • Laparoscopy endoscopy cooperative surgery for gastric plexiform fibromyxoma: a case report
    Yoshikage Inoue, Shutaro Gunji, Kazutaka Obama, Hiroshi Okabe, Yoshiharu Sakai
    Surgical Case Reports.2016;[Epub]     CrossRef
  • Plexiform fibromyxoma with cotyledon-like serosal growth: A case report of a rare gastric tumor and review of the literature
    JOSHUA ROBERT KANE, NATASHA LEWIS, REBECCA LIN, CELINA VILLA, ALEXANDRA LARSON, JEFFREY D. WAYNE, ANJANA V. YELDANDI, WILLIAM B. LASKIN
    Oncology Letters.2016; 11(3): 2189.     CrossRef
  • Plexiform angiomyxoid myofibroblastic tumour of the duodenum: a rare entity
    Niladri Banerjee, Shahana Gupta, Suvashis Dash, Shibajyoti Ghosh
    BMJ Case Reports.2015; 2015: bcr2015210004.     CrossRef
  • A case of gastric plexiform fibromyxoma: radiological and pathological findings
    Katsumi Sakamoto, Masakazu Hirakawa, Kazushige Atsumi, Koshi Mimori, Kohei Shibata, Taro Tobo, Hidetaka Yamamoto, Hiroshi Honda
    Japanese Journal of Radiology.2014; 32(7): 431.     CrossRef
  • Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: Report of a Case and Review of the Literature
    Soo-Heui Baek, Jung-Hee Yoon, Ji-Yeon Kim
    Journal of the Korean Society of Radiology.2014; 70(1): 47.     CrossRef
  • Plexiform Fibromyxoma: Report of Two Pediatric Cases and Review of the Literature
    Lizette Vila Duckworth, Raul S. Gonzalez, Matthew Martelli, Chen Liu, Cheryl M. Coffin, John D. Reith
    Pediatric and Developmental Pathology.2014; 17(1): 21.     CrossRef
Gastric Adenocarcinoma of Fundic Gland Type: Report of Three Cases
Eun Su Park, Young Eun Kim, Cheol Keun Park, Takashi Yao, Ryoji Kushima, Kyoung-Mee Kim
Korean J Pathol. 2012;46(3):287-291.   Published online June 22, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.3.287
  • 12,339 View
  • 111 Download
  • 25 Crossref
AbstractAbstract PDF

Recently, fundic gland type gastric adenocarcinoma (GA-FG) has been reported as a new entity. This report describes GA-FG among Koreans for the first time. From March 2008 to July 2010 we identified only three cases of GA-FG out of over 6,000 GAs resected by endoscopy or surgery. Cell differentiation by mucin proteins, pepsinogen-I, and H+/K+-ATPase was evaluated. All three cases were male patients and diagnosed as early stage GA. Histologically, GA-FGs were well-differentiated adenocarcinoma with pale gray-blue, basophilic columnar or cuboidal cells and mildly enlarged nuclei, resembling chief cells. All three cases were positive for pepsinogen-I and were classified as gastric mucin phenotype. Among three histologic subtypes of GA-FG, since tumors were mainly composed of chief cells, our three cases were classified as chief cell predominant type. In conclusion, GA-FG is very rare among Koreans and pepsinogen-I and MUC6 expression are typical immunohistochemical findings in GA-FG suggesting differentiation toward fundic glands.

Citations

Citations to this article as recorded by  
  • Endoscopic Submucosal Dissection of Early Gastric Adenocarcinoma of Fundic Gland Type: A Case Report
    Ming Zhong, Wei Wei, Huang Zhong, Hang Gong, Tingyu Wang
    Revista Española de Enfermedades Digestivas.2025;[Epub]     CrossRef
  • Oxyntic Gland Neoplasms - From Adenoma to Advanced Gastric Cancer: A Review of 29 Cases
    Gi Hwan Kim, Jun Su Lee, Jeong Hoon Lee, Young Soo Park
    Journal of Gastric Cancer.2024; 24(4): 378.     CrossRef
  • Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type
    Kazushi Fukagawa, Yu Takahashi, Nobutake Yamamichi, Natsuko Kageyama-Yahara, Yoshiki Sakaguchi, Miho Obata, Rina Cho, Nobuyuki Sakuma, Sayaka Nagao, Yuko Miura, Naoki Tamura, Daisuke Ohki, Hiroya Mizutani, Seiichi Yakabi, Chihiro Minatsuki, Keiko Niimi, Y
    Gastric Cancer.2023; 26(1): 44.     CrossRef
  • Clinicopathological Features and the Prevalence of Oxyntic Gland Neoplasm: A Single-center Retrospective Study
    Hikari Asahara, Toshitatsu Takao, Yumiko Asahara, Masakyo Asahara, Douglas Motomura, Hiroya Sakaguchi, Tetsuya Yoshizaki, Nobuaki Ikezawa, Madoka Takao, Yoshinori Morita, Takashi Toyonaga, Masato Komatsu, Ryoji Kushima, Yuzo Kodama
    Internal Medicine.2023; 62(19): 2763.     CrossRef
  • Clinicopathological features of gastric adenocarcinoma of fundic gland type
    Bao-Zhen Guo, Zhen-Zhen Liu, Gao-Fei Shen, Fei Zhu, Hui-Fen Lian, Xin Li, Jun-Yi Zheng, Jin-Peng Li, Shui-Miao Deng, Rui Huang
    World Chinese Journal of Digestology.2023; 31(6): 244.     CrossRef
  • Endoscopic Resection for Gastric Adenocarcinoma of the Fundic Gland Type: A Case Series
    Hwa Jin Lee, Gwang Ha Kim, Dong Chan Joo, Moon Won Lee, Bong Eun Lee, Kyungbin Kim
    The Korean Journal of Gastroenterology.2023; 81(6): 259.     CrossRef
  • Gastric adenocarcinoma of the fundic gland type: A review of the literature
    Zhiyong Zhai, Wei Hu, Zhaoyu Huang, Zemin Chen, Sicun Lu, Wei Gong
    JGH Open.2023; 7(12): 812.     CrossRef
  • Clinicopathological features of early stage gastric adenocarcinoma of fundic gland type
    Huan Zhang, Shuyan Wang, Yongping Zhang, Fusang Ye, Chunnian Wang
    Medicine.2022; 101(2): e28469.     CrossRef
  • Gastric Adenocarcinoma of Fundic Gland Type Treated by Endoscopic Submucosal Dissection
    Yong Bo Park, Gwang Ha Kim, Kyungbin Kim, Tae Kyoung Ha, Guk Bin Park, Young Min Kwak
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 82.     CrossRef
  • Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type
    Hiroya Ueyama, Takashi Yao, Yoichi Akazawa, Takuo Hayashi, Koichi Kurahara, Yumi Oshiro, Masayoshi Yamada, Ichiro Oda, Shin Fujioka, Chiaki Kusumoto, Masayoshi Fukuda, Kunihisa Uchita, Tomohiro Kadota, Yasuhiro Oono, Kazuhisa Okamoto, Kazunari Murakami, Y
    Journal of Gastroenterology.2021; 56(9): 814.     CrossRef
  • Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type
    Masaya Iwamuro, Chiaki Kusumoto, Masahiro Nakagawa, Sayo Kobayashi, Masao Yoshioka, Tomoki Inaba, Tatsuya Toyokawa, Shinichiro Hori, Shouichi Tanaka, Kazuhiro Matsueda, Takehiro Tanaka, Hiroyuki Okada
    Scientific Reports.2021;[Epub]     CrossRef
  • A series of five patients with oxyntic gland adenoma: Deciphering the clinical and histological features of these rare gastric polyps
    Jerry C. Nagaputra, Tracy Jie Zhen Loh, Sangeeta Mantoo, Rafay Azhar, Vikneswaran Namasivayam, Wei Qiang Leow
    Human Pathology Reports.2021; 26: 300566.     CrossRef
  • Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis
    Xiang-yu Meng, Guang Yang, Cheng-ji Dong, Ru-yi Zheng
    Rare Tumors.2021;[Epub]     CrossRef
  • Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection
    Chengfang Li, Xinglong Wu, Shuang Yang, Xiaorong Yang, Jin Yao, Hong Zheng
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Multiple gastric adenocarcinoma of fundic gland type: A case report
    Ou Chen, Ze-Yong Shao, Xiong Qiu, Guang-Ping Zhang
    World Journal of Clinical Cases.2019; 7(18): 2871.     CrossRef
  • Gastric Adenocarcinoma of the Fundic Gland Type
    Mark A Benedict, Gregory Y Lauwers, Dhanpat Jain
    American Journal of Clinical Pathology.2018; 149(6): 461.     CrossRef
  • Oxyntic Gland Adenoma Treated by Endoscopic Mucosal Resection
    In Ji Song, Jin Woo Joo, Jun Chul Park, Sung Kwan Shin, Yong Chan Lee, Sang Kil Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(2): 94.     CrossRef
  • Chief cell‐predominant gastric polyps: a series of 12 cases with literature review
    Karen Chan, Ian S Brown, Trevor Kyle, Gregory Y Lauwers, Marian Priyanthi Kumarasinghe
    Histopathology.2016; 68(6): 825.     CrossRef
  • Twelve-year natural history of a gastric adenocarcinoma of fundic gland type
    Yoshinori Sato, Takashi Fujino, Akira Kasagawa, Ryo Morita, Shun-ichiro Ozawa, Yasumasa Matsuo, Tadateru Maehata, Hiroshi Yasuda, Masayuki Takagi, Fumio Itoh
    Clinical Journal of Gastroenterology.2016; 9(6): 345.     CrossRef
  • Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings
    Takashi Chiba, Katsuaki Kato, Takayuki Masuda, Shuichi Ohara, Noriyuki Iwama, Takenobu Shimada, Daisuke Shibuya
    Digestive Endoscopy.2016; 28(7): 722.     CrossRef
  • Gastric Adenocarcinoma of the Fundic Gland Type Treated by Endoscopic Mucosal Resection: A Case Report and Review of the Literature
    Eleanor Lewin, Philip Daroca, Sanjay Sikka, Tong Wu, Yukihiro Nakanishi
    Case Reports in Pathology.2016; 2016: 1.     CrossRef
  • Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features
    Masaki Miyazawa, Mitsuru Matsuda, Masaaki Yano, Yasumasa Hara, Fumitaka Arihara, Yosuke Horita, Koichiro Matsuda, Akito Sakai, Yatsugi Noda
    World Journal of Gastroenterology.2016; 22(48): 10523.     CrossRef
  • Oxyntic gland adenoma endoscopically mimicking a gastric neuroendocrine tumor: A case report
    Tae-In Lee
    World Journal of Gastroenterology.2015; 21(16): 5099.     CrossRef
  • Oxyntic gland polyp/adenoma
    Rajkumar Vajpeyi, Jyoti Dekate
    Diagnostic Histopathology.2014; 20(11): 446.     CrossRef
  • Gastric adenocarcinoma of fundic gland type with unusual behavior
    Tetsuya Ueo, Hirotoshi Yonemasu, Tetsuya Ishida
    Digestive Endoscopy.2014; 26(2): 293.     CrossRef
Original Article
Genetic Analysis of Epstein-Barr Virus Latent Membrane Protein 1 and Immunohistochemical Expression of Transforming Growth Factor (TGF)-beta1, TGF-betaRII, p21, p16, E2F1, Thymidylate Synthase, and NF-kappaB in Epstein-Barr Virus Encoded RNA-positive Gastric Adenocarcinoma
Mee Yon Cho, Minseob Eom, Kwang Hwa Park, Mee Dong Kim, Seung Hoon Sung, Myoung Soo Kim, Dae Sung Kim, Sun Ju Choi
Korean J Pathol. 2006;40(3):176-184.
  • 2,098 View
  • 22 Download
AbstractAbstract PDF
BACKGROUND
:Although clinicopathologic differences have been described between Epstein-Barr virus (EBV)-positive and negative gastric adenocarcinomas, the pathogenetic basis for these differences remains unclear. In this study, efforts were made to confirm that expression of EBV-latent membrane protein (LMP1) and immunohistochemical characteristics of EBVpositive gastric adenocarcinomas.
METHODS
We investigated genomic deletion, and RNA & protein expression of the EBV-LMP1, as well as immunohistochemical protein expression of transforming growth factor (TGF)-beta1, TGF-bata RII, p21, p16, E2F1, thymidylate synthase, and NF-kappaB in relation to EBV positive gastric adenocarcinoma.
RESULTS
A total of 38 Epstein-Barr Virus Encoded RNA-positive and 80 negative gastric carcinomas were examined. A 30 bp DNA deletion in the EBV-LMP1 gene, initiating at codon 342, was detected in 94.4% of EBVpositive cases. By RT-PCR and western blotting, EBV-LMP1 mRNA and protein expressions were absent in all cases, re-gardless of DNA deletion. No significant differences in TGF-bata1, TGF-betaRII, p21, NF-kappaB, E2F1, or thymidylate synthase expression were identified. However, the decreased expression of p16 was found in 84.2% of EBV-positive carcinomas, relative to only 57.5% of EBV-negative tumors (p=0.024).
CONCLUSION
EBV-LMP1 DNA deletion, mRNA and protein losses are highly prevalent in EBV-positive gastric adenocarcinoma among Korean patients, along with decreased p16 expression.
Case Report
Strongyloidiasis of Gastric and Colonic Mucosa in a Patient with Monoclonal Gammopathy of Undetermined Significance: A Case Report.
Jung Uee Lee, Sang Bum Kang, Hae Joung Sul, Jong Ok Kim
Korean J Pathol. 2011;45:S75-S78.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.S1.S75
  • 3,658 View
  • 20 Download
  • 1 Crossref
AbstractAbstract PDF
Here we report a case of Strongyloides stercoralis infection of the gastric and pancolonic mucosa in a 79-year-old female with a monoclonal gammopathy of undetermined significance. Endoscopic biopsies were performed in gastric antrum, cecum, distal ascending colon, and hepatic flexure of the colon. On microscopic examination, there were many adult worms, larvae and eggs in the gastric and colonic mucosa. Worms, larvae, and eggs were located in the crypts and within the lumen of the crypts. The body wall of the adult worm was composed of cuticle and a weak muscle layer. A routine stool examination failed to detect larvae or ova. Based on the histopathologic examination, these parasites were confirmed as S. stercoralis.

Citations

Citations to this article as recorded by  
  • Is Gastric Involvement by Strongyloides stercoralis in an Immunocompetent Patient a Common Finding? A Case Report and Review of the Literature
    Irene Pecorella, Tom Richard Okello, Gaia Ciardi, David Martin Ogwang
    Acta Parasitologica.2022; 67(1): 94.     CrossRef
Original Article
CpG Island Methylation According to the Histologic Patterns of Early Gastric Adenocarcinoma.
Junjeong Choi, Mee Yon Cho, So Young Jung, Khalilullah Mia Jan, Hyun Soo Kim
Korean J Pathol. 2011;45(5):469-476.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.5.469
  • 4,719 View
  • 22 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Although the importance of aberrant DNA methylation in the development of gastric adenocarcinoma has been described, the mechanism of pathogenesis has not been revealed yet. We quantitatively analyzed methylation of four CpG islands and one repetitive DNA element, according to the histologic features of adenocarcinoma with precursor lesions.
METHODS
We divided the cases as adenocarcinoma with intestinal type precursors (type A, n=19 cases) and adenocarcinoma with diffuse type precursors (type B, n=19 cases). We micro-dissected tumor cells and matched non-neoplastic gastric mucosa from the hematoxylin and eosin-stained slides.
RESULTS
A total of 20 CpG sites of long interspersed nucleotide element-1 (LINE1), RAR-related orphan receptor alpha (RORA), Kruppel-like factor 7 (KLF7), mutL homolog 1 (MLH1), MINT25, and CD133 were analyzed. Methylation was determined by bisulfate-pyro-sequencing, and hypomethylation of LINE1 and CD133 was noted in the tumors, compared to the levels in the non-neoplastic gastric mucosa (p=0.014 and p=0.015, respectively). A statistically different methylation pattern of CpG sites at CD133 and KLF7 was noted only in type B lesions, compared to that in matched non-neoplastic gastric mucosa (p=0.027 and p=0.043, respectively).
CONCLUSIONS
Given that aberrant methylation occurs in a relatively early phase of carcinogenesis, different patterns of methylation may determine the carcinoma phenotype. However, further large-scale study is required to clarify the significance of this difference.

Citations

Citations to this article as recorded by  
  • Molecular function of Krüppel-like factor 7 in biology
    Yi Mao, Yuechan Chen, Zhiwei Zhang
    Acta Biochimica et Biophysica Sinica.2023; 55(5): 713.     CrossRef
  • DNA methylation status of a distinctively different subset of genes is associated with each histologic Lauren classification subtype in early gastric carcinogenesis
    YOSEP CHONG, KHALILULLAH MIA-JAN, HOON RYU, JAMSHID ABDUL-GHAFAR, JIJGEE MUNKHDELGER, SAYAMAA LKHAGVADORJ, SO YOUNG JUNG, MIRA LEE, SUN-YOUNG JI, EUNHEE CHOI, MEE-YON CHO
    Oncology Reports.2014; 31(6): 2535.     CrossRef
Case Report
Bile Ductular Proliferation in the Gastric Wall after Gastric Ulcer Penetration into the Liver.
Eun Jung Cha
Korean J Pathol. 2011;45(4):434-436.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.4.434
  • 3,126 View
  • 15 Download
AbstractAbstract PDF
Liver penetration is one of the most serious complications of peptic ulcer diseases but is rarely encountered. A 57-year-old man was admitted to our hospital for further evaluation of a gastric malignancy. One month before admission, he was diagnosed with an adenocarcinoma by endoscopic biopsy at other hospital. A subtotal gastrectomy was performed to confirm malignancy and relieve the epigastric pain. Histologically, single glands were located between the ulcer base and attached liver tissue and stained positively for cytokeratin 19. The pathologic diagnosis was a gastric ulcer and bile ductular proliferation in the liver and gastric wall. Here, this report is the first Korean case of liver penetration of a gastric ulcer.
Original Article
Insulin-like Growth Factor II mRNA-Binding Protein 3 Expression in Benign and Premalignant Lesions and Carcinomas of the Stomach.
Dae Hyun Song, Jung Wook Yang, Dong Chul Kim, Jong Sil Lee, Jeong Hee Lee, Sang Ho Jeong, Gyung Hyuck Ko
Korean J Pathol. 2011;45(4):379-385.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.4.379
  • 4,254 View
  • 25 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Recent studies have demonstrated that insulin-like growth factor II mRNA-binding protein 3 (IMP3) is expressed in malignant tumors of various organs but not in normal tissue. We investigated IMP3 expression in various benign lesions, premalignant lesions and carcinomas of the stomach.
METHODS
IMP3 immunohistochemical staining was performed on 24 benign gastric lesions, 24 gastric adenomas, and 322 gastric carcinomas.
RESULTS
IMP3 was not expressed in benign gastric lesions including adenomas with low-grade dysplasia, but was expressed in 17% of adenomas with high-grade dysplasia, and in 44% of carcinomas. As the carcinomas were in the advanced stage, they expressed IMP3 more frequently and strongly. Patients with IMP3-positive tumors had poorer survival than those with negative tumors.
CONCLUSIONS
IMP3 expression in gastric carcinoma may be related to tumor invasion and metastasis, and is an independent risk factor for poor prognosis.

Citations

Citations to this article as recorded by  
  • IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Ji Young Park, Misun Choe, Yuna Kang, Sang Sook Lee
    Korean Journal of Pathology.2014; 48(2): 108.     CrossRef
  • Role of combination of insulin-like growth factor II messenger RNA-binding protein 3 and claudin-1 immunostaining in differentiation between endometrial endometrioid carcinoma and uterine serous carcinoma
    Maha M. Shamloula, Dareen A. Mohamed, Ayman El-Dorf
    Egyptian Journal of Pathology.2013; 33(2): 237.     CrossRef
Case Report
Collision Tumor Composed of a Granulocytic Sarcoma and an Adenocarcinoma of the Stomach: A Case Report.
Kyu Yeoun Won, Juhie Lee, Yong Ho Kim, Youn Wha Kim
Korean J Pathol. 2011;45(2):201-204.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.2.201
  • 4,661 View
  • 19 Download
  • 2 Crossref
AbstractAbstract PDF
Granulocytic sarcoma, also called chloroma or myeloblastoma, is an extramedullary invasive tumor composed of neoplastic myeloid cells. In this report, we describe a 43-year-old male patient with a collision tumor composed of an adenocarcinoma and a granulocytic sarcoma in the stomach. The coexistence of a granulocytic sarcoma and adenocarcinoma in the stomach has, to the best of our knowledge, not been reported in the literature. The diagnosis of granulocytic sarcoma is very difficult; especially in the absence of concurrent hematologic disease or in the uncommon setting of coexistence with another tumor. Cautious observation is needed when a finding of unusual atypical cells admixed with an adenocarcinoma in the stomach is confronted.

Citations

Citations to this article as recorded by  
  • Leukemia in gastrointestinal organs as cause of treatment failure: 378 cases analyzed
    Isabel Cunningham, Daniel Worthley
    American Journal of Hematology.2018; 93(11): 1327.     CrossRef
  • One cancer destroys another: short report of a myeloid sarcoma causing ischaemic necrosis of an adenocarcinoma
    D Tucker, P Sarsfield, I Chandler, P Kerr
    Journal of Clinical Pathology.2014; 67(1): 70.     CrossRef
Original Articles
Molecular Biological Characteristics of Differentiated Early Gastric Cancer on the Basis of Mucin Expression.
Nari Shin, Hye Yeon Kim, Woo Kyung Kim, Min Gyung Park, Kyung Bin Kim, Dong Hoon Shin, Kyung Un Choi, Jee Yeon Kim, Chang Hun Lee, Gi Young Huh, Mee Young Sol, Do Youn Park
Korean J Pathol. 2011;45(1):69-78.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.1.69
  • 4,703 View
  • 23 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
It is clear that the biologic characteristics of gastric cancer are different on the basis of mucin phenotypes. However, there are unabated controversies on the exact biologic differences of mucin expression in gastric cancer.
METHODS
We analyzed various protein expressions and microsatellite instability (MSI) status based on mucin expression in 130 differentiated early gastric adenocarcinoma cases. Furthermore, we evaluated the genomic alternation in 10 selected differentiated early gastric adenocarcinoma cases using array based comparative genomic hybridization (aCGH).
RESULTS
Intestinal mucin predominant subtype showed significantly elevated p53 protein and caudal-related homeobox 2 expression, and delocalization of beta catenin expressions compared to the gastric mucin predominant subtype. On MSI status, the gastric mucin predominant subtype more frequently showed unstable status than the intestinal mucin predominant subtype. CGH study showed more frequent chromosomal gain and loss in the intestinal mucin predominant subtype than the gastric mucin predominant subtype, albeit without statistical significance. Interestingly, there were significant differences in chromosomal alternation between four mucin phenotypes.
CONCLUSIONS
Study results suggest possible different points of biologic behaviors in early differentiated gastric adenocarcinomas by mucin expression type.

Citations

Citations to this article as recorded by  
  • Mucin Expression in Gastric Cancer: Reappraisal of Its Clinicopathologic and Prognostic Significance
    Dae Hwan Kim, Nari Shin, Gwang Ha Kim, Geum Am Song, Tae-Yong Jeon, Dong-Heon Kim, Gregory Y. Lauwers, Do Youn Park
    Archives of Pathology & Laboratory Medicine.2013; 137(8): 1047.     CrossRef
  • Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes
    Joo-Yeun Kim, Na Ri Shin, Ahrong Kim, Hyun-Jeong Lee, Won-young Park, Jee-Yeon Kim, Chang-Hun Lee, Gi-Young Huh, Do Youn Park
    Korean Journal of Pathology.2013; 47(1): 28.     CrossRef
HER2 Status in Gastric Adenocarcinomas Assessed by Immunohistochemistry, Automated Silver-Enhanced In Situ Hybridization and Fluorescence In Situ Hybridization.
Aeri Kim, Jung Min Bae, Se Won Kim, Mi Jin Gu, Young Kyung Bae
Korean J Pathol. 2010;44(5):493-501.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.5.493
  • 4,748 View
  • 35 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
Recently, many studies have focused on human epidermal growth factor receptor 2 (HER2) status in gastric cancer due to HER2-targeted therapy using trastuzumab. We investigated HER2 overexpression and amplification and their concordance rate in Korean gastric adenocarcinomas.
METHODS
Tissue microarrays were constructed with 232 gastric adenocarcinoma samples. We performed immunohistochemistry (IHC), silver-enhanced in situ hybridization (SISH) and fluorescence in situ hybridization (FISH) for HER2.
RESULTS
IHC was negative in 94.8% (218/232), equivocal in 1.7% (4/232) and positive in 3.5% (8/232) of cases. HER2 protein expression was heterogeneous in 75% (9/12) of IHC 2+/3+ cancers. Gene amplification was observed in 6.5% (15/230) by SISH and the same 15 cases were also FISH-positive. We observed HER2 amplification in 1.4%, 27.3%, 25%, and 100% of IHC 0, 1+, 2+, and 3+ gastric adenocarcinomas, respectively. The concordance rate between IHC and SISH results was 95.7%.
CONCLUSIONS
HER2 overexpression and amplification were less frequent in gastric adenocarcinomas than breast carcinomas. Compared to breast carcinoma, (1) there may be IHC-negative but gene amplification-positive cases for HER2 and (2) frequent intratumoral heterogeneity of IHC for HER2 in gastric adenocarcinomas.

Citations

Citations to this article as recorded by  
  • Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Cancer
    Kyung Won Seo, Taeyong Jeon, Sewon Kim, Sung Soo Kim, Kwanghee Kim, Byoung-Jo Suh, Sunhwi Hwang, SeongHee Choi, Seungwan Ryu, Jae Seok Min, Young-Joon Lee, Ye Seob Jee, Hyeondong Chae, Doo Hyun Yang, Sang Ho Lee
    Journal of Gastric Cancer.2017; 17(1): 52.     CrossRef
  • Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach
    Jun Haeng Lee, Jae G. Kim, Hye-Kyung Jung, Jung Hoon Kim, Woo Kyoung Jeong, Tae Joo Jeon, Joon Mee Kim, Young Il Kim, Keun Won Ryu, Seong-Ho Kong, Hyoung Il Kim, Hwoon-Yong Jung, Yong Sik Kim, Dae Young Zang, Jae Yong Cho, Joon Oh Park, Do Hoon Lim, Eun S
    The Korean Journal of Gastroenterology.2014; 63(2): 66.     CrossRef
  • Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach
    Jun Haeng Lee, Jae G. Kim, Hye-Kyung Jung, Jung Hoon Kim, Woo Kyoung Jeong, Tae Joo Jeon, Joon Mee Kim, Young Il Kim, Keun Won Ryu, Seong-Ho Kong, Hyoung-Il Kim, Hwoon-Yong Jung, Yong Sik Kim, Dae Young Zang, Jae Yong Cho, Joon Oh Park, Do Hoon Lim, Eun S
    Journal of Gastric Cancer.2014; 14(2): 87.     CrossRef
Detection of JC Virus T-Ag in Early Gastric Cancer.
Eun Jeong Jang, Jung Sik Jang, Jae Hoon Kim, Han Ik Bae, In Soo Suh
Korean J Pathol. 2010;44(5):456-461.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.5.456
  • 4,119 View
  • 41 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
JC virus (JCV) is a polyomavirus that commonly infects humans and can cause progressive multifocal leukoencephalopathy in immunocompromised patients. Recently, many reports have documented detection of JCV in gastrointestinal tract cancers. We investigated the presence of JCV in gastric adenocarcinoma, adenoma, and non-neoplastic gastric mucosa.
METHODS
We selected paraffin-embedded tissue from endoscopic mucosal resections performed from January 2007 to September 2008. DNA was extracted from the paraffin-embedded specimens of 30 adenocarcinomas, 20 adenomas of the stomach, and 20 non-neoplastic gastric mucosa. Polymerase chain reaction amplifications were performed using gene-specific primers to detect the JCV gene sequences, and immunohistochemical staining was performed to detect the T-antigen (T-Ag) protein.
RESULTS
The T-Ag sequence was detected in nine of 30 gastric cancers (30%), two of 20 adenomas (10%), and eight of 20 non-neoplastic gastric mucosa specimens (40%). T-Ag protein expression was found in five of 30 gastric cancers (16.7%) and one of 20 non-neoplastic gastric mucosa specimens (5%), whereas no expression was observed in any of the adenomas.
CONCLUSIONS
Although we could not detect a correlation between JCV and gastric cancer, we demonstrated the presence of JCV T-Ag expression in human gastric cancers. These findings suggest a possible role for JCV in gastric carcinogenesis.

Citations

Citations to this article as recorded by  
  • Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies
    Hui Wang, Xiao-Long Chen, Kai Liu, Dan Bai, Wei-Han Zhang, Xin-Zu Chen, Jian-Kun Hu
    Clinical and Translational Gastroenterology.2020; 11(7): e00201.     CrossRef
Case Report
Fine Needle Aspiration Cytology of Gastric Glomus Tumor: A Case Report.
Dong Geun Lee, Kyu Yun Jang, Myoung Ja Chung, Woo Sung Moon, Myoung Jae Kang, Ho Sung Park
Korean J Pathol. 2010;44(4):448-452.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.4.448
  • 4,181 View
  • 49 Download
  • 2 Crossref
AbstractAbstract PDF
Glomus tumors of the stomach are rare and are usually found as a solitary, intramural lesion. Here, we report a case of a gastric glomus tumor in a 60-year-old woman diagnosed by endoscopic ultrasound-guided fine-needle aspiration cytology. Endoscopic ultrasound revealed a 4 x 3 cm-sized, round, isoechoic mass at the fourth layer of the gastric wall. Smears revealed cohesive clusters of small, uniform, round to polygonal cells with scant cytoplasm and round, hyperchromatic nuclei with homogeneous chromatin. Immunocytochemistry by liquid-based cytology was positive for smooth muscle actin. The cytologic diagnosis of a glomus tumor was confirmed by a specimen from the laparoscopic resection. Although the cytologic features of glomus tumors are quite distinctive, an immunocytochemical stain from a liquid-based cytology preparation can further help to ascertain the diagnosis.

Citations

Citations to this article as recorded by  
  • Glomus Tumor of the Stomach: A Systematic Review and Illustrative Case Report
    Andrea Pansa, Laura Samà, Laura Ruspi, Federico Sicoli, Ferdinando Carlo Maria Cananzi, Vittorio Quagliuolo
    Digestive Diseases.2023; 41(1): 17.     CrossRef
  • Cytologic analysis of a glomus tumor in the left second toe: Case report
    Jay Hwang, Susan McDowell, Bradley Cole, Aaron Huber, Maria Cecilia D. Reyes
    Diagnostic Cytopathology.2022;[Epub]     CrossRef
Original Articles
Mutation and Expression of DNA2 Gene in Gastric and Colorectal Carcinomas.
Sung Hak Lee, Yoo Ri Kim, Nam Jin Yoo, Sug Hyung Lee
Korean J Pathol. 2010;44(4):354-359.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.4.354
  • 4,801 View
  • 35 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
Deregulation of DNA repair and replication are involved in cancer development. DNA2 is a nuclease/helicase that plays roles in DNA repair and replication. The aim of this study was to explore DNA2 mutation and DNA2 protein expression in gastric cancers (GCs) and colorectal cancers (CRCs).
METHODS
We analyzed two mononucleotide repeats in DNA2 in 27 GCs with high microsatellite instability (MSI-H), 34 GCs with stable MSI (MSS), 29 CRCs with MSI-H and 35 CRCs with MSS by single-strand conformation polymorphism. We also analyzed DNA2 expression in GCs and CRCs either with MSI-H or MSS.
RESULTS
We found DNA2 mutations in two GCs (7.1%) and two CRCs with MSI-H (6.9%), but not in cancers with MSS. The mutations consisted of three cases of a c.2593delT and one of a c.2592_2593delTT, which would result in premature stopping of amino acid synthesis (p.Ser865Hisfsx6 and p.Ser865Thrfsx20, respectively). DNA2 expression was observed in 16 (80%) of the GCs and 15 (75%) of the CRCs with MSI-H, but all of the cancers with DNA2 frameshift mutations were weak or negative for DNA2.
CONCLUSIONS
Our data indicate that DNA2 mutation and loss of DNA2 expression occur in GCs and CRCs, and suggest that these alterations may contribute to cancer pathogenesis by deregulating DNA repair and replication.

Citations

Citations to this article as recorded by  
  • Multiple roles of DNA2 nuclease/helicase in DNA metabolism, genome stability and human diseases
    Li Zheng, Yuan Meng, Judith L Campbell, Binghui Shen
    Nucleic Acids Research.2020; 48(1): 16.     CrossRef
  • Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis
    Claudia Cava, Gloria Bertoli, Antonio Colaprico, Catharina Olsen, Gianluca Bontempi, Isabella Castiglioni
    BMC Genomics.2018;[Epub]     CrossRef
  • Replication intermediates that escape Dna2 activity are processed by Holliday junction resolvase Yen1
    Gizem Ölmezer, Maryna Levikova, Dominique Klein, Benoît Falquet, Gabriele Alessandro Fontana, Petr Cejka, Ulrich Rass
    Nature Communications.2016;[Epub]     CrossRef
Prognostic Value of Phosphorylated Akt and Survivin Expression in Gastric Adenocarcinoma.
Soong Lee, Yun Cheol Kim, Hyeon Min Lee, Ki Sang Lee, Byung Chul Shin, Hyung Seok Kim, Jae Hyuk Lee, Chang Soo Park, Kyung Hwa Lee
Korean J Pathol. 2010;44(3):252-258.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.3.252
  • 4,710 View
  • 22 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
pAkt (the phosphorylated form of the proto-oncogene protein c-akt) and survivin (human BIRC5 protein) are candidate apoptosis-related molecules that may be responsible for cancer progression. The aim of this study was to determine the expression of pAkt and survivin in malignant stomach neoplasm, and their value as prognostic indicators of cancer.
METHODS
The expression of pAkt and survivin in 144 cases of gastric cancer was detected by immunohistochemistry and compared with established clinicopathological parameters and prognosis of this disease.
RESULTS
Expression of pAkt showed significant correlations with depth of invasion, lymph node and distant metastasis, as well as the stage (p < 0.05 for all three correlations), but not with the Lauren classification. Survivin expression closely correlated with histological type, Lauren classification, depth of invasion, metastasis, and stage (p < 0.05 for all). The overall survival of patients with pAkt/survivin expression was inferior to that of patients with loss of pAkt/survivin expression. Cox multivariate analysis demonstrated a significant correlation between stage (p = 0.04), survivin expression (p = 0.02), and prognosis.
CONCLUSIONS
Patients with pAkt/survivin expression in gastric cancer are at increased risk of cancer-related mortality via the apoptosis resistance pathway. Expression of pAkt and survivin could be used as a prognostic indicator for gastric cancer.

Citations

Citations to this article as recorded by  
  • Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer
    Feifei Ren, Qitai Zhao, Bin Liu, Xiangdong Sun, Youcai Tang, Huang Huang, Lu Mei, Yong Yu, Hui Mo, Haibin Dong, Pengyuan Zheng, Yang Mi
    Journal of Cellular Physiology.2020; 235(3): 2738.     CrossRef
  • The Relationship Between Estrogen/Progesterone Receptor and Expression of mTOR/pAkt Proteins and the Analysis of Prognosis in Breast Cancer
    Sun Wook Han, Moon Soo Lee, Sung Yong Kim, Gil Ho Kang, Zi Sun Kim, Cheol Wan Lim, Ji Hyun Lee, Hyun Ju Lee, Mee-Hye Oh, Min Hyuk Lee
    Journal of Breast Disease.2013; 1(1): 8.     CrossRef
  • Clinicopathological correlations of mTOR and pAkt expression in non-small cell lung cancer
    Mee-Hye Oh, Hyun Ju Lee, Seol Bong Yoo, Xianhua Xu, Jae Sung Choi, Yong Hoon Kim, Seok Yeol Lee, Choon-Taek Lee, Sanghoon Jheon, Jin-Haeng Chung
    Virchows Archiv.2012; 460(6): 601.     CrossRef
The Prognostic Significance of the Tumor-Infiltrating FoxP3-Positive Regulatory T Cells in Gastric Carcinoma.
Sang Jae Noh, Shin Young Park, Kyung Ryoul Kim, Chan Young Kim, Keun Sang Kwon, Ho Sung Park, Ho Lee, Myoung Ja Chung, Woo Sung Moon, Kyu Yun Jang
Korean J Pathol. 2010;44(1):9-15.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.1.9
  • 4,445 View
  • 42 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Regulatory T cells (Tregs) are known to be key regulators of immune responses in patients with autoimmune disease and infection and also for attenuating antitumor immunity by the host. It has been reported that high numbers of tumor-infiltrating Tregs might be associated with poor clinical outcomes for several malignant tumors. Therefore, this study aimed to examine the impact of tumor-infiltrating Tregs on the prognosis of gastric carcinoma patients.
METHODS
The immunohistochemical staining for anti-fork head Box P3 (FoxP3) antibody was performed by using a 3 mm core from the tumor specimens of each of the 173 gastric cancer patients for constructing a tissue microarray. FoxP3-positive Tregs were quantified by calculating the numbers of positive cells per 5 high-power fields on light microscopy. Thereafter, the 173 patients were subdivided into the low Tregs group (< or = 3/5 high power fields [HPF], n = 41) and the high Tregs group (> 3/5 HPF, n = 132).
RESULTS
The high Tregs group was significantly associated with a higher stage, more invasion depth and lymph node metastasis (p = 0.009, p = 0.036, p = 0.006, respectively). The high Tregs group showed significantly poorer overall survival and event-free survival (p = 0.004, p = 0.017, respectively) on the univariate analysis. The Tregs group and the tumor, node and metastasis stage were also independent prognostic factors that were significantly associated with overall survival (p = 0.025, p < 0.001, respectively) by multivariate analysis.
CONCLUSIONS
Our results indicated that a high number of tumor-infiltrating FoxP3-positive Tregs could be an indicator of poor long term survival for gastric carcinoma patients.

Citations

Citations to this article as recorded by  
  • Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma
    Myoung Jae Kang, Kyoung Min Kim, Jun Sang Bae, Ho Sung Park, Ho Lee, Myoung Ja Chung, Woo Sung Moon, Dong Geun Lee, Kyu Yun Jang
    Translational Oncology.2013; 6(3): 282.     CrossRef
  • Significance of Foxp3 Positive Regulatory T Cell and Tumor Infiltrating T Lymphocyte in Triple Negative Breast Cancer
    Hanna Kang, Harin Cheong, Min Sun Cho, Heasoo Koo, Woon Sup Han, Kyung Eun Lee, Byung In Moon, Sun Hee Sung
    The Korean Journal of Pathology.2011; 45(1): 53.     CrossRef
Case Reports
A Case of Gastric Carcinosarcoma with Neuroendocrine and Smooth Muscle Differentiation.
Se Min Jang, Si Hyong Jang, Kyueng Whan Min, Woong Na, Young Jin Jun, Seung Sam Paik
Korean J Pathol. 2010;44(1):87-91.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.1.87
  • 4,411 View
  • 32 Download
  • 5 Crossref
AbstractAbstract PDF
Carcinosarcoma of the stomach is a rarely occurring malignant biphasic tumor that consists of both carcinomatous and sarcomatous components simultaneously in a single tumor. The common carcinoma component is tubular or papillary adenocarcinoma and the mesenchymal sarcomatous components are variable and these include leiomyosarcoma, rhabdomyosarcoma, osteosarcoma and chondrosarcoma. However, neuroendocrine carcinomatous differentiation in the carcinomatous component is extremely rare. We present here a rare gastric carcinosarcoma that demonstrated neuroendocrine carcinomatous and leiomyosarcomatous differentiation in a 47-year-old man.

Citations

Citations to this article as recorded by  
  • Asymptomatic giant gastric carcinosarcoma
    Hitesh Sarda, Anshuman Pandey, Abhishek Gatuam, Hareesh Shanthappa Nellikoppad
    BMJ Case Reports.2023; 16(10): e255680.     CrossRef
  • Carcinosarcoma of Stomach Confined to the Mucosa
    Hirohiko Kuroda, Hiroaki Saito, Yusuke Kono, Yuki Murakami, Yuji Shishido, Tomoyuki Matsunaga, Yoji Fukumoto, Tomohiro Osaki, Keigo Ashida, Kanae Nosaka, Yoshihisa Umekita, Yoshiyuki Fujiwara
    Yonago Acta Medica.2017; 60(4): 246.     CrossRef
  • A Rare Case of Gastric Carcinosarcoma with Neuroendocrine Differentiation
    Hae Jin Shin, Jong Seok Ju, Hee Seok Moon, Sun Hyung Kang, Jae Kyu Sung, Hyun Yong Jeong, Kyu Sang Song
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2014; 14(2): 121.     CrossRef
  • Gastric Sarcomatoid Carcinoma
    Fabio Carboni, Giovanni Battista Levi Sandri, Mario Valle, Renato Covello, Alfredo Garofalo
    Journal of Gastrointestinal Surgery.2013; 17(11): 2025.     CrossRef
  • Gastric carcinosarcoma: A case report and review of the literature
    ROBERTO CIROCCHI, STEFANO TRASTULLI, JACOPO DESIDERIO, VERONICA GRASSI, IVAN BARILLARO, ALBERTO SANTORO, CARLO BOSELLI, NICOLA AVENIA, GIUSEPPE NOYA, ANGELO DE SOL
    Oncology Letters.2012; 4(1): 53.     CrossRef
Malignant Glomus Tumors of the Stomach: A Report of 2 Cases with Multiple Metastases.
Hyunjoo Lee, Yoon Seok Choi, Sang Cheul Oh, Jong Jae Park, Chul Whan Kim, Han Kyeom Kim, Insun Kim
Korean J Pathol. 2009;43(4):358-363.
DOI: https://doi.org/10.4132/KoreanJPathol.2009.43.4.358
  • 4,868 View
  • 97 Download
  • 6 Crossref
AbstractAbstract PDF
Glomus tumors are mesenchymal neoplasms usually developing in the dermis or subcutis of the extremities. The majority of glomus tumors are entirely benign, and malignant glomus tumors are very rare, especially those arising in the visceral organs. Here, we are presenting two cases of malignant glomus tumor, initially diagnosed in the stomach by endoscopic biopsy. Case 1 was found in the stomach, right kidney, brain and humerus of a 65-year-old woman, and Case 2 in the stomach and liver of a 63-year-old man. Histologically, the tumor was composed of solid sheets and nests of round and short-spindle shaped tumor cells with vesicular nucleus and prominent nucleolus. The tumor cells were closely admixed with blood vessels of varying size. Immunohistochemically, the tumor cells showed diffuse and strong positive staining for smooth muscle actin and paranuclear, dot-like staining for synaptophysin, but negative for desmin, c-kit, CD34 and S-100 protein. These two are rare cases of a malignant glomus tumor with widespread metastases.

Citations

Citations to this article as recorded by  
  • Malignant gastric glomus tumor with heterochronous liver metastases: a case report and review of the literature
    Shining Xu, Teng Xu, Yihao Zhi, Feng Dong, Chao Wu, Minhua Zheng
    Journal of Medical Case Reports.2025;[Epub]     CrossRef
  • Clinicopathologic features of gastric glomus tumor: A report of 15 cases and literature review
    Minying Deng, Rongkui Luo, Jie Huang, Yuanlong Luo, Qi Song, Huaiyu Liang, Chen Xu, Wei Yuan, Yingyong Hou
    Pathology and Oncology Research.2023;[Epub]     CrossRef
  • Glomus Tumor of the Stomach: A Systematic Review and Illustrative Case Report
    Andrea Pansa, Laura Samà, Laura Ruspi, Federico Sicoli, Ferdinando Carlo Maria Cananzi, Vittorio Quagliuolo
    Digestive Diseases.2023; 41(1): 17.     CrossRef
  • Locally Advanced Glomus Tumor of the Stomach With Synchronous Liver Metastases: Case Report and Literature Review
    Fabio Frosio, Carmine Petruzziello, Elia Poiasina, Michele Pisano, Alessandro Lucianetti
    Cureus.2023;[Epub]     CrossRef
  • Gastric Glomus Tumor: A Clinicopathologic and Immunohistochemical Study of 21 Cases
    Jun Lin, Juan Shen, Hao Yue, Qiongqiong Li, Yuqing Cheng, Mengyun Zhou, Yujiang Fang
    BioMed Research International.2020;[Epub]     CrossRef
  • Malignant glomus tumor of the gastric antrum with hepatic metastases: a case report and literature review
    Adina A. Bodolan, Rebecca Wilcox, Michelle X. Yang
    Human Pathology: Case Reports.2018; 14: 81.     CrossRef
Original Articles
Expression of Survivin in Gastric Carcinoma and its Relation to Tumor Cell Proliferation and Apoptosis.
Wan Sik Lee, Sung Bum Cho, Jong Sun Rew, Jae Hyuk Lee, Chang Soo Park, Young Eun Joo
Korean J Pathol. 2009;43(4):329-334.
DOI: https://doi.org/10.4132/KoreanJPathol.2009.43.4.329
  • 4,136 View
  • 43 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Survivin, a novel antiapoptotic gene has been linked with tumor development and progression in various human carcinomas including gastric carcinomas. The aim of this study was to evaluate the expression of survivin in gastric carcinoma and its correlation with tumor cell proliferation and apoptosis. METHODS: Expression of survivin was evaluated immunohistochemically in 84 surgically resected gastric carcinomas. Tumor cell apoptosis was evaluated with terminal deoxynucleotidyl transferase (TdT) mediated deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL), and Ki-67 immunostaining was used for evaluation of tumor cell proliferation. RESULTS: Expression of survivin was noted in 53.6% of the gastric carcinomas, and was significantly associated with depth of invasion, status of lymph node metastasis or tumor stage (p=0.022, 0.034, 0.040, respectively). There was an inverse correlation between survivin expression and apoptotic index (p=0.015). But there was no significant correlation between survivin expression and Ki-67 labeling index (p=0.430). CONCLUSIONS: These results suggest that survivin expression may contribute to tumor development and progression by inhibiting apoptosis in human gastric carcinoma.

Citations

Citations to this article as recorded by  
  • Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression
    SOO-AH KIM, RAN HONG
    Oncology Letters.2014; 7(5): 1589.     CrossRef
Prognostic Significance of Thymosin- 4 in Gastric Adenocarcinoma Patients.
Lucia Kim, Ye Ji Kim, Suk Jin Choi, In Suh Park, Jee Young Han, Young Chae Chu, Joon Mee Kim
Korean J Pathol. 2007;41(3):176-182.
  • 2,210 View
  • 23 Download
AbstractAbstract PDF
Background
: Thymosin- 4 is an actin-sequestering protein that regulates actin polymerization. It is known to be associated with cell migration, angiogenesis and wound healing, as well as with tumor metastasis.
Methods
: We immunohistochemically evaluated the thymosin- 4 expression in gastric adenocarcinoma specimens, the relationship between this protein and the pathologic features and other tumor-related proteins, and its influence on the patient outcome.
Results
: We demonstrated that 40 specimens (26.3%) of 152 gastric adenocarcinomas showed positivity for thymosin- 4. The thymosin- 4 expression was statistically associated with advanced tumor stage (p=0.010), the nodal stage (p=0.029), the TNM stage (p=0.008), and the presence of lymphovascular invasion (p=0.009). The thymosin- 4 protein expression was closely related to the positivity for VEGF (p=0.000), c-Myc (p=0.007), and cyclin D1 (p=0.005), but it was not associated with the E-cadherin (p=0.861) or -catenin (p=0.640) expressions. The median survival and disease relapse time of patients showing thymosin-4 immunoreactivity were statistically shorter than those of patients without expression. Multivariate analysis showed that the tumor stage (p=0.003), nodal stage (p=0.005), thymosin- 4 expression (p=0.019) and Lauren's classification (p=0.037) were statistically important prognostic factors for gastric adenocarcinomas.
Conclusions
: The thymosin- 4 expression might be associated with disease progression of gastric adenocarcinomas and it should be regarded as an important prognostic factor for estimating patient survival.
The Correlation between the Proliferative Activity in Biopsied Specimen of Gastric Adenocarcinoma and the Pathologic Findings of Resected Specimen.
Hye Sun Kim, Jae Bok Lee, Se Min Kim, Jong Sang Choi, Han Kyeom Kim
Korean J Pathol. 1997;31(3):211-218.
  • 2,064 View
  • 17 Download
AbstractAbstract PDF
Studies on the correlation between proliferative activity of biopsied specimen and pathologic findings of resected specimen have been carried out to find the prognostic factors. To estimate the proliferative activity, 100 cases of biopsied specimen of gastric adenocarcinoma were tested for the PCNA (proliferating cell nuclear antigen) and the AgNOR (argyrophilic nucleolar organizer region) by the immunohistochemical and histochemical stainings, respectively. The resected tumors classified by histologic type, differentiation, depth of invasion, and nodal metastatic status were followed by cell cycle analysis using flow cytometry. The PCNA LI (labelling index) were higher in well or moderately differentiated tumors (P<0.01) than the poorly differentiated ones and the aneuploid tumors (P<0.05) more than in diploid ones. However, there were no correlations among histologic types, depth of invasion, nodal metastatic status and PCNA LI. The AgNOR counts were higher in advanced tumor than in the EGC (early gastric cancer) (P<0.01). In cases with nodal metastasis, most of them showed the AgNOR counts higher than those without nodal metastasis. There were no correlations between the AgNOR counts and the DNA ploidy, histologic type, or differentiation. High PCNA LI and high AgNOR counts were shown in cases with advanced tumors (P=0.000) and nodal metastasis (P<0.05). No correlation was shown with the histologic type or differentiation. The results show that proliferative activity of the biopsied specimen of gastric adenocarcinoma is correlated with the differentiation and the invasion depth of resected specimen. Especially, better correlation is obtained by analyzing both the PCNA LI and the AgNOR counts than by analyzing each.
Case Report
Carcinosarcoma and Multiple Early Gastric Carcinomas of the Stomach.
Won Mee Lee, Young Ha Oh, Moon Hyang Park, Kwang Su Lee, Jung Dal Lee
Korean J Pathol. 1997;31(3):252-256.
  • 1,917 View
  • 13 Download
AbstractAbstract PDF
We report a rare case of carcinosarcoma arising in the stomach. The tumor is presented in the posterior wall of the gastric lower body and antrum of a 56-year-old man. Grossly the tumor has polypoid appearance with diffuse surface ulceration and measures 5.5 cm in diameter. The tumor is accompanied with three separate well differentiated early gastric adenocarcinomas (two EGC type IIc & IIa). Microscopically, the tumor consists of moderately well differentiated adenocarcinoma in the periphery, and lobulated sarcomatous areas in the center, which shows chondroid differentiation. Transitional areas between adenocarcinoma and chondrosarcoma are evident. Immunohistochemical studies show positivity for cytokeratin and carcinoembryonic antigen in the epithelial component, and for vimentin and S-100 in the sarcomatous component. The transitional areas are positive in carcinoembryonic antigen, vimentin, S-100, and cytokeratin. The tumor extended to the subserosa and showed metastasis of only adenocarcinomatous component in six out of 47 dissected perigastric lymph nodes.
Original Articles
Genetic Expression Pattern of Gastric Carcinomas According to Cellular Mucin Phenotypes.
Won Ae Lee, In Soo Suh, Ying Hua Li, Ji Hyun Eum, Wan Sik Yu, Han Ik Bae
Korean J Pathol. 2007;41(5):307-315.
  • 2,142 View
  • 16 Download
AbstractAbstract PDF
BACKGROUND
Gastric carcinomas (GCs) have recently been reclassified according to the mucin phenotypes. We aimed to characterize the relationship between the mucin phenotypes and the genetic alterations or the clinicopathologic parameters of GCs.
METHODS
Immunohistochemistry was performed for MUC1, MUC5AC, MUC6, MUC2, CD10, p53, hMLH1, CerbB2 and E-cadherin in 150 GCs. The mucin phenotypes of the GCs were classified as 4 phenotypes: gastric, intestinal, mixed and unclassified.
RESULTS
MUC1, MUC5AC, MUC6, MUC2 and CD10 were expressed in 63.3%, 42.7%, 14.0%, 24.7% and 14.0% of the GCs, respectively. The mucin phenotypes of the GCs corresponded to the gastric type in 31.3%, the intestinal type in 20.0%, the mixed type in 15.3% and the unclassified type in 33.3%. The incidence of a p53 overexpression was higher in the gastric or mixed phenotype than in the intestinal or unclassified phenotype. MUC5AC expression, p53 overexpression and the gastric or mixed phenotype were associated with poor patient survival by multivariate analysis.
CONCLUSION
This study suggests the gastric or mixed mucin phenotype may more likely go through the p53 pathway in carcinogenesis and the mucin phenotype may be considered as a prognostic indicator.
Gastric Lymphoid Follicles in Helicobacter Pylori Infection: Frequency, Distribution and Relationship to Inflammation in 331 Gastric Biopsy Material.
Kyoung Mee Kim, Anhi Lee, Sang In Shim, Hyun Suk Chae
Korean J Pathol. 1995;29(4):442-449.
  • 2,590 View
  • 24 Download
AbstractAbstract PDF
Helicobacter pylori(H. pylori) infection is considered the most important cause of chronic active gastritis and peptic ulcer. To determine the prevalence, distribution and it's relationship to degree of inflammation, gastric biopsy specimens were obtained from 331 nonulcer dyspepsia(NUD) patients consisting of 52 H. pylori negative normal volunteers and 279 H. pylori infected patients. Lymphoid follicles, degree of acute and chronic inflammation(Grade 0 to 3), and degree of H. pylori(Grade 0 to 4) were observed. The prevalence of H. pylori in NUD was 84.29%. The lymphoid follicles were found in 138 patients(41.7%) and only 5 patients(l.5%) without H. pylori showed lymphoid follicles. There was strong a relationship between lymphoid follicles and degree of acute and chronic inflammation and intensity of H. pylori infection(P<0.001). Acute and chronic inflammation were more serious in the antrum than body in H. pylori infected patients. There was no relationship between lymphoid follicles and the site in the stomach of H. pylori infection(P<0.078), but the body portion had an increased frequency of lymphoid follicles compared to the in antrum. Our results indicate that the prevalence of H. pylori infection in Korea is higher than in Western people and the degree of acute and chronic inflammation are strongly correlated with the presence of lymphoid follicles. The lymphoid follicles are believed to be absent from the normal stomach and their presence is strongly associated with H. pylori infection. The fact there is an that increased frequency of lymphoid follicles in H. pylori infected patients, and that they are more prevalent in the body of the antrum, support the concept that H. pylori may be a precursor in the development of primary gastric lymphoma.
The Prognostic Significance of p53 Protein and PCNA in Advanced Gastric Carcinoma.
Ho Won Hwang, Hyung Bae Moon
Korean J Pathol. 1995;29(4):450-458.
  • 1,919 View
  • 15 Download
AbstractAbstract PDF
The 5 year-survival rates were examined to evaluate the prognositic significance of the expression of the p53 protein and the positivity of the PCNA in 108 cases of advanced gastric carcinoma. The p53 protein and PCNA were stained by immunohistochemistry in the tissue of the gastrectomized specimen. The results were as follows. 1) The overall 5 year-survival rate of advanced gastric carcinoma was 42.3 % and the significant prognostic factors were a pathologic stage and p53 protein(p<0.005). 2) The expanding or infiltrating type by Ming's classification and the intestinal or difftise type by Lauren's classification had similar prognosis. 514_ @@l %R-t 3) The 5 year-survival rate of the p53-positive group was 25.1% and that of p53-negative group was 56.1%(p<0.005). 4) The 5 year-survival rate of the PCNA low-grade tumors by PCNA stain(<50%)was 48.7% and that of the high-grade tumor(>=50%)was 29.9%(p>0.1). 5) There was a tendency to have a good prognosis in the p53-negative group and low grade tumors in the stage 11, III, and IV. There was a significant difference between p53 protein positive and negative groups in the stage III(p<0.005), but no significant differences were found in the other groups. The above results indicate that the p53 protein is an another useful tool for prediction of the prognosis in advanced gastric carcinoma.
Case Reports
Placental Metastais of Maternal Gastric Adenocarcinoma: A case report.
Hye Seung Lee, Young Ah Kim, Chong Jai Kim, Je Geun Chi
Korean J Pathol. 1999;33(3):214-216.
  • 2,042 View
  • 15 Download
AbstractAbstract PDF
Metastasis of a maternal neoplasm to the products of conception is extremely rare. About 50% of the reported cases were not examined grossly or had no grossly visible tumor deposit. A case of placental micrometastasis of gastric adenocarcinoma in a 28-year-old woman is presented. Artificial termination was performed in 22 weeks of gestation and a female fetus weighing 440 gm was delivered. The placenta weighed 220 gm and was grossly normal. Microscopic examination revealed a small number of micrometastasis scattered in the intervillous space.
Adenocarcinoma with Yolk Sac Tumor of the Stomach: Case Report with Review of the Literature and an Immunohistochemical Study.
Ran Hong, Chae Hong Suh, Mi Ja Lee
Korean J Pathol. 2007;41(5):352-357.
  • 2,101 View
  • 16 Download
AbstractAbstract PDF
Gastric yolk sac tumors are extremely rare with only a few cases reported in the literature. Here, we present the case of a 50-year-old man with an adenocarcinoma and a yolk sac tumor of the stomach, without metastasis to the lymph nodes. The tumor was an early gastric carcinoma confined to the submucosa. Twelve months post-operation the patient was alive with no complications. The yolk sac tumor showed positive labeling for alpha-fetoprotein (AFP), alpha1-antitrypsin (alpha1-AT), cytokeratin (CK) and carcinoembryonic antigen (CEA), but was negative for human chorionic gonadotrophin (hCG), placental alkaline phosphatase (PLAP), epithelial membrane antigen (EMA) and p53. The adenocarcinoma was positive for alpha1-AT, CK, EMA, and CEA, but was negative for AFP, hCG, PLAP, and p53. These findings suggest that the yolk sac tumor and the adenocarcinoma components are closely related and may represent distinct phenotypes that arise from a common mucosal epithelial cell.
Coexisting Adenocarcinoma and Epithelioid Leiomyosarcoma of Stomach: A case report.
Jung Youn Kim, Jae Soo Koh, Kyung Ja Cho, Ja June Jang
Korean J Pathol. 1995;29(4):521-523.
  • 2,050 View
  • 17 Download
AbstractAbstract PDF
We report a case of malignant tumor of the stomach showing both carcinoma and sarcoma components in a 47 year-old woman. The resected stomach revealed two tumors which were in different location. The one mass was a 2 x I cm, poorly demarcated tumor at the body, along the lesser curvature and the other was a 6 x 7 cm, well demarcated polypoid tumor with a central depression at cardia of the posterior stomach wall. The tumor at the body was a poorly differentiated adenocarcinoma which showed strong reactivity for CEA. The tumor at the cardia was composed of epithelioid or spindle shaped cells with abundant eosinophilic cytoplasm and revealed 5-6 mitoses per ten high power field. The tumor at the cardia was diagnosed as epithelioid leiomyosarcoma and showed reactivity for vimentin but none for actin, desmin,keratin, and CEA. This is different from the usual carcinosarcoma.
Original Articles
Inflammatory Gastric Adenocarcinoma with Neutrophil Leukcytosis.
Eon Sub Park, Yong Il Kim
Korean J Pathol. 1993;27(2):195-197.
  • 2,264 View
  • 17 Download
AbstractAbstract PDF
A 36-year-old man received a subtotal gastrectomy for Borrmann type 2 advanced carcinoma in the antrum of the posterior well. Preoperatively, peripheral white blood cell count was 16,400/mn3 with 80% of neutrophils. Microscopically, the tumor was of a poorly differentiated adeocarcinoma with intense eutrophilic infiltration which was totally confined within the neoplastic portion and in the metastatic focus in the regional lympho nodes. Repeated postoperative whits blood cell counts dropped down to the normal level. Neither infectious nor knowledge, this is the first case of gastric carcinoma with massive neutrophilic stromal reaction(inflammatory carcinoma) and leukocytosis in the literature in the korea.
Caspase 3 and Ki-67 Immunoreactivity and Its Correlation with Frequency of Apoptosis in Gastric Adenomas and Carcinomas.
Jin Hee Sohn, Seoung Wan Chae, Kyung Chan Choi, Hyung Sik Shin
Korean J Pathol. 2001;35(4):286-290.
  • 2,083 View
  • 27 Download
AbstractAbstract PDF
BACKGROUND
Apoptosis, also known as programmed cell death, is under genetic control and is mediated by apoptosis-specific genes, certain oncogenes and tumor suppressor genes. Caspase 3, a group of cystein proteases, is involved in the induction of apoptosis and has been considered to be correlated with apoptosis. Therefore, we tried to define whether caspase 3 is expressed in gastric adenoma and carcinoma, and correlated with apoptosis.
METHODS
The apoptotic index and caspase 3 and Ki-67 immunoreactivity were observed in 25 gastric adenomas, 31 early gastric carcinomas (EGC) and 64 advanced gastric carcinomas (AGC) by in situ labelling and immunohistochemistry. RESULTS: The mean number of apoptotic bodies and caspase 3 immunoreactivity were significantly increased from adenoma through EGC to AGC. Ki-67 immunoreactivity was more increased in AGC than in adenoma and EGC. And the number of apoptotic bodies were positively correlated with caspase 3 and Ki-67 immunoreactivity, and caspase 3 immunoreactivity was negatively correlated with Ki-67 immunoreactivity even though they were statistically insignificant.
CONCLUSIONS
Our results suggest that caspase 3 activation is important for inducing apoptosis, and both caspase 3 and apoptosis are increased along the tumor progression.

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP